Nitric Oxide and Peroxynitrite in Health and Disease

References

• 1. Abdelkarim GE, Gertz K, Harms C, Katchanov J, Dirnagl U, Szabo C, Endres MProtective effects of PJ34, a novel, potent inhibitor of poly(ADP-ribose) polymerase (PARP) in in vitro and in vivo models of stroke. Int J Mol Med. 2001;7:255–260.[PubMed][Google Scholar]
• 2. Abe K, Aoki M, Kawagoe J, Yoshida T, Hattori A, Kogure K, Itoyama Y. Ischemic delayed neuronal death. A mitochondrial hypothesis. Stroke. 1995;26:1478–1489.[PubMed]
• 3. Abe K, Pan LH, Watanabe M, Kato T, Itoyama YInduction of nitrotyrosine-like immunoreactivity in the lower motor neuron of amyotrophic lateral sclerosis. Neurosci Lett. 1995;199:152–154.[PubMed][Google Scholar]
• 4. Abe K, Pan LH, Watanabe M, Konno H, Kato T, Itoyama YUpregulation of protein-tyrosine nitration in the anterior horn cells of amyotrophic lateral sclerosis. Neurol Res. 1997;19:124–128.[PubMed][Google Scholar]
• 5. Abou-Mohamed G, Johnson JA, Jin L, El-Remessy AB, Do K, Kaesemeyer WH, Caldwell RB, Caldwell RWRoles of superoxide, peroxynitrite, and protein kinase C in the development of tolerance to nitroglycerin. J Pharmacol Exp Ther. 2004;308:289–299.[PubMed][Google Scholar]
• 6. Acarin L, Peluffo H, Barbeito L, Castellano B, Gonzalez BAstroglial nitration after postnatal excitotoxic damage: correlation with NO sources, cytoskeletal, apoptotic and antioxidant proteins. J Neurotrauma. 2005;22:189–200.[PubMed][Google Scholar]
• 7. Adler A, Messina E, Sherman B, Wang Z, Huang H, Linke A, Hintze THNAD(P)H oxidase-generated superoxide anion accounts for reduced control of myocardial O₂ consumption by NO in old Fischer 344 rats. Am J Physiol Heart Circ Physiol. 2003;285:H1015–H1022.[PubMed][Google Scholar]
• 8. Ago T, Kitazono T, Kuroda J, Kumai Y, Kamouchi M, Ooboshi H, Wakisaka M, Kawahara T, Rokutan K, Ibayashi S, Iida MNAD(P)H oxidases in rat basilar arterial endothelial cells. Stroke. 2005;36:1040–1046.[PubMed][Google Scholar]
• 9. Ahn B, Ohshima HSuppression of intestinal polyposis in Apc-(Min/+) mice by inhibiting NO production. Cancer Res. 2001;61:8357–8360.[PubMed][Google Scholar]
• 10. Akhand AA, Pu M, Senga T, Kato M, Suzuki H, Miyata T, Hamaguchi M, Nakashima INO controls src kinase activity through a sulfhydryl group modification-mediated Tyr-527-independent and Tyr-416-linked mechanism. J Biol Chem. 1999;274:25821–25826.[PubMed][Google Scholar]
• 11. Akizuki E, Akaike T, Okamoto S, Fujii S, Yamaguchi Y, Ogawa M, Maeda HRole of NO and superoxide in acute cardiac allograft rejection in rats. Proc Soc Exp Biol Med. 2000;225:151–159.[PubMed][Google Scholar]
• 12. Albertini M, Lafortuna CL, Ciminaghi B, Mazzola S, Clement MGEndothelin involvement in respiratory centre activity. Prostaglandins Leukot Essent Fatty Acids. 2001;65:157–163.[PubMed][Google Scholar]
• 13. Allen DA, Harwood S, Varagunam M, Raftery MJ, Yaqoob MMHigh glucose-induced oxidative stress causes apoptosis in proximal tubular epithelial cells and is mediated by multiple caspases. FASEB J. 2003;17:908–910.[PubMed][Google Scholar]
• 14. Altug S, Demiryurek AT, Kane KA, Kanzik IEvidence for the involvement of peroxynitrite in ischaemic preconditioning in rat isolated hearts. Br J Pharmacol. 2000;130:125–131.[Google Scholar]
• 15. Alvarez B, Demicheli V, Duran R, Trujillo M, Cervenansky C, Freeman BA, Radi RInactivation of human Cu,Zn SOD by peroxynitrite and formation of histidinyl radical. Free Radic Biol Med. 2004;37:813–822.[PubMed][Google Scholar]
• 16. Alvarez B, Radi RPeroxynitrite reactivity with amino acids and proteins. Amino Acids. 2003;25:295–311.[PubMed][Google Scholar]
• 17. Alvarez S, Boveris AMitochondrial NO metabolism in rat muscle during endotoxemia. Free Radic Biol Med. 2004;37:1472–1478.[PubMed][Google Scholar]
• 18. Ambs S, Merriam WG, Bennett WP, Felley-Bosco E, Ogunfusika MO, Oser SM, Klein S, Shields PG, Billiar TR, Harris CCFrequent NO synthase-2 expression in human colon adenomas: implication for tumor angiogenesis and colon cancer progression. Cancer Res. 1998;58:334–341.[PubMed][Google Scholar]
• 19. Ambs S, Merriam WG, Ogunfusika MO, Bennett WP, Ishibe N, Hussain SP, Tzeng EE, Geller DA, Billiar TR, Harris CCp53 and vascular endothelial growth factor regulate tumor growth of NOS2-expressing human carcinoma cells. Nat Med. 1998;4:1371–1376.[PubMed][Google Scholar]
• 20. Andersen JKOxidative stress in neurodegeneration: cause or consequence? Nat Med. 2004;10(Suppl):S18–S25.[PubMed][Google Scholar]
• 21. Anderson KEHuntington’s disease and related disorders. Psychiatr Clin North Am. 2005;28:275–290.[PubMed][Google Scholar]
• 22. Andrekopoulos C, Zhang H, Joseph J, Kalivendi S, Kalyanaraman BBicarbonate enhances alpha-synuclein oligomerization and nitration: intermediacy of carbonate radical anion and nitrogen dioxide radical. Biochem J. 2004;378:435–447.[Google Scholar]
• 23. Andreone TL, O’Connor M, Denenberg A, Hake PW, Zingarelli BPoly(ADP-ribose) polymerase-1 regulates activation of activator protein-1 in murine fibroblasts. J Immunol. 2003;170:2113–2120.[PubMed][Google Scholar]
• 24. Anversa P, Nadal-Ginard BMyocyte renewal and ventricular remodelling. Nature. 2002;415:240–243.[PubMed][Google Scholar]
• 25. Anversa P, Puntillo E, Nikitin P, Olivetti G, Capasso JM, Sonnenblick EHEffects of age on mechanical and structural properties of myocardium of Fischer 344 rats. Am J Physiol Heart Circ Physiol. 1989;256:H1440–H1449.[PubMed][Google Scholar]
• 26. Anversa P, Puntillo E, Olivetti G, Sonnenblick EH, Capasso JMLoad dependence of myocardial growth during maturation and aging. G Ital Cardiol. 1989;19:330–342.[PubMed][Google Scholar]
• 27. Aoyama K, Matsubara K, Fujikawa Y, Nagahiro Y, Shimizu K, Umegae N, Hayase N, Shiono H, Kobayashi SNitration of manganese superoxide dismutase in cerebrospinal fluids is a marker for peroxynitrite-mediated oxidative stress in neurodegenerative diseases. Ann Neurol. 2000;47:524–527.[PubMed][Google Scholar]
• 28. Ara J, Przedborski S, Naini AB, Jackson-Lewis V, Trifiletti RR, Horwitz J, Ischiropoulos HInactivation of tyrosine hydroxylase by nitration following exposure to peroxynitrite and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Proc Natl Acad Sci USA. 1998;95:7659–7663.[Google Scholar]
• 29. Armstrong JSMitochondrial membrane permeabilization: the sine qua non for cell death. Bioessays. 2006;28:253–260.[PubMed][Google Scholar]
• 30. Arstall MA, Sawyer DB, Fukazawa R, Kelly RACytokine-mediated apoptosis in cardiac myocytes: the role of inducible NO synthase induction and peroxynitrite generation. Circ Res. 1999;85:829–840.[PubMed][Google Scholar]
• 31. Arteel GE, Briviba K, Sies HProtection against peroxynitrite. FEBS Lett. 1999;445:226–230.[PubMed][Google Scholar]
• 32. Artz JD, Schmidt B, McCracken JL, Marletta MAEffects of nitroglycerin on soluble guanylate cyclase: implications for nitrate tolerance. J Biol Chem. 2002;277:18253–18256.[PubMed][Google Scholar]
• 33. Aslan M, Ozben TReactive oxygen and nitrogen species in Alzheimer’s disease. Curr Alzheimer Res. 2004;1:111–119.[PubMed][Google Scholar]
• 34. Augusto O, Bonini MG, Amanso AM, Linares E, Santos CC, De Menezes SLNitrogen dioxide and carbonate radical anion: two emerging radicals in biology. Free Radic Biol Med. 2002;32:841–859.[PubMed][Google Scholar]
• 35. Aulak KS, Miyagi M, Yan L, West KA, Massillon D, Crabb JW, Stuehr DJProteomic method identifies proteins nitrated in vivo during inflammatory challenge. Proc Natl Acad Sci USA. 2001;98:12056–12061.[Google Scholar]
• 36. Aydin A, Orhan H, Sayal A, Ozata M, Sahin G, Isimer AOxidative stress and nitric oxide related parameters in type II diabetes mellitus: effects of glycemic control. Clin Biochem. 2001;34:65–70.[PubMed][Google Scholar]
• 37. Azevedo LC, Pedro MA, Souza LC, de Souza HP, Janiszewski M, da Luz PL, Laurindo FROxidative stress as a signaling mechanism of the vascular response to injury: the redox hypothesis of restenosis. Cardiovasc Res. 2000;47:436–445.[PubMed][Google Scholar]
• 38. Bachmaier K, Neu N, Yeung RS, Mak TW, Liu P, Penninger JMGeneration of humanized mice susceptible to peptide-induced inflammatory heart disease. Circulation. 1999;99:1885–1891.[PubMed][Google Scholar]
• 39. Bachschmid M, Thurau S, Zou MH, Ullrich VEndothelial cell activation by endotoxin involves superoxide/NO-mediated nitration of prostacyclin synthase and thromboxane receptor stimulation. FASEB J. 2003;17:914–916.[PubMed][Google Scholar]
• 40. Bachschmid M, van der Loo B, Schuler K, Labugger R, Thurau S, Eto M, Kilo J, Holz R, Luscher TF, Ullrich VOxidative stress-associated vascular aging is independent of the protein kinase C/NAD(P)H oxidase pathway. Arch Gerontol Geriatr. 2004;38:181–190.[PubMed][Google Scholar]
• 41. Bagasra O, Michaels FH, Zheng YM, Bobroski LE, Spitsin SV, Fu ZF, Tawadros R, Koprowski HActivation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis. Proc Natl Acad Sci USA. 1995;92:12041–12045.[Google Scholar]
• 42. Bagi Z, Ungvari Z, Koller AXanthine oxidase-derived reactive oxygen species convert flow-induced arteriolar dilation to constriction in hyperhomocysteinemia: possible role of peroxynitrite. Arterioscler Thromb Vasc Biol. 2002;22:28–33.[PubMed][Google Scholar]
• 43. Bagnasco P, MacMillan-Crow LA, Greendorfer JS, Young CJ, Andrews L, Thompson JAPeroxynitrite modulates acidic fibroblast growth factor (FGF-1) activity. Arch Biochem Biophys. 2003;419:178–189.[PubMed][Google Scholar]
• 44. Bai P, Mabley JG, Liaudet L, Virag L, Szabo C, Pacher PMatrix metalloproteinase activation is an early event in doxorubicin-induced cardiotoxicity. Oncol Rep. 2004;11:505–508.[PubMed][Google Scholar]
• 45. Baines CP, Molkentin JDSTRESS signaling pathways that modulate cardiac myocyte apoptosis. J Mol Cell Cardiol. 2005;38:47–62.[PubMed][Google Scholar]
• 46. Bajt ML, Knight TR, Farhood A, Jaeschke HScavenging peroxynitrite with glutathione promotes regeneration and enhances survival during acetaminophen-induced liver injury in mice. J Pharmacol Exp Ther. 2003;307:67–73.[PubMed][Google Scholar]
• 47. Baker CS, Dutka DP, Pagano D, Rimoldi O, Pitt M, Hall RJ, Polak JM, Bonser RS, Camici PGImmunocytochemical evidence for inducible nitric oxide synthase and cyclooxygenase-2 expression with nitrotyrosine formation in human hibernating myocardium. Basic Res Cardiol. 2002;97:409–415.[PubMed][Google Scholar]
• 48. Baker CS, Frost MT, Rimoldi O, Moore K, Halliwell B, Polak JM, Camici PG, Hall RJRepetitive myocardial stunning in pigs is associated with an increased formation of reactive nitrogen species. Heart. 2002;87:77–78.[Google Scholar]
• 49. Baker CS, Hall RJ, Evans TJ, Pomerance A, Maclouf J, Creminon C, Yacoub MH, Polak JMCyclooxygenase-2 is widely expressed in atherosclerotic lesions affecting native and transplanted human coronary arteries and colocalizes with inducible nitric oxide synthase and nitrotyrosine particularly in macrophages. Arterioscler Thromb Vasc Biol. 1999;19:646–655.[PubMed][Google Scholar]
• 50. Baker PR, Schopfer FJ, Sweeney S, Freeman BARed cell membrane and plasma linoleic acid nitration products: synthesis, clinical identification, and quantitation. Proc Natl Acad Sci USA. 2004;101:11577–11582.[Google Scholar]
• 51. Balaban RS, Nemoto S, Finkel TMitochondria, oxidants, and aging. Cell. 2005;120:483–495.[PubMed][Google Scholar]
• 52. Balafanova Z, Bolli R, Zhang J, Zheng Y, Pass JM, Bhatnagar A, Tang XL, Wang O, Cardwell E, Ping PNitric oxide (NO) induces nitration of protein kinase Cepsilon (PKCepsilon), facilitating PKCepsilon translocation via enhanced PKCepsilon-RACK2 interactions: a novel mechanism of NO-triggered activation of PKCepsilon. J Biol Chem. 2002;277:15021–15027.[PubMed][Google Scholar]
• 53. Ballard RA, Truog WE, Cnaan A, Martin RJ, Ballard PL, Merrill JD, Walsh MC, Durand DJ, Mayock DE, Eichenwald EC, Null DR, Hudak ML, Puri AR, Golombek SG, Courtney SE, Stewart DL, Welty SE, Phibbs RH, Hibbs AM, Luan X, Wadlinger SR, Asselin JM, Coburn CEInhaled nitric oxide in preterm infants undergoing mechanical ventilation. N Engl J Med. 2006;355:343–353.[PubMed][Google Scholar]
• 54. Banan A, Fields JZ, Decker H, Zhang Y, Keshavarzian ANitric oxide and its metabolites mediate ethanol-induced microtubule disruption and intestinal barrier dysfunction. J Pharmacol Exp Ther. 2000;294:997–1008.[PubMed][Google Scholar]
• 55. Banan A, Fields JZ, Zhang Y, Keshavarzian AiNOS upregulation mediates oxidant-induced disruption of F-actin and barrier of intestinal monolayers. Am J Physiol Gastrointest Liver Physiol. 2001;280:G1234–G1246.[PubMed][Google Scholar]
• 56. Banham HAL, Haldane JS, Savage TThe presence post mortem of nitric-oxide-haemoglobin. Br Med J Aug. 1925;1:187–189.[PubMed][Google Scholar]
• 57. Bapat S, Verkleij A, Post JAPeroxynitrite activates mitogen-activated protein kinase (MAPK) via a MEK-independent pathway: a role for protein kinase C. FEBS Lett. 2001;499:21–26.[PubMed][Google Scholar]
• 58. Barbeito LH, Pehar M, Cassina P, Vargas MR, Peluffo H, Viera L, Estevez AG, Beckman JSA role for astrocytes in motor neuron loss in amyotrophic lateral sclerosis. Brain Res. 2004;47:263–274.[PubMed][Google Scholar]
• 59. Barber SC, Mead RJ, Shaw PJOxidative stress in ALS: a mechanism of neurodegeneration and a therapeutic target. Biochim Biophys Acta. In press. [[PubMed]
• 60. Barker JE, Bolanos JP, Land JM, Clark JB, Heales SJGlutathione protects astrocytes from peroxynitrite-mediated mitochondrial damage: implications for neuronal/astrocytic trafficking and neurodegeneration. Dev Neurosci. 1996;18:391–396.[PubMed][Google Scholar]
• 61. Barnes PJ, Ito K, Adcock IMCorticosteroid resistance in chronic obstructive pulmonary disease: inactivation of histone deacetylase. Lancet. 2004;363:731–733.[PubMed][Google Scholar]
• 62. Barnham KJ, Masters CL, Bush AINeurodegenerative diseases and oxidative stress. Nat Rev Drug Discov. 2004;3:205–214.[PubMed][Google Scholar]
• 63. Bar-Shai M, Reznick AZPeroxynitrite induces an alternative NF-kappaB activation pathway in L8 rat myoblasts. Antioxid Redox Signal. 2006;8:639–652.[PubMed][Google Scholar]
• 64. Bartesaghi S, Valez V, Trujillo M, Peluffo G, Romero N, Zhang H, Kalyanaraman B, Radi RMechanistic studies of peroxynitrite-mediated tyrosine nitration in membranes using the hydrophobic probe N-t-BOC-L-tyrosine tert-butyl ester. Biochemistry. 2006;45:6813–6825.[PubMed][Google Scholar]
• 65. Barton CH, Ni Z, Vaziri NDEnhanced nitric oxide inactivation in aortic coarctation-induced hypertension. Kidney Int. 2001;60:1083–1087.[PubMed][Google Scholar]
• 66. Battaini FProtein kinase C isoforms as therapeutic targets in nervous system disease states. Pharmacol Res. 2001;44:353–361.[PubMed][Google Scholar]
• 67. Bayir H, Kochanek PM, Clark RSTraumatic brain injury in infants and children: mechanisms of secondary damage and treatment in the intensive care unit. Crit Care Clin. 2003;19:529–549.[PubMed][Google Scholar]
• 68. Beal MFExcitotoxicity and nitric oxide in Parkinson’s disease pathogenesis. Ann Neurol. 1998;44:S110–S114.[PubMed][Google Scholar]
• 69. Beal MF, Ferrante RJ, Browne SE, Matthews RT, Kowall NW, Brown RH., Jr Increased 3-nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis. Ann Neurol. 1997;42:644–654.[PubMed]
• 70. Becker JS, Adler A, Schneeberger A, Huang H, Wang Z, Walsh E, Koller A, Hintze THHyperhomocysteinemia, a cardiac metabolic disease: role of nitric oxide and the p22phox subunit of NADPH oxidase. Circulation. 2005;111:2112–2118.[PubMed][Google Scholar]
• 71. Beckman JSIschaemic injury mediator. Nature. 1990;345:27–28.[PubMed][Google Scholar]
• 72. Beckman JSOxidative damage and tyrosine nitration from peroxynitrite. Chem Res Toxicol. 1996;9:836–844.[PubMed][Google Scholar]
• 73. Beckman JSPeroxynitrite versus hydroxyl radical: the role of nitric oxide in superoxide-dependent cerebral injury. Ann NY Acad Sci. 1994;738:69–75.[PubMed][Google Scholar]
• 74. Beckman JS. The physiological and pathological chemistry of nitric oxide. In: Lancaster JR, editor. Nitric Oxide: Principles and Actions. Orlando, FL: Academic; 1996. pp. 1–82. [PubMed]
• 75. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BAApparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA. 1990;87:1620–1624.[Google Scholar]
• 76. Beckman JS, Carson M, Smith CD, Koppenol WHALS, SOD and peroxynitrite. Nature. 1993;364:584.[PubMed][Google Scholar]
• 77. Beckman JS, Estevez AG, Crow JP, Barbeito LSuperoxide dismutase and the death of motoneurons in ALS. Trends Neurosci. 2001;24:S15–S20.[PubMed][Google Scholar]
• 78. Beckman JS, Koppenol WHNitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol Cell Physiol. 1996;271:C1424–C1437.[PubMed][Google Scholar]
• 79. Beckman JS, Tsai JHMReactions and diffusion of nitric oxide and peroxynitrite. Biochemist. 1994;16:8–10.[PubMed][Google Scholar]
• 80. Beckman JS, Ye YZ, Anderson PG, Chen J, Accavitti MA, Tarpey MM, White CRExtensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry. Biol Chem Hoppe-Seyler. 1994;375:81–88.[PubMed][Google Scholar]
• 81. Bejma J, Ramires P, Ji LLFree radical generation and oxidative stress with ageing and exercise: differential effects in the myocardium and liver. Acta Physiol Scand. 2000;169:343–351.[PubMed][Google Scholar]
• 82. Beller CJ, Radovits T, Kosse J, Gero D, Szabo C, Szabo GActivation of the peroxynitrite-poly(adenosine diphosphate-ribose) polymerase pathway during neointima proliferation: a new target to prevent restenosis after endarterectomy. J Vasc Surg. 2006;43:824–830.[PubMed][Google Scholar]
• 83. Benkusky NA, Lewis SJ, Kooy NWAttenuation of vascular relaxation after development of tachyphylaxis to peroxynitrite in vivo. Am J Physiol Heart Circ Physiol. 1998;275:H501–H508.[PubMed][Google Scholar]
• 84. Benkusky NA, Lewis SJ, Kooy NWPeroxynitrite-mediated attenuation of alpha- and beta-adrenoceptor agonist-induced vascular responses in vivo. Eur J Pharmacol. 1999;364:151–158.[PubMed][Google Scholar]
• 85. Benton DJ, Moore PKinetics and mechanism of the formation and decay of peroxynitrous acid in perchloric acid solutions. J Chem Soc. 1970:3179–3182.[PubMed][Google Scholar]
• 86. Berger NAPoly(ADP-ribose) in the cellular response to DNA damage. Radiat Res. 1985;101:4–15.[PubMed][Google Scholar]
• 87. Berges A, Van Nassauw L, Bosmans J, Timmermans JP, Vrints CRole of nitric oxide and oxidative stress in ischaemic myocardial injury and preconditioning. Acta Cardiol. 2003;58:119–132.[PubMed][Google Scholar]
• 88. Berkowitz DE, White R, Li D, Minhas KM, Cernetich A, Kim S, Burke S, Shoukas AA, Nyhan D, Champion HC, Hare JMArginase reciprocally regulates nitric oxide synthase activity and contributes to endothelial dysfunction in aging blood vessels. Circulation. 2003;108:2000–2006.[PubMed][Google Scholar]
• 89. Berlett BS, Friguet B, Yim MB, Chock PB, Stadtman ERPeroxynitrite-mediated nitration of tyrosine residues in Escherichia coli glutamine synthetase mimics adenylylation: relevance to signal transduction. Proc Natl Acad Sci USA. 1996;93:1776–1780.[Google Scholar]
• 90. Berlett BS, Levine RL, Stadtman ERCarbon dioxide stimulates peroxynitrite-mediated nitration of tyrosine residues and inhibits oxidation of methionine residues of glutamine synthetase: both modifications mimic effects of adenylylation. Proc Natl Acad Sci USA. 1998;95:2784–2789.[Google Scholar]
• 91. Bertram L, Tanzi REThe genetic epidemiology of neurodegenerative disease. J Clin Invest. 2005;115:1449–1457.[Google Scholar]
• 92. Besson VC, Croci N, Boulu RG, Plotkine M, Marchand-Verrecchia CDeleterious poly(ADP-ribose)polymerase-1 pathway activation in traumatic brain injury in rat. Brain Res. 2003;989:58–66.[PubMed][Google Scholar]
• 93. Besson VC, Margaill I, Plotkine M, Marchand-Verrecchia CDeleterious activation of poly(ADP-ribose)polymerase-1 in brain after in vivo oxidative stress. Free Radic Res. 2003;37:1201–1208.[PubMed][Google Scholar]
• 94. Besson VC, Zsengeller Z, Plotkine M, Szabo C, Marchand-Verrecchia CBeneficial effects of PJ34 and INO-1001, two novel water-soluble poly(ADP-ribose) polymerase inhibitors, on the consequences of traumatic brain injury in rat. Brain Res. 2005;1041:149–156.[PubMed][Google Scholar]
• 95. Beswick RA, Zhang H, Marable D, Catravas JD, Hill WD, Webb RCLong-term antioxidant administration attenuates mineralocorticoid hypertension and renal inflammatory response. Hypertension. 2001;37:781–786.[PubMed][Google Scholar]
• 96. Bevan AL, Zhang H, Li Y, Archard LCNitric oxide and Cox-sackievirus B3 myocarditis: differential expression of inducible nitric oxide synthase in mouse heart after infection with virulent or attenuated virus. J Med Virol. 2001;64:175–182.[PubMed][Google Scholar]
• 97. Bharath S, Andersen JKGlutathione depletion in a midbrain-derived immortalized dopaminergic cell line results in limited tyrosine nitration of mitochondrial complex I subunits: implications for Parkinson’s disease. Antioxid Redox Signal. 2005;7:900–910.[PubMed][Google Scholar]
• 98. Bhattacharya M, Babwah AV, Ferguson SSSmall GTP-binding protein-coupled receptors. Biochem Soc Trans. 2004;32:1040–1044.[PubMed][Google Scholar]
• 99. Bhusate LL, Herbert KE, Scott DL, Perrett DIncreased DNA strand breaks in mononuclear cells from patients with rheumatoid arthritis. Ann Rheum Dis. 1992;51:8–12.[Google Scholar]
• 100. Bianchi C, Wakiyama H, Faro R, Khan T, McCully JD, Levitsky S, Szabo C, Sellke FWA novel peroxynitrite decomposer catalyst (FP-15) reduces myocardial infarct size in an in vivo peroxynitrite decomposer and acute ischemia-reperfusion in pigs. Ann Thorac Surg. 2002;74:1201–1207.[PubMed][Google Scholar]
• 101. Bidmon HJ, Wu J, Buchkremer-Ratzmann I, Mayer B, Witte OW, Zilles KTransient changes in the presence of nitric oxide synthases and nitrotyrosine immunoreactivity after focal cortical lesions. Neuroscience. 1998;82:377–395.[PubMed][Google Scholar]
• 102. Birnboim HC, Lemay AM, Lam DK, Goldstein R, Webb JRCutting edge: MHC class II-restricted peptides containing the inflammation-associated marker 3-nitrotyrosine evade central tolerance and elicit a robust cell-mediated immune response. J Immunol. 2003;171:528–532.[PubMed][Google Scholar]
• 103. Blanchard-Fillion B, Souza JM, Friel T, Jiang GC, Vrana K, Sharov V, Barron L, Schoneich C, Quijano C, Alvarez B, Radi R, Przedborski S, Fernando GS, Horwitz J, Ischiropoulos HNitration and inactivation of tyrosine hydroxylase by peroxynitrite. J Biol Chem. 2001;276:46017–46023.[PubMed][Google Scholar]
• 104. Blough NV, Zafiriou OCReaction of superoxide with nitric oxide to form peroxonitrite in alkaline aqueous solution. Inorg Chem. 1985;24:3502–3504.[PubMed][Google Scholar]
• 105. Blumberg RS, Saubermann LJ, Strober WAnimal models of mucosal inflammation and their relation to human inflammatory bowel disease. Curr Opin Immunol. 1999;11:648–656.[PubMed][Google Scholar]
• 106. Boccini F, Herold SMechanistic studies of the oxidation of oxyhemoglobin by peroxynitrite. Biochemistry. 2004;43:16393–16404.[PubMed][Google Scholar]
• 107. Boczkowski J, Lisdero CL, Lanone S, Samb A, Carreras MC, Boveris A, Aubier M, Poderoso JJEndogenous peroxynitrite mediates mitochondrial dysfunction in rat diaphragm during endotoxemia. FASEB J. 1999;13:1637–1646.[PubMed][Google Scholar]
• 108. Bohle DS, Hansert B, Paulson SC, Smith BDBiomemetic synthesis of the putative cytotoxin peroxynitrite, ONOO−, and its characterization as a tetramethylammonium salt. J Am Chem Soc. 1994;116:7423–7424.[PubMed][Google Scholar]
• 109. Bolaffi JL, Rodd GG, Wang J, Grodsky GMInterrelationship of changes in islet nicotine adeninedinucleotide, insulin secretion, and cell viability induced by interleukin-1 beta. Endocrinology. 1994;134:537–542.[PubMed][Google Scholar]
• 110. Bolanos JP, Almeida ARoles of nitric oxide in brain hypoxiaischemia. Biochim Biophys Acta. 1999;1411:415–436.[PubMed][Google Scholar]
• 111. Bolanos JP, Heales SJ, Land JM, Clark JBEffect of peroxynitrite on the mitochondrial respiratory chain: differential susceptibility of neurones and astrocytes in primary culture. J Neurochem. 1995;64:1965–1972.[PubMed][Google Scholar]
• 112. Bolli R, Jeroudi MO, Patel BS, Aruoma OI, Halliwell B, Lai EK, McCay PB. Marked reduction of free radical generation and contractile dysfunction by antioxidant therapy begun at the time of reperfusion. Evidence that myocardial “stunning” is a manifestation of reperfusion injury. Circ Res. 1989;65:607–622.[PubMed]
• 113. Bolli R, Marban EMolecular and cellular mechanisms of myocardial stunning. Physiol Rev. 1999;79:609–634.[PubMed][Google Scholar]
• 114. Boluyt MO, Converso K, Hwang HS, Mikkor A, Russell MWEchocardiographic assessment of age-associated changes in systolic and diastolic function of the female F344 rat heart. J Appl Physiol. 2004;96:822–828.[PubMed][Google Scholar]
• 115. Bonfoco E, Krainc D, Ankarcrona M, Nicotera P, Lipton SAApoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures. Proc Natl Acad Sci USA. 1995;92:7162–7166.[Google Scholar]
• 116. Bonizzi G, Karin MThe two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol. 2004;25:280–288.[PubMed][Google Scholar]
• 117. Borbely A, Toth A, Edes I, Virag L, Papp JG, Varro A, Paulus WJ, van der Velden J, Stienen GJ, Papp ZPeroxynitrite-induced alpha-actinin nitration and contractile alterations in isolated human myocardial cells. Cardiovasc Res. 2005;67:225–233.[PubMed][Google Scholar]
• 118. Borutaite V, Morkuniene R, Brown GCRelease of cytochrome c from heart mitochondria is induced by high Ca ^{and peroxynitrite and is responsible for Ca -induced inhibition of substrate oxidation.} Biochim Biophys Acta. 1999;1453:41–48.[PubMed][Google Scholar]
• 119. Bosse HM, Bachmann SImmunohistochemically detected protein nitration indicates sites of renal nitric oxide release in Gold-blatt hypertension. Hypertension. 1997;30:948–952.[PubMed][Google Scholar]
• 120. Bossy-Wetzel E, Talantova MV, Lee WD, Scholzke MN, Harrop A, Mathews E, Gotz T, Han J, Ellisman MH, Perkins GA, Lipton SACrosstalk between nitric oxide and zinc pathways to neuronal cell death involving mitochondrial dysfunction and p38-activated K ^channels. Neuron. 2004;41:351–365.[PubMed][Google Scholar]
• 121. Bouchier-Hayes L, Lartigue L, Newmeyer DDMitochondria: pharmacological manipulation of cell death. J Clin Invest. 2005;115:2640–2647.[Google Scholar]
• 122. Boulares AH, Yakovlev AG, Ivanova V, Stoica BA, Wang G, Iyer S, Smulson M. Role of poly(ADP-ribose) polymerase (PARP) cleavage in apoptosis. Caspase 3-resistant PARP mutant increases rates of apoptosis in transfected cells. J Biol Chem. 1999;274:22932–22940.[PubMed]
• 123. Boullerne AI, Petry KG, Meynard M, Geffard MIndirect evidence for nitric oxide involvement in multiple sclerosis by characterization of circulating antibodies directed against conjugated S-nitrosocysteine. J Neuroimmunol. 1995;60:117–124.[PubMed][Google Scholar]
• 124. Boulos M, Astiz ME, Barua RS, Osman MImpaired mitochondrial function induced by serum from septic shock patients is attenuated by inhibition of nitric oxide synthase and poly(ADP-ribose) synthase. Crit Care Med. 2003;31:353–358.[PubMed][Google Scholar]
• 125. Bouloumie A, Bauersachs J, Linz W, Scholkens BA, Wiemer G, Fleming I, Busse REndothelial dysfunction coincides with an enhanced nitric oxide synthase expression and superoxide anion production. Hypertension. 1997;30:934–941.[PubMed][Google Scholar]
• 126. Boulton CL, Southam E, Garthwaite JNitric oxide-dependent long-term potentiation is blocked by a specific inhibitor of soluble guanylyl cyclase. Neuroscience. 1995;69:699–703.[PubMed][Google Scholar]
• 127. Boveris A, Alvarez S, Navarro AThe role of mitochondrial nitric oxide synthase in inflammation and septic shock. Free Radic Biol Med. 2002;33:1186–1193.[PubMed][Google Scholar]
• 128. Boyle EM, Jr, Canty TG, Jr, Morgan EN, Yun W, Pohlman TH, Verrier EDTreating myocardial ischemia-reperfusion injury by targeting endothelial cell transcription. Ann Thorac Surg. 1999;68:1949–1953.[PubMed][Google Scholar]
• 129. Brahn E, Banquerigo ML, Firestein GS, Boyle DL, Salzman AL, Szabo CCollagen induced arthritis: reversal by mercaptoethylguanidine, a novel antiinflammatory agent with a combined mechanism of action. J Rheumatol. 1998;25:1785–1793.[PubMed][Google Scholar]
• 130. Braughler JM, Mittal CK, Murad FEffects of thiols, sugars, and proteins on nitric oxide activation of guanylate cyclase. J Biol Chem. 1979;254:12450–12454.[PubMed][Google Scholar]
• 131. Braunwald E, Kloner RAThe stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation. 1982;66:1146–1149.[PubMed][Google Scholar]
• 132. Brealey D, Brand M, Hargreaves I, Heales S, Land J, Smolenski R, Davies NA, Cooper CE, Singer MAssociation between mitochondrial dysfunction and severity and outcome of septic shock. Lancet. 2002;360:219–223.[PubMed][Google Scholar]
• 133. Bredt DS, Hwang PM, Snyder SHLocalization of nitric oxide synthase indicating a neural role for nitric oxide. Nature. 1990;347:768–770.[PubMed][Google Scholar]
• 134. Bredt DS, Snyder SHNitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proc Natl Acad Sci USA. 1989;86:9030–9033.[Google Scholar]
• 135. Bredt DS, Synder HSIsolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc Natl Acad Sci USA. 1990;87:682–685.[Google Scholar]
• 136. Brennan ML, Wu W, Fu X, Shen Z, Song W, Frost H, Vadseth C, Narine L, Lenkiewicz E, Borchers MT, Lusis AJ, Lee JJ, Lee NA, Abu-Soud HM, Ischiropoulos H, Hazen SLA tale of two controversies: defining both the role of peroxidases in nitrotyrosine formation in vivo using eosinophil peroxidase and myeloperoxidase-deficient mice, and the nature of peroxidase-generated reactive nitrogen species. J Biol Chem. 2002;277:17415–17427.[PubMed][Google Scholar]
• 137. Brito C, Naviliat M, Tiscornia AC, Vuillier F, Gualco G, Dighiero G, Radi R, Cayota AMPeroxynitrite inhibits T lymphocyte activation and proliferation by promoting impairment of tyrosine phosphorylation and peroxynitrite-driven apoptotic death. J Immunol. 1999;162:3356–3366.[PubMed][Google Scholar]
• 138. Brodsky SV, Gealekman O, Chen J, Zhang F, Togashi N, Crabtree M, Gross SS, Nasjletti A, Goligorsky MSPrevention and reversal of premature endothelial cell senescence and vasculopathy in obesity-induced diabetes by ebselen. Circ Res. 2004;94:377–384.[PubMed][Google Scholar]
• 139. Broholm H, Andersen B, Wanscher B, Frederiksen JL, Rubin I, Pakkenberg B, Larsson HB, Lauritzen MNitric oxide synthase expression and enzymatic activity in multiple sclerosis. Acta Neurol Scand. 2004;109:261–269.[PubMed][Google Scholar]
• 140. Brookes PSMitochondrial nitric oxide synthase. Mitochondrion. 2004;3:187–204.[PubMed][Google Scholar]
• 141. Brookes PS, Bolanos JP, Heales SJThe assumption that nitric oxide inhibits mitochondrial ATP synthesis is correct. FEBS Lett. 1999;446:261–263.[PubMed][Google Scholar]
• 142. Brookes PS, Darley-Usmar VMRole of calcium and superoxide dismutase in sensitizing mitochondria to peroxynitrite-induced permeability transition. Am J Physiol Heart Circ Physiol. 2004;286:H39–H46.[PubMed][Google Scholar]
• 143. Brown GCNitric oxide and mitochondrial respiration. Biochim Biophys Acta. 1999;1411:351–369.[PubMed][Google Scholar]
• 144. Brown GCRegulation of mitochondrial respiration by nitric oxide inhibition of cytochrome c oxidase. Biochim Biophys Acta. 2001;1504:46–57.[PubMed][Google Scholar]
• 145. Brown GC, Bal-Price AInflammatory neurodegeneration mediated by nitric oxide, glutamate, and mitochondria. Mol Neurobiol. 2003;27:325–355.[PubMed][Google Scholar]
• 146. Brown GC, Borutaite VInhibition of mitochondrial respiratory complex I by nitric oxide, peroxynitrite and S-nitrosothiols. Biochim Biophys Acta. 2004;1658:44–49.[PubMed][Google Scholar]
• 147. Brown GC, Borutaite VNitric oxide, cytochrome c and mitochondria. Biochem Soc Symp. 1999;66:17–25.[PubMed][Google Scholar]
• 148. Brown GC, Borutaite VNitric oxide, mitochondria, and cell death. IUBMB Life. 2001;52:189–195.[PubMed][Google Scholar]
• 149. Brown TH, Chapman PF, Kairiss EW, Keenan CLLong-term synaptic potentiation. Science. 1988;242:724–728.[PubMed][Google Scholar]
• 150. Brownlee MBiochemistry and molecular cell biology of diabetic complications. Nature. 2001;414:813–820.[PubMed][Google Scholar]
• 151. Bruijn LI, Beal MF, Becher MW, Schulz JB, Wong PC, Price DL, Cleveland DWElevated free nitrotyrosine levels, but not protein-bound nitrotyrosine or hydroxyl radicals, throughout amyotrophic lateral sclerosis (ALS)-like disease implicate tyrosine nitration as an aberrant in vivo property of one familial ALS-linked superoxide dismutase 1 mutant. Proc Natl Acad Sci USA. 1997;94:7606–7611.[Google Scholar]
• 152. Bruijn LI, Miller TM, Cleveland DWUnraveling the mechanisms involved in motor neuron degeneration in ALS. Annu Rev Neurosci. 2004;27:723–749.[PubMed][Google Scholar]
• 153. Brunelli L, Yermilov V, Beckman JSModulation of catalase peroxidatic and catalatic activity by nitric oxide. Free Radic Biol Med. 2001;30:709–714.[PubMed][Google Scholar]
• 154. Brüning GNADPH-diaphorase histochemistry in the postnatal mouse cerebellum suggests specific development functions for nitric oxide. J Neurosci Res. 1993;36:580–587.[PubMed][Google Scholar]
• 155. Bryk R, Griffin P, Nathan CPeroxynitrite reductase activity of bacterial peroxiredoxins. Nature. 2000;407:211–215.[PubMed][Google Scholar]
• 156. Bryk R, Lima CD, Erdjument-Bromage H, Tempst P, Nathan CMetabolic enzymes of mycobacteria linked to antioxidant defense by a thioredoxin-like protein. Science. 2002;295:1073–1077.[PubMed][Google Scholar]
• 157. Buchczyk DP, Grune T, Sies H, Klotz LOModifications of glyceraldehyde-3-phosphate dehydrogenase induced by increasing concentrations of peroxynitrite: early recognition by 20S proteasome. Biol Chem. 2003;384:237–241.[PubMed][Google Scholar]
• 158. Burner U, Furtmüller PG, Kettle AJ, Koppenol WH, Obinger CMechanism of reaction of myeloperoxidase with nitrite. J Biol Chem. 2000;275:20597–20601.[PubMed][Google Scholar]
• 159. Burnett AL, Musicki B, Jin L, Bivalacqua TJNitric oxide/redox-based signalling as a therapeutic target for penile disorders. Expert Opin Ther Targets. 2006;10:445–457.[PubMed][Google Scholar]
• 160. Burney S, Caulfield JL, Niles JC, Wishnok JS, Tannenbaum SRThe chemistry of DNA damage from nitric oxide and peroxynitrite. Mutat Res. 1999;424:37–49.[PubMed][Google Scholar]
• 161. Butler AR, Megson IL, Wright PGDiffusion of nitric oxide and scavenging by blood in the vasculature. Biochim Biophys Acta. 1998;1425:168–176.[PubMed][Google Scholar]
• 162. Butterfield DA, Boyd-Kimball DAmyloid beta-peptide(1–42) contributes to the oxidative stress and neurodegeneration found in Alzheimer disease brain. Brain Pathol. 2004;14:426–432.[PubMed][Google Scholar]
• 163. Butterfield DA, Howard BJ, LaFontaine MABrain oxidative stress in animal models of accelerated aging and the age-related neurodegenerative disorders, Alzheimer’s disease and Huntington’s disease. Curr Med Chem. 2001;8:815–828.[PubMed][Google Scholar]
• 164. Buttery LD, Springall DR, Chester AH, Evans TJ, Standfield EN, Parums DV, Yacoub MH, Polak JMInducible nitric oxide synthase is present within human atherosclerotic lesions and promotes the formation and activity of peroxynitrite. Lab Invest. 1996;75:77–85.[PubMed][Google Scholar]
• 165. Caballero AE, Arora S, Saouaf R, Lim SC, Smakowski P, Park JY, King GL, LoGerfo FW, Horton ES, Veves AMicrovascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes. Diabetes. 1999;48:1856–1862.[PubMed][Google Scholar]
• 166. Cai H, Harrison DGEndothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res. 2000;87:840–844.[PubMed][Google Scholar]
• 167. Cai H, McNally JS, Weber M, Harrison DGOscillatory shear stress upregulation of endothelial nitric oxide synthase requires intracellular hydrogen peroxide and CaMKII. J Mol Cell Cardiol. 2004;37:121–125.[PubMed][Google Scholar]
• 168. Calabrese V, Scapagnini G, Ravagna A, Bella R, Foresti R, Bates TE, Giuffrida Stella AM, Pennisi GNitric oxide synthase is present in the cerebrospinal fluid of patients with active multiple sclerosis and is associated with increases in cerebrospinal fluid protein nitrotyrosine and S-nitrosothiols and with changes in glutathione levels. J Neurosci Res. 2002;70:580–587.[PubMed][Google Scholar]
• 169. Calles-Escandon J, Cipolla MDiabetes and endothelial dysfunction: a clinical perspective. Endocr Rev. 2001;22:36–52.[PubMed][Google Scholar]
• 170. Calo L, Giacon B, Davis PA, Pagnin E, Piccin A, Riegler P, Huber W, Antonello A, Semplicini A. Oxidative stress and TGFbeta in kidney-transplanted patients with cyclosporin-induced hypertension. Effect of carvedilol and nifedipine. Clin Nephrol. 2002;58:103–110.[PubMed]
• 171. Capasso JM, Palackal T, Olivetti G, Anversa PSevere myocardial dysfunction induced by ventricular remodeling in aging rat hearts. Am J Physiol Heart Circ Physiol. 1990;259:H1086–H1096.[PubMed][Google Scholar]
• 172. Cardillo C, Kilcoyne CM, Quyyumi AA, Cannon RO, 3rd, Panza JASelective defect in nitric oxide synthesis may explain the impaired endothelium-dependent vasodilation in patients with essential hypertension. Circulation. 1998;97:851–856.[PubMed][Google Scholar]
• 173. Carri MT, Ferri A, Cozzolino M, Calabrese L, Rotilio GNeurodegeneration in amyotrophic lateral sclerosis: the role of oxidative stress and altered homeostasis of metals. Brain Res Bull. 2003;61:365–374.[PubMed][Google Scholar]
• 174. Carter CA, Kane CJTherapeutic potential of natural compounds that regulate the activity of protein kinase C. Curr Med Chem. 2004;11:2883–2902.[PubMed][Google Scholar]
• 175. Caselli A, Camici G, Manao G, Moneti G, Pazzagli L, Cappugi G, Ramponi GNitric oxide causes inactivation of the low molecular weight phosphotyrosine protein phosphatase. J Biol Chem. 1994;269:24878–24882.[PubMed][Google Scholar]
• 176. Casoni F, Basso M, Massignan T, Gianazza E, Cheroni C, Salmona M, Bendotti C, Bonetto VProtein nitration in a mouse model of familial amyotrophic lateral sclerosis: possible multifunctional role in the pathogenesis. J Biol Chem. 2005;280:16295–16304.[PubMed][Google Scholar]
• 177. Cassina A, Radi RDifferential inhibitory action of nitric oxide and peroxynitrite on mitochondrial electron transport. Arch Biochem Biophys. 1996;328:309–316.[PubMed][Google Scholar]
• 178. Cassina AM, Hodara R, Souza JM, Thomson L, Castro L, Ischiropoulos H, Freeman BA, Radi RCytochrome c nitration by peroxynitrite. J Biol Chem. 2000;275:21409–21415.[PubMed][Google Scholar]
• 179. Cassina P, Peluffo H, Pehar M, Martinez-Palma L, Ressia A, Beckman JS, Estevez AG, Barbeito LPeroxynitrite triggers a phenotypic transformation in spinal cord astrocytes that induces motor neuron apoptosis. J Neurosci Res. 2002;67:21–29.[PubMed][Google Scholar]
• 180. Castegna A, Thongboonkerd V, Klein JB, Lynn B, Markesbery WR, Butterfield DAProteomic identification of nitrated proteins in Alzheimer’s disease brain. J Neurochem. 2003;85:1394–1401.[PubMed][Google Scholar]
• 181. Castillo J, Rama R, Davalos ANitric oxide-related brain damage in acute ischemic stroke. Stroke. 2000;31:852–857.[PubMed][Google Scholar]
• 182. Castro L, Rodriguez M, Radi RAconitase is readily inactivated by peroxynitrite, but not by its precursor, nitric oxide. J Biol Chem. 1994;269:29409–29415.[PubMed][Google Scholar]
• 183. Cayatte AJ, Palacino JJ, Horten K, Cohen RAChronic inhibition of nitric oxide production accelerates neointima formation and impairs endothelial function in hypercholesterolemic rabbits. Arterioscler Thromb. 1994;14:753–759.[PubMed][Google Scholar]
• 184. Ceriello ANew insights on oxidative stress and diabetic complications may lead to a “causal” antioxidant therapy. Diabetes Care. 2003;26:1589–1596.[PubMed][Google Scholar]
• 185. Ceriello ANitrotyrosine: new findings as a marker of postprandial oxidative stress. Int J Clin Pract Suppl. 2002:51–58.[PubMed][Google Scholar]
• 186. Ceriello A, Mercuri F, Quagliaro L, Assaloni R, Motz E, Tonutti L, Taboga CDetection of nitrotyrosine in the diabetic plasma: evidence of oxidative stress. Diabetologia. 2001;44:834–838.[PubMed][Google Scholar]
• 187. Ceriello A, Piconi L, Quagliaro L, Wang Y, Schnabel CA, Ruggles JA, Gloster MA, Maggs DG, Weyer CEffects of pramlintide on postprandial glucose excursions and measures of oxidative stress in patients with type 1 diabetes. Diabetes Care. 2005;28:632–637.[PubMed][Google Scholar]
• 188. Ceriello A, Quagliaro L, Catone B, Pascon R, Piazzola M, Bais B, Marra G, Tonutti L, Taboga C, Motz ERole of hyperglycemia in nitrotyrosine postprandial generation. Diabetes Care. 2002;25:1439–1443.[PubMed][Google Scholar]
• 189. Ceriello A, Quagliaro L, D’Amico M, Di Filippo C, Marfella R, Nappo F, Berrino L, Rossi F, Giugliano DAcute hyperglycemia induces nitrotyrosine formation and apoptosis in perfused heart from rat. Diabetes. 2002;51:1076–1082.[PubMed][Google Scholar]
• 190. Ceriello A, Taboga C, Tonutti L, Quagliaro L, Piconi L, Bais B, Da Ros R, Motz EEvidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia on endothelial dysfunction and oxidative stress generation: effects of short- and long-term simvastatin treatment. Circulation. 2002;106:1211–1218.[PubMed][Google Scholar]
• 191. Cerioni L, Palomba L, Cantoni OThe Raf/MEK inhibitor PD98059 enhances ERK1/2 phosphorylation mediated by peroxynitrite via enforced mitochondrial formation of reactive oxygen species. FEBS Lett. 2003;547:92–96.[PubMed][Google Scholar]
• 192. Cesselli D, Jakoniuk I, Barlucchi L, Beltrami AP, Hintze TH, Nadal-Ginard B, Kajstura J, Leri A, Anversa POxidative stress-mediated cardiac cell death is a major determinant of ventricular dysfunction and failure in dog dilated cardiomyopathy. Circ Res. 2001;89:279–286.[PubMed][Google Scholar]
• 193. Chabrier PE, Auguet M, Spinnewyn B, Auvin S, Cornet S, Demerle-Pallardy C, Guilmard-Favre C, Marin JG, Pignol B, Gillard-Roubert V, Roussillot-Charnet C, Schulz J, Viossat I, Bigg D, Moncada SBN 80933, a dual inhibitor of neuronal nitric oxide synthase and lipid peroxidation: a promising neuroprotective strategy. Proc Natl Acad Sci USA. 1999;96:10824–10829.[Google Scholar]
• 194. Chabrier PE, Demerle-Pallardy C, Auguet MNitric oxide synthases: targets for therapeutic strategies in neurological diseases. Cell Mol Life Sci. 1999;55:1029–1035.[PubMed][Google Scholar]
• 195. Chakraborti T, Das S, Chakraborti SProteolytic activation of protein kinase Calpha by peroxynitrite in stimulating cytosolic phospholipase A₂ in pulmonary endothelium: involvement of a pertussis toxin sensitive protein. Biochemistry. 2005;44:5246–5257.[PubMed][Google Scholar]
• 196. Chakraborty S, Balakotaiah V, Bidani ADiffusing capacity reexamined: relative roles of diffusion and chemical reaction in red cell uptake of. J Appl Physiol. 2004;97 O₂, CO, CO₂, and NO. 2284–2302. [[PubMed][Google Scholar]
• 197. Chandrasekar B, Colston JT, Freeman GLInduction of proinflammatory cytokine and antioxidant enzyme gene expression following brief myocardial ischaemia. Clin Exp Immunol. 1997;108:346–351.[Google Scholar]
• 198. Chang L, Karin MMammalian MAP kinase signalling cascades. Nature. 2001;410:37–40.[PubMed][Google Scholar]
• 199. Chang W, Webster DR, Salam AA, Gruber D, Prasad A, Eiserich JP, Bulinski JCAlteration of the C-terminal amino acid of tubulin specifically inhibits myogenic differentiation. J Biol Chem. 2002;277:30690–30698.[PubMed][Google Scholar]
• 200. Chatterjee PK, Patel NS, Sivarajah A, Kvale EO, Dugo L, Cuzzocrea S, Brown PA, Stewart KN, Mota-Filipe H, Britti D, Yaqoob MM, Thiemermann CGW274150, a potent and highly selective inhibitor of iNOS, reduces experimental renal ischemia/reperfusion injury. Kidney Int. 2003;63:853–865.[PubMed][Google Scholar]
• 201. Chaves AA, Mihm MJ, Schanbacher BL, Basuray A, Liu C, Ayers LW, Bauer JACardiomyopathy in a murine model of AIDS: evidence of reactive nitrogen species and corroboration in human HIV/AIDS cardiac tissues. Cardiovasc Res. 2003;60:108–118.[PubMed][Google Scholar]
• 202. Chavez AM, Menconi MJ, Hodin RA, Fink MPCytokine-induced intestinal epithelial hyperpermeability: role of nitric oxide. Crit Care Med. 1999;27:2246–2251.[PubMed][Google Scholar]
• 203. Chen J, Kuhlencordt P, Urano F, Ichinose H, Astern J, Huang PLEffects of chronic treatment with L-arginine on atherosclerosis in apoE knockout and apoE/inducible NO synthase double-knockout mice. Arterioscler Thromb Vasc Biol. 2003;23:97–103.[PubMed][Google Scholar]
• 204. Chen L, Fuller CM, Kleyman TR, Matalon SMutations in the extracellular loop of alpha-rENaC alter sensitivity to amiloride and reactive species. Am J Physiol Renal Physiol. 2004;286:F1202–F1208.[PubMed][Google Scholar]
• 205. Chen LW, Egan L, Li ZW, Greten FR, Kagnoff MF, Karin MThe two faces of IKK and NF-kappaB inhibition: prevention of systemic inflammation but increased local injury following intestinal ischemia-reperfusion. Nat Med. 2003;9:575–581.[PubMed][Google Scholar]
• 206. Chen M, Ona VO, Li M, Ferrante RJ, Fink KB, Zhu S, Bian J, Guo L, Farrell LA, Hersch SM, Hobbs W, Vonsattel JP, Cha JH, Friedlander RMMinocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease. Nat Med. 2000;6:797–801.[PubMed][Google Scholar]
• 207. Chen T, Zamora R, Zuckerbraun B, Billiar TRRole of nitric oxide in liver injury. Curr Mol Med. 2003;3:519–526.[PubMed][Google Scholar]
• 208. Chen Y, Traverse JH, Du R, Hou M, Bache RJNitric oxide modulates myocardial oxygen consumption in the failing heart. Circulation. 2002;106:273–279.[PubMed][Google Scholar]
• 209. Cheng C, Zochodne DWSensory neurons with activated caspase-3 survive long-term experimental diabetes. Diabetes. 2003;52:2363–2371.[PubMed][Google Scholar]
• 210. Cheng XS, Shimokawa H, Momii H, Oyama J, Fukuyama N, Egashira K, Nakazawa H, Takeshita ARole of superoxide anion in the pathogenesis of cytokine-induced myocardial dysfunction in dogs in vivo. Cardiovasc Res. 1999;42:651–659.[PubMed][Google Scholar]
• 211. Cheung PY, Danial H, Jong J, Schulz RThiols protect the inhibition of myocardial aconitase by peroxynitrite. Arch Biochem Biophys. 1998;350:104–108.[PubMed][Google Scholar]
• 212. Cheung PY, Wang W, Schulz RGlutathione protects against myocardial ischemia-reperfusion injury by detoxifying peroxynitrite. J Mol Cell Cardiol. 2000;32:1669–1678.[PubMed][Google Scholar]
• 213. Chi Q, Wang T, Huang KEffect of insulin nitration by peroxynitrite on its biological activity. Biochem Biophys Res Commun. 2005;330:791–796.[PubMed][Google Scholar]
• 214. Chiarugi APoly(ADP-ribosyl)ation and stroke. Pharmacol Res. 2005;52:15–24.[PubMed][Google Scholar]
• 215. Cho HJ, Xie QW, Calaycay J, Mumford RA, Swiderek KM, Lee TD, Nathan CCalmodulin is a subunit of nitric oxide synthase from macrophages. J Exp Med. 1992;176:599–604.[Google Scholar]
• 216. Choi JW, Yoo BK, Ryu MK, Choi MS, Park GH, Ko KHAdenosine and purine nucleosides prevent the disruption of mitochondrial transmembrane potential by peroxynitrite in rat primary astrocytes. Arch Pharm Res. 2005;28:810–815.[PubMed][Google Scholar]
• 217. Chou SM, Wang HS, Komai KColocalization of NOS and SOD1 in neurofilament accumulation within motor neurons of amyotrophic lateral sclerosis: an immunohistochemical study. J Chem Neuroanat. 1996;10:249–258.[PubMed][Google Scholar]
• 218. Chou SM, Wang HS, Taniguchi ARole of SOD-1 and nitric oxide/cyclic GMP cascade on neurofilament aggregation in ALS/MND. J Neurol Sci. 1996;139(Suppl):16–26.[PubMed][Google Scholar]
• 219. Chung KK, Dawson TM, Dawson VLNitric oxide, S-nitrosylation and neurodegeneration. Cell Mol Biol. 2005;51:247–254.[PubMed][Google Scholar]
• 220. Cleeter MWJ, Cooper JM, Darley-Usmar VM, Moncada S, Schapira AHVReversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide. FEBS Lett. 1994;345:50–54.[PubMed][Google Scholar]
• 221. Clements MK, Siemsen DW, Swain SD, Hanson AJ, Nelson-Overton LK, Rohn TT, Quinn MTInhibition of actin polymerization by peroxynitrite modulates neutrophil functional responses. J Leukoc Biol. 2003;73:344–355.[PubMed][Google Scholar]
• 222. Cobbs CS, Samanta M, Harkins LE, Gillespie GY, Merrick BA, MacMillan-Crow LAEvidence for peroxynitrite-mediated modifications to p53 in human gliomas: possible functional consequences. Arch Biochem Biophys. 2001;394:167–172.[PubMed][Google Scholar]
• 223. Cobbs CS, Whisenhunt TR, Wesemann DR, Harkins LE, Van Meir EG, Samanta MInactivation of wild-type p53 protein function by reactive oxygen and nitrogen species in malignant glioma cells. Cancer Res. 2003;63:8670–8673.[PubMed][Google Scholar]
• 224. Coddington JW, Hurst JK, Lymar SVHydroxyl radical formation during peroxynitrous acid decomposition. J Am Chem Soc. 1999;121:2438–2443.[PubMed][Google Scholar]
• 225. Coma M, Guix FX, Uribesalgo I, Espuna G, Sole M, Andreu D, Munoz FJLack of oestrogen protection in amyloid-mediated endothelial damage due to protein nitrotyrosination. Brain. 2005;128:1613–1621.[PubMed][Google Scholar]
• 226. Compston A, Coles AMultiple sclerosis. Lancet. 2002;359:1221–1231.[PubMed][Google Scholar]
• 227. Connor JR, Manning PT, Settle SL, Moore WM, Jerome GM, Webber RK, Tjoeng FS, Currie MGSuppression of adjuvant-induced arthritis by selective inhibition of inducible nitric oxide synthase. Eur J Pharmacol. 1995;273:15–24.[PubMed][Google Scholar]
• 228. Cooke CL, Davidge STPeroxynitrite increases iNOS through NF-kappaB and decreases prostacyclin synthase in endothelial cells. Am J Physiol Cell Physiol. 2002;282:C395–C402.[PubMed][Google Scholar]
• 229. Cooke JP, Singer AH, Tsao P, Zera P, Rowan RA, Billingham MEAntiatherogenic effects of L-arginine in the hypercholesterolemic rabbit. J Clin Invest. 1992;90:1168–1172.[Google Scholar]
• 230. Coppey LJ, Gellett JS, Davidson EP, Dunlap JA, Lund DD, Salvemini D, Yorek MAEffect of M40403 treatment of diabetic rats on endoneurial blood flow, motor nerve conduction velocity and vascular function of epineurial arterioles of the sciatic nerve. Br J Pharmacol. 2001;134:21–29.[Google Scholar]
• 231. Coppey LJ, Gellett JS, Davidson EP, Dunlap JA, Lund DD, Yorek MAEffect of antioxidant treatment of streptozotocin-induced diabetic rats on endoneurial blood flow, motor nerve conduction velocity, and vascular reactivity of epineurial arterioles of the sciatic nerve. Diabetes. 2001;50:1927–1937.[PubMed][Google Scholar]
• 232. Coppey LJ, Gellett JS, Davidson EP, Yorek MAPreventing superoxide formation in epineurial arterioles of the sciatic nerve from diabetic rats restores endothelium-dependent vasodilation. Free Radic Res. 2003;37:33–40.[PubMed][Google Scholar]
• 233. Corbett JA, Sweetland MA, Wang JL, Lancaster JR, Jr, Mc-Daniel MLNitric oxide mediates cytokine-induced inhibition of insulin secretion by human islets of Langerhans. Proc Natl Acad Sci USA. 1993;90:1731–1735.[Google Scholar]
• 234. Corbett JA, Wang JL, Sweetland MA, Lancaster JR, Jr, Mc-Daniel ML. Interleukin 1 beta induces the formation of nitric oxide by beta-cells purified from rodent islets of Langerhans. Evidence for the beta-cell as a source and site of action of nitric oxide. J Clin Invest. 1992;90:2384–2391.
• 235. Corcoran GB, Bauer JA, Lau TWImmediate rise in intracellular calcium and glycogen phosphorylase a activities upon acetaminophen covalent binding leading to hepatotoxicity in mice. Toxicology. 1988;50:157–167.[PubMed][Google Scholar]
• 236. Cosentino F, Eto M, De Paolis P, van der Loo B, Bachschmid M, Ullrich V, Kouroedov A, Delli Gatti C, Joch H, Volpe M, Luscher TFHigh glucose causes upregulation of cyclooxygenase-2 and alters prostanoid profile in human endothelial cells: role of protein kinase C and reactive oxygen species. Circulation. 2003;107:1017–1023.[PubMed][Google Scholar]
• 237. Cosentino F, Hishikawa K, Katusic ZS, Luscher TFHigh glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells. Circulation. 1997;96:25–28.[PubMed][Google Scholar]
• 238. Coussens LM, Werb ZInflammation and cancer. Nature. 2002;420:860–867.[Google Scholar]
• 239. Cover C, Mansouri A, Knight TR, Bajt ML, Lemasters JJ, Pessayre D, Jaeschke HPeroxynitrite-induced mitochondrial and endonuclease-mediated nuclear DNA damage in acetaminophen hepatotoxicity. J Pharmacol Exp Ther. 2005;315:879–887.[PubMed][Google Scholar]
• 240. Cromheeke KM, Kockx MM, De Meyer GR, Bosmans JM, Bult H, Beelaerts WJ, Vrints CJ, Herman AGInducible nitric oxide synthase colocalizes with signs of lipid oxidation/peroxidation in human atherosclerotic plaques. Cardiovasc Res. 1999;43:744–754.[PubMed][Google Scholar]
• 241. Cross AH, Manning PT, Keeling RM, Schmidt RE, Misko TPPeroxynitrite formation within the central nervous system in active multiple sclerosis. J Neuroimmunol. 1998;88:45–56.[PubMed][Google Scholar]
• 242. Cross AH, Misko TP, Lin RF, Hickey WF, Trotter JL, Tilton RGAminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice. J Clin Invest. 1994;93:2684–2690.[Google Scholar]
• 243. Crouser ED, Julian MW, Weinstein DM, Fahy RJ, Bauer JAEndotoxin-induced ileal mucosal injury and nitric oxide dysregulation are temporally dissociated. Am J Respir Crit Care Med. 2000;161:1705–1712.[PubMed][Google Scholar]
• 244. Crow JP, Beckman JSQuantitation of protein tyrosine, 3-nitrotyrosine, and 3-aminotyrosine utilizing HPCL and intrinsic ultraviolet absorbance. Methods. 1995;7:116–120.[PubMed][Google Scholar]
• 245. Crow JP, Beckman JS, McCord JMSensitivity of the essential zinc-thiolate moiety of yeast alcohol dehydrogenase to hypochlorite and peroxynitrite. Biochemistry. 1995;34:3544–3552.[PubMed][Google Scholar]
• 246. Crow JP, Sampson JB, Zhuang Y, Thompson JA, Beckman JSDecreased zinc affinity of amyotrophic lateral sclerosis-associated superoxide dismutase mutants leads to enhanced catalysis of tyrosine nitration by peroxynitrite. J Neurochem. 1997;69:1936–1944.[PubMed][Google Scholar]
• 247. Crow JP, Ye YZ, Strong M, Kirk M, Barnes S, Beckman JSSuperoxide dismutase catalyzes nitration of tyrosines by peroxynitrite in the rod and head domains of neurofilament-L. J Neurochem. 1997;69:1945–1953.[PubMed][Google Scholar]
• 248. Csiszar A, Pacher P, Kaley G, Ungvari ZRole of oxidative and nitrosative stress, longevity genes and poly(ADP-ribose) polymerase in cardiovascular dysfunction associated with aging. Curr Vasc Pharmacol. 2005;3:285–291.[Google Scholar]
• 249. Csiszar A, Ungvari Z, Edwards JG, Kaminski P, Wolin MS, Koller A, Kaley GAging-induced phenotypic changes and oxidative stress impair coronary arteriolar function. Circ Res. 2002;90:1159–1166.[PubMed][Google Scholar]
• 250. Csiszar A, Ungvari Z, Koller A, Edwards JG, Kaley GAging-induced proinflammatory shift in cytokine expression profile in coronary arteries. FASEB J. 2003;17:1183–1185.[PubMed][Google Scholar]
• 251. Csiszar A, Ungvari Z, Koller A, Edwards JG, Kaley GProinflammatory phenotype of coronary arteries promotes endothelial apoptosis in aging. Physiol Gen. 2004;17:21–30.[PubMed][Google Scholar]
• 252. Csonka C, Csont T, Onody A, Ferdinandy PPreconditioning decreases ischemia/reperfusion-induced peroxynitrite formation. Biochem Biophys Res Commun. 2001;285:1217–1219.[PubMed][Google Scholar]
• 253. Cunningham JM, Mabley JG, Delaney CA, Green ICThe effect of nitric oxide donors on insulin secretion, cyclic GMP and cyclic AMP in rat islets of Langerhans and the insulin-secreting cell lines HIT-T15 and RINm5F. Mol Cell Endocrinol. 1994;102:23–29.[PubMed][Google Scholar]
• 254. Cuzzocrea SShock, inflammation and PARP. Pharmacol Res. 2005;52:72–82.[PubMed][Google Scholar]
• 255. Cuzzocrea S, Caputi APProtective effect of melatonin on zymosan-induced cellular damage. Biol Signals Recept. 1999;8:136–142.[PubMed][Google Scholar]
• 256. Cuzzocrea S, Chatterjee PK, Mazzon E, McDonald MC, Dugo L, Di Paola R, Serraino I, Britti D, Caputi AP, Thiemermann CBeneficial effects of GW274150, a novel, potent and selective inhibitor of iNOS activity, in a rodent model of collagen-induced arthritis. Eur J Pharmacol. 2002;453:119–129.[PubMed][Google Scholar]
• 257. Cuzzocrea S, Costantino G, Caputi APProtective effect of N-acetylcysteine on cellular energy depletion in a non-septic shock model induced by zymosan in the rat. Shock. 1999;11:143–148.[PubMed][Google Scholar]
• 258. Cuzzocrea S, Costantino G, Mazzon E, Caputi APProtective effect of N-acetylcysteine on multiple organ failure induced by zymosan in the rat. Crit Care Med. 1999;27:1524–1532.[PubMed][Google Scholar]
• 259. Cuzzocrea S, Costantino G, Mazzon E, De Sarro A, Caputi APBeneficial effects of Mn(III)tetrakis(4-benzoic acid)porphyrin (MnTBAP), a superoxide dismutase mimetic, in zymosan-induced shock. Br J Pharmacol. 1999;128:1241–1251.[Google Scholar]
• 260. Cuzzocrea S, Costantino G, Mazzon E, Micali A, De Sarro A, Caputi APBeneficial effects of melatonin in a rat model of splanchnic artery occlusion and reperfusion. J Pineal Res. 2000;28:52–63.[PubMed][Google Scholar]
• 261. Cuzzocrea S, Costantino G, Mazzon E, Zingarelli B, De Sarro A, Caputi APProtective effects of Mn(III)tetrakis(4-benzoic acid)porphyrin (MnTBAP), a superoxide dismutase mimetic, in paw oedema induced by carrageenan in the rat. Biochem Pharmacol. 1999;58:171–176.[PubMed][Google Scholar]
• 262. Cuzzocrea S, Costantino G, Zingarelli B, Mazzon E, Micali A, Caputi APThe protective role of endogenous glutathione in carrageenan-induced pleurisy in the rat. Eur J Pharmacol. 1999;372:187–197.[PubMed][Google Scholar]
• 263. Cuzzocrea S, Mazzon E, Costantino G, Serraino I, De Sarro A, Caputi APEffects of n-acetylcysteine in a rat model of ischemia and reperfusion injury. Cardiovasc Res. 2000;47:537–548.[PubMed][Google Scholar]
• 264. Cuzzocrea S, Mazzon E, Costantino G, Serraino I, Dugo L, Calabro G, Cucinotta G, De Sarro A, Caputi APBeneficial effects of n-acetylcysteine on ischaemic brain injury. Br J Pharmacol. 2000;130:1219–1226.[Google Scholar]
• 265. Cuzzocrea S, Mazzon E, Di Paola R, Esposito E, Macarthur H, Matuschak GM, Salvemini DA role for nitric oxide-mediated peroxynitrite formation in a model of endotoxin induced shock. J Pharmacol Exp Ther. In press. [[PubMed]
• 266. Cuzzocrea S, Mazzon E, Dugo L, Barbera A, Centorrino T, Ciccolo A, Fonti MT, Caputi APInducible nitric oxide synthase knockout mice exhibit resistance to the multiple organ failure induced by zymosan. Shock. 2001;16:51–58.[PubMed][Google Scholar]
• 267. Cuzzocrea S, Mazzon E, Dugo L, Caputi AP, Aston K, Riley DP, Salvemini DProtective effects of a new stable, highly active SOD mimetic, M40401 in splanchnic artery occlusion and reperfusion. Br J Pharmacol. 2001;132:19–29.[Google Scholar]
• 268. Cuzzocrea S, Mazzon E, Dugo L, Caputi AP, Riley DP, Salvemini DProtective effects of M40403, a superoxide dismutase mimetic, in a rodent model of colitis. Eur J Pharmacol. 2001;432:79–89.[PubMed][Google Scholar]
• 269. Cuzzocrea S, Mazzon E, Dugo L, Di Paola R, Caputi AP, Salvemini DSuperoxide: a key player in hypertension. FASEB J. 2004;18:94–101.[PubMed][Google Scholar]
• 270. Cuzzocrea S, McDonald MC, Mazzon E, Filipe HM, Centorrino T, Lepore V, Terranova ML, Ciccolo A, Caputi AP, Thiemermann CBeneficial effects of tempol, a membrane-permeable radical scavenger, on the multiple organ failure induced by zymosan in the rat. Crit Care Med. 2001;29:102–111.[PubMed][Google Scholar]
• 271. Cuzzocrea S, McDonald MC, Mazzon E, Filipe HM, Costantino G, Caputi AP, Thiemermann CBeneficial effects of tempol, a membrane-permeable radical scavenger, in a rodent model of splanchnic artery occlusion and reperfusion. Shock. 2000;14:150–156.[PubMed][Google Scholar]
• 272. Cuzzocrea S, Misko TP, Costantino G, Mazzon E, Micali A, Caputi AP, Macarthur H, Salvemini DBeneficial effects of peroxynitrite decomposition catalyst in a rat model of splanchnic artery occlusion and reperfusion. FASEB J. 2000;14:1061–1072.[PubMed][Google Scholar]
• 273. Cuzzocrea S, Riley DP, Caputi AP, Salvemini DAntioxidant therapy: a new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury. Pharmacol Rev. 2001;53:135–159.[PubMed][Google Scholar]
• 274. Cuzzocrea S, Zingarelli B, Caputi APRole of constitutive nitric oxide synthase and peroxynitrite production in a rat model of splanchnic artery occlusion shock. Life Sci. 1998;63:789–799.[PubMed][Google Scholar]
• 275. Cuzzocrea S, Zingarelli B, Caputi APRole of peroxynitrite and poly (ADP-ribosyl) synthetase activation in cardiovascular derangement induced by zymosan in the rat. Life Sci. 1998;63:923–933.[PubMed][Google Scholar]
• 276. Cuzzocrea S, Zingarelli B, Costantino G, Caputi APProtective effect of melatonin in a non-septic shock model induced by zymosan in the rat. J Pineal Res. 1998;25:24–33.[PubMed][Google Scholar]
• 277. Cuzzocrea S, Zingarelli B, Costantino G, Szabo A, Salzman AL, Caputi AP, Szabo CBeneficial effects of 3-aminobenzamide, an inhibitor of poly(ADP-ribose) synthetase in a rat model of splanchnic artery occlusion and reperfusion. Br J Pharmacol. 1997;121:1065–1074.[Google Scholar]
• 278. Cuzzocrea S, Zingarelli B, O’Connor M, Salzman AL, Szabo CEffect of L-buthionine-(S,R)-sulphoximine, an inhibitor of gamma-glutamylcysteine synthetase on peroxynitrite- and endotoxic shock-induced vascular failure. Br J Pharmacol. 1998;123:525–537.[Google Scholar]
• 279. Da Ros R, Assaloni R, Ceriello AAntioxidant therapy in diabetic complications: what is new? Curr Vasc Pharmacol. 2004;2:335–341.[PubMed][Google Scholar]
• 280. Dai ZK, Tan MS, Chai CY, Yeh JL, Chou SH, Chiu CC, Jeng AY, Chen IJ, Wu JRUpregulation of endothelial nitric oxide synthase and endothelin-1 in pulmonary hypertension secondary to heart failure in aorta-banded rats. Pediatr Pulmonol. 2004;37:249–256.[PubMed][Google Scholar]
• 281. Daiber A, Herold S, Schoneich C, Namgaladze D, Peterson JA, Ullrich V. Nitration and inactivation of cytochrome P450BM-3 by peroxynitrite. Stopped-flow measurements prove ferryl intermediates. Eur J Biochem. 2000;267:6729–6739.[PubMed]
• 282. Daiber A, Mulsch A, Hink U, Mollnau H, Warnholtz A, Oelze M, Munzel TThe oxidative stress concept of nitrate tolerance and the antioxidant properties of hydralazine. Am J Cardiol. 2005;96:25i–36i.[PubMed][Google Scholar]
• 283. Daiber A, Schoneich C, Schmidt P, Jung C, Ullrich VAuto-catalytic nitration of P450CAM by peroxynitrite. J Inorg Biochem. 2000;81:213–220.[PubMed][Google Scholar]
• 284. Dairou J, Atmane N, Rodrigues-Lima F, Dupret JMPeroxynitrite irreversibly inactivates the human xenobiotic-metabolizing enzyme arylamine N-acetyltransferase 1 (NAT1) in human breast cancer cells: a cellular and mechanistic study. J Biol Chem. 2004;279:7708–7714.[PubMed][Google Scholar]
• 285. Damy T, Ratajczak P, Shah AM, Camors E, Marty I, Hasenfuss G, Marotte F, Samuel JL, Heymes CIncreased neuronal nitric oxide synthase-derived NO production in the failing human heart. Lancet. 2004;363:1365–1367.[PubMed][Google Scholar]
• 286. Darley-Usmar VM, Hogg N, O’Leary VJ, Wilson MT, Moncada SThe simultaneous generation of superoxide and nitric oxide can initiate lipid peroxidation in human low density lipoprotein. Free Radic Res Commun. 1992;17:9–20.[PubMed][Google Scholar]
• 287. Davidovic L, Vodenicharov M, Affar EB, Poirier GGImportance of poly(ADP-ribose) glycohydrolase in the control of poly-(ADP-ribose) metabolism. Exp Cell Res. 2001;268:7–13.[PubMed][Google Scholar]
• 288. Davignon J, Ganz PRole of endothelial dysfunction in atherosclerosis. Circulation. 2004;109(Suppl III):III-27–III-32.[PubMed][Google Scholar]
• 289. Davis B, Zou MHCD40 ligand-dependent tyrosine nitration of prostacyclin synthase in vivo. Circulation. 2005;112:2184–2192.[PubMed][Google Scholar]
• 290. Davis RJSignal transduction by the JNK group of MAP kinases. Cell. 2000;103:239–252.[PubMed][Google Scholar]
• 291. Dawson TM, Bredt DS, Fotuhi M, Hwang PM, Snyder SHNitric oxide synthase and neuronal NADPH diaphorase are identical in brain and peripheral tissues. Proc Natl Acad Sci USA. 1991;88:7797–7801.[Google Scholar]
• 292. Dawson TM, Dawson VLMolecular pathways of neurodegeneration in Parkinson’s disease. Science. 2003;302:819–822.[PubMed][Google Scholar]
• 293. Dawson VL, Dawson TMDeadly conversations: nuclear-mitochondrial cross-talk. J Bioenerget Biomembr. 2004;36:287–294.[PubMed][Google Scholar]
• 294. Dawson VL, Dawson TM, London ED, Bredt DS, Snyder SHNitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc Natl Acad Sci USA. 1991;88:6368–6371.[Google Scholar]
• 295. De Groote MA, Ochsner UA, Shiloh MU, Nathan C, McCord JM, Dinauer MC, Libby SJ, Vazquez-Torres A, Xu Y, Fang FCPeriplasmic superoxide dismutase protects Salmonella from products of phagocyte NADPH-oxidase and nitric oxide synthase. Proc Natl Acad Sci USA. 1997;94:13997–14001.[Google Scholar]
• 296. De la Monte SM, Lu BX, Sohn YK, Etienne D, Kraft J, Ganju N, Wands JRAberrant expression of nitric oxide synthase III in Alzheimer’s disease: relevance to cerebral vasculopathy and neurodegeneration. Neurobiol Aging. 2000;21:309–319.[PubMed][Google Scholar]
• 297. De la Monte SM, Sohn YK, Etienne D, Kraft J, Wands JRRole of aberrant nitric oxide synthase-3 expression in cerebrovascular degeneration and vascular-mediated injury in Alzheimer’s disease. Ann NY Acad Sci. 2000;903:61–71.[PubMed][Google Scholar]
• 298. d’Emmanuele di Villa Bianca R, Marzocco S, Di Paola R, Autore G, Pinto A, Cuzzocrea S, Sorrentino RMelatonin prevents lipopolysaccharide-induced hyporeactivity in rat. J Pineal Res. 2004;36:146–154.[PubMed][Google Scholar]
• 299. De Murcia G, Menissier de Murcia JPoly(ADP-ribose) polymerase: a molecular nick sensor. Trends Biochem Sci. 1994;19:172–176.[PubMed][Google Scholar]
• 300. Deckel AW, Duffy JDVasomotor hyporeactivity in the anterior cerebral artery during motor activation in Huntington’s disease patients. Brain Res. 2000;872:258–261.[PubMed][Google Scholar]
• 301. Deckel AW, Gordinier A, Nuttal D, Tang V, Kuwada C, Freitas R, Gary KAReduced activity and protein expression of NOS in R6/2 HD transgenic mice: effects of L-NAME on symptom progression. Brain Res. 2001;919:70–81.[PubMed][Google Scholar]
• 302. Deckel AW, Volmer P, Weiner R, Gary KA, Covault J, Sasso D, Schmerler N, Watts D, Yan Z, Abeles IDietary arginine alters time of symptom onset in Huntington’s disease transgenic mice. Brain Res. 2000;875:187–195.[PubMed][Google Scholar]
• 303. Deeb RS, Hao G, Gross SS, Laine M, Qiu JH, Resnick B, Barbar EJ, Hajjar DP, Upmacis RKHeme catalyzes Tyr385 nitration and inactivation of prostaglandin H2 synthase-1 by peroxynitrite. J Lipid Res. 2006;47:898–911.[PubMed][Google Scholar]
• 304. Deeb RS, Shen H, Gamss C, Gavrilova T, Summers BD, Kraemer R, Hao G, Gross SS, Laine M, Maeda N, Hajjar DP, Upmacis RKInducible nitric oxide synthase mediates prostaglandin h2 synthase nitration and suppresses eicosanoid production. Am J Pathol. 2006;168:349–362.[Google Scholar]
• 305. Deguchi T, Yoshioka ML-Arginine identified as an endogenous activator for soluble guanylate cyclase from neuroblastoma cells. J Biol Chem. 1982;257:10147–10151.[PubMed][Google Scholar]
• 306. Dejardin E, Droin NM, Delhase M, Haas E, Cao Y, Makris C, Li ZW, Karin M, Ware CF, Green DRThe lymphotoxin-beta receptor induces different patterns of gene expression via two NF-kappaB pathways. Immunity. 2002;17:525–535.[PubMed][Google Scholar]
• 307. Delaney CA, Green MH, Lowe JE, Green ICEndogenous nitric oxide induced by interleukin-1 beta in rat islets of Langerhans and HIT-T15 cells causes significant DNA damage as measured by the “comet” assay. FEBS Lett. 1993;333:291–295.[PubMed][Google Scholar]
• 308. Delaney CA, Pavlovic D, Hoorens A, Pipeleers DG, Eizirik DLCytokines induce deoxyribonucleic acid strand breaks and apoptosis in human pancreatic islet cells. Endocrinology. 1997;138:2610–2614.[PubMed][Google Scholar]
• 309. Delaney CA, Tyrberg B, Bouwens L, Vaghef H, Hellman B, Eizirik DLSensitivity of human pancreatic islets to peroxynitrite-induced cell dysfunction and death. FEBS Lett. 1996;394:300–306.[PubMed][Google Scholar]
• 310. Denicola A, Freeman BA, Trujillo M, Radi RPeroxynitrite reaction with carbon dioxide/bicarbonate: kinetics and influence on peroxynitrite-mediated oxidations. Arch Biochem Biophys. 1996;333:49–58.[PubMed][Google Scholar]
• 311. Denicola A, Radi RPeroxynitrite and drug-dependent toxicity. Toxicology. 2005;208:273–288.[PubMed][Google Scholar]
• 312. Denicola A, Souza JM, Radi RDiffusion of peroxynitrite across erythrocyte membranes. Proc Natl Acad Sci USA. 1998;95:3566–3571.[Google Scholar]
• 313. Depre C, Havaux X, Renkin J, Vanoverschelde JL, Wijns WExpression of inducible nitric oxide synthase in human coronary atherosclerotic plaque. Cardiovasc Res. 1999;41:465–472.[PubMed][Google Scholar]
• 314. Dhar A, Brindley JM, Stark C, Citro ML, Keefer LK, Colburn NHNitric oxide does not mediate but inhibits transformation and tumor phenotype. Mol Cancer Ther. 2003;2:1285–1293.[PubMed][Google Scholar]
• 315. Dhar A, Kaundal RK, Sharma SSNeuroprotective effects of FeTMPyP: a peroxynitrite decomposition catalyst in global cerebral ischemia model in gerbils. Pharmacol Res. In press. [[PubMed]
• 316. Di Filippo C, Cuzzocrea S, Marfella R, Fabbroni V, Scollo G, Berrino L, Giugliano D, Rossi F, D’Amico MM40403 prevents myocardial injury induced by acute hyperglycaemia in perfused rat heart. Eur J Pharmacol. 2004;497:65–74.[PubMed][Google Scholar]
• 317. Di Stasi AM, Mallozzi C, Macchia G, Maura G, Petrucci TC, Minetti MPeroxynitrite affects exocytosis and SNARE complex formation and induces tyrosine nitration of synaptic proteins. J Neurochem. 2002;82:420–429.[PubMed][Google Scholar]
• 318. Di Stasi AM, Mallozzi C, Macchia G, Petrucci TC, Minetti MPeroxynitrite induces tryosine nitration and modulates tyrosine phosphorylation of synaptic proteins. J Neurochem. 1999;73:727–735.[PubMed][Google Scholar]
• 319. Dickhout JG, Hossain GS, Pozza LM, Zhou J, Lhotak S, Austin RCPeroxynitrite causes endoplasmic reticulum stress and apoptosis in human vascular endothelium: implications in atherogenesis. Arterioscler Thromb Vasc Biol. 2005;25:2623–2629.[PubMed][Google Scholar]
• 320. Digerness SB, Harris KD, Kirklin JW, Urthaler F, Viera L, Beckman JS, Darley-Usmar VPeroxynitrite irreversibly decreases diastolic and systolic function in cardiac muscle. Free Radic Biol Med. 1999;27:1386–1392.[PubMed][Google Scholar]
• 321. Dijkstra G, Moshage H, van Dullemen HM, de Jager-Krikken A, Tiebosch AT, Kleibeuker JH, Jansen PL, van Goor HExpression of nitric oxide synthases and formation of nitrotyrosine and reactive oxygen species in inflammatory bowel disease. J Pathol. 1998;186:416–421.[PubMed][Google Scholar]
• 322. Dikopoulos N, Nussler AK, Liptay S, Bachem M, Reinshagen M, Stiegler M, Schmid RM, Adler G, Weidenbach HInhibition of nitric oxide synthesis by aminoguanidine increases intestinal damage in the acute phase of rat TNB-colitis. Eur J Clin Invest. 2001;31:234–239.[PubMed][Google Scholar]
• 323. Dimmeler S, Lottspeich F, Brüne BNitric oxide causes ADP-ribosylation and inhibition of glyceraldehyde-3-phosphate dehydrogenase. J Biol Chem. 1992;267:16771–16774.[PubMed][Google Scholar]
• 324. Ding X, Hiraku Y, Ma N, Kato T, Saito K, Nagahama M, Semba R, Kuribayashi K, Kawanishi SInducible nitric oxide synthase-dependent DNA damage in mouse model of inflammatory bowel disease. Cancer Sci. 2005;96:157–163.[PubMed][Google Scholar]
• 325. Ding Y, Gonick HC, Vaziri ND, Liang K, Wei L. Lead-induced hypertension. III. Increased hydroxyl radical production. Am J Hypertens. 2001;14:169–173.[PubMed]
• 326. Dirnagl U, Iadecola C, Moskowitz MAPathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 1999;22:391–397.[PubMed][Google Scholar]
• 327. Dobrian AD, Schriver SD, Prewitt RLRole of angiotensin II and free radicals in blood pressure regulation in a rat model of renal hypertension. Hypertension. 2001;38:361–366.[PubMed][Google Scholar]
• 328. Dong C, Davis RJ, Flavell RAMAP kinases in the immune response. Annu Rev Immunol. 2002;20:55–72.[PubMed][Google Scholar]
• 329. Drapier JD, Hibbs JBDifferentiation of murine macrophages to express nonspecific cytotoxicity for tumor cells results in L-arginine-dependent inhibition of mitochondrial iron-sulfur enzymes in the macrophage effector cells. J Immunol. 1988;140:2829–2838.[PubMed][Google Scholar]
• 330. Drayton DL, Bonizzi G, Ying X, Liao S, Karin M, Ruddle NHIκB kinase complex αkinase activity controls chemokine and high endothelial venule gene expression in lymph nodes and nasal-associated lymphoid tissue. J Immunol. 2004;173:6161–6168.[PubMed][Google Scholar]
• 331. Drel VR, Pacher P, Stevens MJ, Obrosova IGAldose reductase inhibition counteracts nitrosative stress and poly(ADP-ribose) polymerase activation in diabetic rat kidney and high-glucose-exposed human mesangial cells. Free Radic Biol Med. 2006;40:1454–1465.[Google Scholar]
• 332. Du X, Matsumura T, Edelstein D, Rossetti L, Zsengeller Z, Szabo C, Brownlee MInhibition of GAPDH activity by poly-(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells. J Clin Invest. 2003;112:1049–1057.[Google Scholar]
• 333. Du Y, Smith MA, Miller CM, Kern TSDiabetes-induced nitrative stress in the retina, and correction by aminoguanidine. J Neurochem. 2002;80:771–779.[PubMed][Google Scholar]
• 334. Ducrocq C, Blanchard B, Pignatelli B, Ohshima HPeroxynitrite: an endogenous oxidizing and nitrating agent. Cell Mol Life Sci. 1999;55:1068–1077.[PubMed][Google Scholar]
• 335. Duranski MR, Greer JJ, Dejam A, Jaganmohan S, Hogg N, Langston W, Patel RP, Yet SF, Wang X, Kevil CG, Gladwin MT, Lefer DJCytoprotective effects of nitrite during in vivo ischemia-reperfusion of the heart and liver. J Clin Invest. 2005;115:1232–1240.[Google Scholar]
• 336. East SJ, Garthwaite JNMDA receptor activation in the rat hippocampus induces cyclic GMP formation through the L-arginine-nitric oxide pathway. Neurosci Lett. 1991;123:17–19.[PubMed][Google Scholar]
• 337. Ebadi M, Sharma SKPeroxynitrite and mitochondrial dysfunction in the pathogenesis of Parkinson’s disease. Antioxid Redox Signal. 2003;5:319–335.[PubMed][Google Scholar]
• 338. Ebadi M, Sharma SK, Ghafourifar P, Brown-Borg H, El Refaey HPeroxynitrite in the pathogenesis of Parkinson’s disease and the neuroprotective role of metallothioneins. Methods Enzymol. 2005;396:276–298.[PubMed][Google Scholar]
• 339. Eberhardt RT, Forgione MA, Cap A, Leopold JA, Rudd MA, Trolliet M, Heydrick S, Stark R, Klings ES, Moldovan NI, Yaghoubi M, Goldschmidt-Clermont PJ, Farber HW, Cohen R, Loscalzo JEndothelial dysfunction in a murine model of mild hyperhomocyst(e)inemia. J Clin Invest. 2000;106:483–491.[Google Scholar]
• 340. Egan LJ, Eckmann L, Greten FR, Chae S, Li ZW, Myhre GM, Robine S, Karin M, Kagnoff MFIkappaB-kinasebeta-dependent NF-kappaB activation provides radioprotection to the intestinal epithelium. Proc Natl Acad Sci USA. 2004;101:2452–2457.[Google Scholar]
• 341. Egan TM, Hoffmann SC, Sevala M, Sadoff JD, Schlidt SANitroglycerin reperfusion reduces ischemia-reperfusion injury in non-heart-beating donor lungs. J Heart Lung Transplant. 2006;25:110–119.[PubMed][Google Scholar]
• 342. Egi K, Conrad NE, Bedynek A, Ferdinandy P, Reichart B, Wildhirt SMImprovement of cardiac allograft function by 1400W, a highly selective inducible nitric oxide synthase inhibitor and superoxide dismutase: role of peroxynitrite. J Heart Lung Transplant. 2001;20:154.[PubMed][Google Scholar]
• 343. Eid HM, Lyberg T, Larsen J, Arnesen H, Seljeflot IReactive oxygen species generation by leukocytes in populations at risk for atherosclerotic disease. Scand J Clin Lab Invest. 2002;62:431–439.[PubMed][Google Scholar]
• 344. Eizirik DL, Delaney CA, Green MH, Cunningham JM, Thorpe JR, Pipeleers DG, Hellerstrom C, Green ICNitric oxide donors decrease the function and survival of human pancreatic islets. Mol Cell Endocrinol. 1996;118:71–83.[PubMed][Google Scholar]
• 345. Eizirik DL, Sandler S, Welsh N, Cetkovic-Cvrlje M, Nieman A, Geller DA, Pipeleers DG, Bendtzen K, Hellerstrom CCytokines suppress human islet function irrespective of their effects on nitric oxide generation. J Clin Invest. 1994;93:1968–1974.[Google Scholar]
• 346. El Kossi MM, Zakhary MMOxidative stress in the context of acute cerebrovascular stroke. Stroke. 2000;31:1889–1892.[PubMed][Google Scholar]
• 347. El-Dwairi Q, Comtois A, Guo Y, Hussain SNEndotoxin-induced skeletal muscle contractile dysfunction: contribution of nitric oxide synthases. Am J Physiol Cell Physiol. 1998;274:C770–C779.[PubMed][Google Scholar]
• 348. Eliasson MJ, Huang Z, Ferrante RJ, Sasamata M, Molliver ME, Snyder SH, Moskowitz MANeuronal nitric oxide synthase activation and peroxynitrite formation in ischemic stroke linked to neural damage. J Neurosci. 1999;19:5910–5918.[Google Scholar]
• 349. Eliasson MJ, Sampei K, Mandir AS, Hurn PD, Traystman RJ, Bao J, Pieper A, Wang ZQ, Dawson TM, Snyder SH, Dawson VLPoly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia. Nat Med. 1997;3:1089–1095.[PubMed][Google Scholar]
• 350. Eligini S, Habib A, Lebret M, Creminon C, Levy-Toledano S, Maclouf JInduction of cyclo-oxygenase-2 in human endothelial cells by SIN-1 in the absence of prostaglandin production. Br J Pharmacol. 2001;133:1163–1171.[Google Scholar]
• 351. Ellis EA, Guberski DL, Hutson B, Grant MBTime course of NADH oxidase, inducible nitric oxide synthase and peroxynitrite in diabetic retinopathy in the BBZ/WOR rat. Nitric Oxide. 2002;6:295–304.[PubMed][Google Scholar]
• 352. El-Remessy AB, Abou-Mohamed G, Caldwell RW, Caldwell RBHigh glucose-induced tyrosine nitration in endothelial cells: role of eNOS uncoupling and aldose reductase activation. Invest Ophthalmol Vis Sci. 2003;44:3135–3143.[PubMed][Google Scholar]
• 353. El-Remessy AB, Bartoli M, Platt DH, Fulton D, Caldwell RBOxidative stress inactivates VEGF survival signaling in retinal endothelial cells via PI 3-kinase tyrosine nitration. J Cell Sci. 2005;118:243–252.[PubMed][Google Scholar]
• 354. El-Remessy AB, Behzadian MA, Abou-Mohamed G, Franklin T, Caldwell RW, Caldwell RBExperimental diabetes causes breakdown of the blood-retina barrier by a mechanism involving tyrosine nitration and increases in expression of vascular endothelial growth factor and urokinase plasminogen activator receptor. Am J Pathol. 2003;162:1995–2004.[Google Scholar]
• 355. El-Sokkary GH, Reiter RJ, Cuzzocrea S, Caputi AP, Hassanein AF, Tan DXRole of melatonin in reduction of lipid peroxidation and peroxynitrite formation in non-septic shock induced by zymosan. Shock. 1999;12:402–408.[PubMed][Google Scholar]
• 356. Emerit J, Edeas M, Bricaire FNeurodegenerative diseases and oxidative stress. Biomed Pharmacother. 2004;58:39–46.[PubMed][Google Scholar]
• 357. Endres M, Laufs U, Huang Z, Nakamura T, Huang P, Moskowitz MA, Liao JKStroke protection by 3-hydroxy-3-methyl-glutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase. Proc Natl Acad Sci USA. 1998;95:8880–8885.[Google Scholar]
• 358. Endres M, Laufs U, Liao JK, Moskowitz MATargeting eNOS for stroke protection. Trends Neurosci. 2004;27:283–289.[PubMed][Google Scholar]
• 359. Endres M, Scott G, Namura S, Salzman AL, Huang PL, Moskowitz MA, Szabo CRole of peroxynitrite and neuronal nitric oxide synthase in the activation of poly(ADP-ribose) synthetase in a murine model of cerebral ischemia-reperfusion. Neurosci Lett. 1998;248:41–44.[PubMed][Google Scholar]
• 360. Endres M, Wang ZQ, Namura S, Waeber C, Moskowitz MAIschemic brain injury is mediated by the activation of poly(ADP-ribose)polymerase. J Cereb Blood Flow Metab. 1997;17:1143–1151.[PubMed][Google Scholar]
• 361. Erdelyi K, Bakondi E, Gergely P, Szabo C, Virag LPathophysiologic role of oxidative stress-induced poly(ADP-ribose) polymerase-1 activation: focus on cell death and transcriptional regulation. Cell Mol Life Sci. 2005;62:751–759.[PubMed][Google Scholar]
• 362. Eriksen JL, Wszolek Z, Petrucelli LMolecular pathogenesis of Parkinson disease. Arch Neurol. 2005;62:353–357.[PubMed][Google Scholar]
• 363. Esaki T, Hayashi T, Muto E, Kano H, Kumar TN, Asai Y, Sumi D, Iguchi AExpression of inducible nitric oxide synthase and Fas/Fas ligand correlates with the incidence of apoptotic cell death in atheromatous plaques of human coronary arteries. Nitric Oxide. 2000;4:561–571.[PubMed][Google Scholar]
• 364. Esberg LB, Ren JRole of nitric oxide, tetrahydrobiopterin and peroxynitrite in glucose toxicity-associated contractile dysfunction in ventricular myocytes. Diabetologia. 2003;46:1419–1427.[PubMed][Google Scholar]
• 365. Escobales N, Crespo MJOxidative-nitrosative stress in hypertension. Curr Vasc Pharmacol. 2005;3:231–246.[PubMed][Google Scholar]
• 366. Estevez AG, Crow JP, Sampson JB, Reiter C, Zhuang Y, Richardson GJ, Tarpey MM, Barbeito L, Beckman JSInduction of nitric oxide-dependent apoptosis in motor neurons by zinc-deficient superoxide dismutase. Science. 1999;286:2498–2500.[PubMed][Google Scholar]
• 367. Estevez AG, Radi R, Barbeito L, Shin JT, Thompson JA, Beckman JSPeroxynitrite-induced cytotoxicity in PC12 cells: evidence for an apoptotic mechanism differentially modulated by neurotrophic factors. J Neurochem. 1995;65:1543–1550.[PubMed][Google Scholar]
• 368. Estevez AG, Sampson JB, Zhuang YX, Spear N, Richardson GJ, Crow JP, Tarpey MM, Barbeito L, Beckman JSLiposome-delivered superoxide dismutase prevents nitric oxide-dependent motor neuron death induced by trophic factor withdrawal. Free Radic Biol Med. 2000;28:437–446.[PubMed][Google Scholar]
• 369. Estevez AG, Spear N, Manuel SM, Barbeito L, Radi R, Beckman JSRole of endogenous nitric oxide and peroxynitrite formation in the survival and death of motor neurons in culture. Prog Brain Res. 1998;118:269–280.[PubMed][Google Scholar]
• 370. Estevez AG, Spear N, Manuel SM, Radi R, Henderson CE, Barbeito L, Beckman JSNitric oxide and superoxide contribute to motor neuron apoptosis induced by trophic factor deprivation. J Neurosci. 1998;18:923–931.[Google Scholar]
• 371. Estevez AG, Spear N, Pelluffo H, Kamaid A, Barbeito L, Beckman JS. Examining apoptosis in cultured cells after exposure to nitric oxide and peroxynitrite. In: Packer L, editor. Nitric Oxide: Biological and Antioxidant Activities. San Diego, CA: Academic; 1998. pp. 393–402. [[PubMed]
• 372. Evgenov OV, Pacher P, Schmidt PM, Hasko G, Schmidt HHW, Stasch JPNitric oxide-independent stimulators and activators of soluble guanylate cyclase. Nat Rev Drug Discov. 2006;5:755–768.[Google Scholar]
• 373. Evgenov OV, Liaudet LRole of nitrosative stress and activation of poly(ADP-ribose) polymerase-1 in cardiovascular failure associated with septic and hemorrhagic shock. Curr Vasc Pharmacol. 2005;3:293–299.[PubMed][Google Scholar]
• 374. Fabian RH, DeWitt DS, Kent TAIn vivo detection of superoxide anion production by the brain using a cytochrome c electrode. J Cereb Blood Flow Metab. 1995;15:242–247.[PubMed][Google Scholar]
• 375. Facchinetti F, Sasaki M, Cutting FB, Zhai P, MacDonald JE, Reif D, Beal MF, Huang PL, Dawson TM, Gurney ME, Dawson VLLack of involvement of neuronal nitric oxide synthase in the pathogenesis of a transgenic mouse model of familial amyotrophic lateral sclerosis. Neuroscience. 1999;90:1483–1492.[PubMed][Google Scholar]
• 376. Faden AINeuroprotection and traumatic brain injury: theoretical option or realistic proposition. Curr Opin Neurol. 2002;15:707–712.[PubMed][Google Scholar]
• 377. Farrell AJ, Blake DR, Palmer RM, Moncada SIncreased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases. Ann Rheum Dis. 1992;51:1219–1222.[Google Scholar]
• 378. Fehsel K, Jalowy A, Qi S, Burkart V, Hartmann B, Kolb HIslet cell DNA is a target of inflammatory attack by nitric oxide. Diabetes. 1993;42:496–500.[PubMed][Google Scholar]
• 379. Feigl EOEDRF-a protective factor? Nature. 1988;331:490–491.[PubMed][Google Scholar]
• 380. Feihl F, Waeber B, Liaudet LIs nitric oxide overproduction the target of choice for the management of septic shock? Pharmacol Ther. 2001;91:179–213.[PubMed][Google Scholar]
• 381. Feletou M, Vanhoutte PMEndothelial dysfunction: a multifaceted disorder. Am J Physiol Heart Circ Physiol. 2006;291:H985–H1002.[PubMed][Google Scholar]
• 382. Feliciello A, Gottesman ME, Avvedimento EVcAMP-PKA signaling to the mitochondria: protein scaffolds, mRNA and phosphatases. Cell Signal. 2005;17:279–287.[PubMed][Google Scholar]
• 383. Feng Q, Lu X, Jones DL, Shen J, Arnold JMIncreased inducible nitric oxide synthase expression contributes to myocardial dysfunction and higher mortality after myocardial infarction in mice. Circulation. 2001;104:700–704.[PubMed][Google Scholar]
• 384. Ferdinandy P, Danial H, Ambrus I, Rothery RA, Schulz RPeroxynitrite is a major contributor to cytokine-induced myocardial contractile failure. Circ Res. 2000;87:241–247.[PubMed][Google Scholar]
• 385. Ferdinandy P, Panas D, Schulz RPeroxynitrite contributes to spontaneous loss of cardiac efficiency in isolated working rat hearts. Am J Physiol Heart Circ Physiol. 1999;276:H1861–H1867.[PubMed][Google Scholar]
• 386. Ferdinandy P, Schulz RNitric oxide, superoxide, and peroxynitrite in myocardial ischaemia-reperfusion injury and preconditioning. Br J Pharmacol. 2003;138:532–543.[Google Scholar]
• 387. Feron O, Belhassen L, Kobzik L, Smith TW, Kelly RA, Michel TEndothelial nitric oxide synthase targeting to caveolae. J Biol Chem. 1996;271:22810–22814.[PubMed][Google Scholar]
• 388. Ferrante RJ, Shinobu LA, Schulz JB, Matthews RT, Thomas CE, Kowall NW, Gurney ME, Beal MFIncreased 3-nitrotyrosine and oxidative damage in mice with a human copper/zinc superoxide dismutase mutation. Ann Neurol. 1997;42:326–334.[PubMed][Google Scholar]
• 389. Ferreiro CR, Chagas AC, Carvalho MH, Dantas AP, Scavone C, Souza LC, Buffolo E, da Luz PLExpression of inducible nitric oxide synthase is increased in patients with heart failure due to ischemic disease. Braz J Med Biol Res. 2004;37:1313–1320.[PubMed][Google Scholar]
• 390. Ferriero DM, Holtzman DM, Black SM, Sheldon RANeonatal mice lacking neuronal nitric oxide synthase are less vulnerable to hypoxic-ischemic injury. Neurobiol Dis. 1996;3:64–71.[PubMed][Google Scholar]
• 391. Filep JG, Beauchamp M, Baron C, Paquette YPeroxynitrite mediates IL-8 gene expression and production in lipopolysaccharide-stimulated human whole blood. J Immunol. 1998;161:5656–5662.[PubMed][Google Scholar]
• 392. Fink MPBench-to-bedside review: cytopathic hypoxia. Crit Care. 2002;6:491–499.[Google Scholar]
• 393. Fink MPRole of reactive oxygen and nitrogen species in acute respiratory distress syndrome. Curr Opin Crit Care. 2002;8:6–11.[PubMed][Google Scholar]
• 394. Finkel T, Holbrook NJOxidants, oxidative stress and the biology of ageing. Nature. 2000;408:239–247.[PubMed][Google Scholar]
• 395. Fiocchi CInflammatory bowel disease: etiology and pathogenesis. Gastroenterology. 1998;115:182–205.[PubMed][Google Scholar]
• 396. Firestein GSEvolving concepts of rheumatoid arthritis. Nature. 2003;423:356–361.[PubMed][Google Scholar]
• 397. Fiser SM, Tribble CG, Long SM, Kaza AK, Cope JT, Laubach VE, Kern JA, Kron ILLung transplant reperfusion injury involves pulmonary macrophages and circulating leukocytes in a biphasic response. J Thorac Cardiovasc Surg. 2001;121:1069–1075.[PubMed][Google Scholar]
• 398. Fletcher DS, Widmer WR, Luell S, Christen A, Orevillo C, Shah S, Visco DTherapeutic administration of a selective inhibitor of nitric oxide synthase does not ameliorate the chronic inflammation and tissue damage associated with adjuvant-induced arthritis in rats. J Pharmacol Exp Ther. 1998;284:714–721.[PubMed][Google Scholar]
• 399. Flodstrom M, Tyrberg B, Eizirik DL, Sandler SReduced sensitivity of inducible nitric oxide synthase-deficient mice to multiple low-dose streptozotocin-induced diabetes. Diabetes. 1999;48:706–713.[PubMed][Google Scholar]
• 400. Floris R, Piersma SR, Yang G, Jones P, Wever R. Interaction of myeloperoxidase with peroxynitrite. A comparison with lactoperoxidase, horseradish peroxidase and catalase. Eur J Biochem. 1993;215:767–775.[PubMed]
• 401. Fontijn A, Sadadell AJ, Ronco RJHomogeneous chemiluminescent measurement of nitric oxide with ozone. Anal Chem. 1970;42:575–578.[PubMed][Google Scholar]
• 402. Forbes JM, Cooper ME, Thallas V, Burns WC, Thomas MC, Brammar GC, Lee F, Grant SL, Burrell LA, Jerums G, Osicka TMReduction of the accumulation of advanced glycation end products by ACE inhibition in experimental diabetic nephropathy. Diabetes. 2002;51:3274–3282.[PubMed][Google Scholar]
• 403. Forsmark-Andree P, Persson B, Radi R, Dallner G, Ernster LOxidative modification of nicotinamide nucleotide transhydrogenase in submitochondrial particles: effect of endogenous ubiquinol. Arch Biochem Biophys. 1996;336:113–120.[PubMed][Google Scholar]
• 404. Forster C, Clark HB, Ross ME, Iadecola CInducible nitric oxide synthase expression in human cerebral infarcts. Acta Neuropathol. 1999;97:215–220.[PubMed][Google Scholar]
• 405. Forstermann UEndothelial NO synthase as a source of NO and superoxide. Eur J Clin Pharmacol. 2006;62(Suppl 13):5–12.[PubMed][Google Scholar]
• 406. Forstermann U. NO synthases. In: Offermanns S, Rosenthal W, editors. Encyclopedic Reference of Molecular Pharmacology. Berlin: Springer-Verlag; 2003. pp. 653–658. [PubMed]
• 407. Forstermann U, Munzel TEndothelial nitric oxide synthase in vascular disease: from marvel to menace. Circulation. 2006;113:1708–1714.[PubMed][Google Scholar]
• 408. Fortenberry JD, Owens ML, Brown MR, Atkinson D, Brown LAExogenous nitric oxide enhances neutrophil cell death and DNA fragmentation. Am J Respir Cell Mol Biol. 1998;18:421–428.[PubMed][Google Scholar]
• 409. Francia P, delli Gatti C, Bachschmid M, Martin-Padura I, Savoia C, Migliaccio E, Pelicci PG, Schiavoni M, Luscher TF, Volpe M, Cosentino FDeletion of p66shc gene protects against age-related endothelial dysfunction. Circulation. 2004;110:2889–2895.[PubMed][Google Scholar]
• 410. Fridovich IQuantitative aspects of the production of superoxide anion radical by milk xanthine oxidase. J Biol Chem. 1970;245:4053–4057.[PubMed][Google Scholar]
• 411. Frostell CG, Blomqvist H, Hedenstierna G, Lundberg J, Zapol WMInhaled nitric oxide selectively reverses human hypoxic pulmonary vasoconstriction without causing systemic vasodilation. Anesthesiology. 1993;78:427–435.[PubMed][Google Scholar]
• 412. Frostell D, Fratacci MD, Wain JC, Jones R, Zapol WM. Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation. 1991;83:2038–2047.[PubMed]
• 413. Frustaci A, Kajstura J, Chimenti C, Jakoniuk I, Leri A, Maseri A, Nadal-Ginard B, Anversa PMyocardial cell death in human diabetes. Circ Res. 2000;87:1123–1132.[PubMed][Google Scholar]
• 414. Fu Y, Sies H, Lei XGOpposite roles of selenium-dependent glutathione peroxidase-1 in superoxide generator diquat- and peroxynitrite-induced apoptosis and signaling. J Biol Chem. 2001;276:43004–43009.[PubMed][Google Scholar]
• 415. Fujigaki H, Saito K, Lin F, Fujigaki S, Takahashi K, Martin BM, Chen CY, Masuda J, Kowalak J, Takikawa O, Seishima M, Markey SPNitration and inactivation of IDO by peroxynitrite. J Immunol. 2006;176:372–379.[PubMed][Google Scholar]
• 416. Fukui T, Ishizaka N, Rajagopalan S, Laursen JB, Capers Qt Taylor WR, Harrison DG, de Leon H, Wilcox JN, Griendling KKp22phox mRNA expression and NADPH oxidase activity are increased in aortas from hypertensive rats. Circ Res. 1997;80:45–51.[PubMed][Google Scholar]
• 417. Fukumoto K, Pierro A, Zammit VA, Spitz L, Eaton STyrosine nitration of carnitine palmitoyl transferase I during endotoxaemia in suckling rats. Biochim Biophys Acta. 2004;1683:1–6.[PubMed][Google Scholar]
• 418. Fukumura D, Kashiwagi S, Jain RKThe role of nitric oxide in tumour progression. Nat Rev Cancer. 2006;6:521–534.[PubMed][Google Scholar]
• 419. Fukushima T, Tawara T, Isobe A, Hojo N, Shiwaku K, Yamane YRadical formation site of cerebral complex I and Parkinson’s disease. J Neurosci Res. 1995;42:385–390.[PubMed][Google Scholar]
• 420. Fukuyama N, Takebayashi Y, Hida M, Ishida H, Ichimori K, Nakazawa HClinical evidence of peroxynitrite formation in chronic renal failure patients with septic shock. Free Radic Biol Med. 1997;22:771–774.[PubMed][Google Scholar]
• 421. Funakoshi H, Kubota T, Kawamura N, Machida Y, Feldman AM, Tsutsui H, Shimokawa H, Takeshita ADisruption of inducible nitric oxide synthase improves beta-adrenergic inotropic responsiveness but not the survival of mice with cytokine-induced cardiomyopathy. Circ Res. 2002;90:959–965.[PubMed][Google Scholar]
• 422. Furchgott RF, Zawadzki JVThe obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 1980;288:373–376.[PubMed][Google Scholar]
• 423. Gahm C, Danilov A, Holmin S, Wiklund PN, Brundin L, Mathiesen TReduced neuronal injury after treatment with N^{-nitro-L-arginine methyl ester (L-NAME) or 2-sulfo-phenyl-}N-tert-butyl nitrone (S-PBN) following experimental brain contusion. Neurosurgery. 2005;57:1272–1281.[PubMed][Google Scholar]
• 424. Galkina SI, Dormeneva EV, Bachschmid M, Pushkareva MA, Sud’ina GF, Ullrich VEndothelium-leukocyte interactions under the influence of the superoxide-nitrogen monoxide system. Med Sci Monit. 2004;10:BR307–316.[PubMed][Google Scholar]
• 425. Galley HF, Davies MJ, Webster NRXanthine oxidase activity and free radical generation in patients with sepsis syndrome. Crit Care Med. 1996;24:1649–1653.[PubMed][Google Scholar]
• 426. Gally JA, Montague PR, Reeke GN, Jr, Edelman GMThe NO hypothesis: possible effects of a short-lived, rapidly diffusible signal in the development and function of the nervous system. Proc Natl Acad Sci USA. 1990;87:3547–3551.[Google Scholar]
• 427. Galpern WR, Matthews RT, Beal MF, Isacson ONGF attenuates 3-nitrotyrosine formation in a 3-NP model of Huntington’s disease. Neuroreport. 1996;7:2639–2642.[PubMed][Google Scholar]
• 428. Gao CQ, Sawicki G, Suarez-Pinzon WL, Csont T, Wozniak M, Ferdinandy P, Schulz RMatrix metalloproteinase-2 mediates cytokine-induced myocardial contractile dysfunction. Cardiovasc Res. 2003;57:426–433.[PubMed][Google Scholar]
• 429. Gao F, Yao CL, Gao E, Mo QZ, Yan WL, McLaughlin R, Lopez BL, Christopher TA, Ma XLEnhancement of glutathione cardioprotection by ascorbic acid in myocardial reperfusion injury. J Pharmacol Exp Ther. 2002;301:543–550.[PubMed][Google Scholar]
• 430. Garcia Soriano F, Virag L, Jagtap P, Szabo E, Mabley JG, Liaudet L, Marton A, Hoyt DG, Murthy KG, Salzman AL, Southan GJ, Szabo CDiabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation. Nat Med. 2001;7:108–113.[PubMed][Google Scholar]
• 431. Gardian G, Vecsei LHuntington’s disease: pathomechanism and therapeutic perspectives. J Neural Transm. 2004;111:1485–1494.[PubMed][Google Scholar]
• 432. Gardner CR, Laskin JD, Dambach DM, Sacco M, Durham SK, Bruno MK, Cohen SD, Gordon MK, Gerecke DR, Zhou P, Laskin DLReduced hepatotoxicity of acetaminophen in mice lacking inducible nitric oxide synthase: potential role of tumor necrosis factor-alpha and interleukin-10. Toxicol Appl Pharmacol. 2002;184:27–36.[PubMed][Google Scholar]
• 433. Garthwaite JGlutamate, nitric oxide and cell-cell signalling in the nervous system. Trends Neurosci. 1991;14:75–82.[PubMed][Google Scholar]
• 434. Garthwaite J, Boulton CLNitric oxide signaling in the central nervous system. Annu Rev Physiol. 1995;57:683–706.[PubMed][Google Scholar]
• 435. Garthwaite J, Charles SL, Chess-Williams REndothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature. 1988;336:385–388.[PubMed][Google Scholar]
• 436. Garthwaite J, Sotham E, Boulton CL, Nielsen EB, Schmidt K, Mayer BPotent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by1H[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one. Biochem Pharmacol. 1996;48:184–188.[PubMed][Google Scholar]
• 437. Gatto EM, Riobo NA, Carreras MC, Chernavsky A, Rubio A, Satz ML, Poderoso JJOverexpression of neutrophil neuronal nitric oxide synthase in Parkinson’s disease. Nitric Oxide. 2000;4:534–539.[PubMed][Google Scholar]
• 438. Gaut JP, Yeh GC, Tran HD, Byun J, Henderson JP, Richter GM, Brennan ML, Lusis AJ, Belaaouaj A, Hotchkiss RS, Heinecke JWNeutrophils employ the myeloperoxidase system to generate antimicrobial brominating and chlorinating oxidants during sepsis. Proc Natl Acad Sci USA. 2001;98:11961–11966.[Google Scholar]
• 439. Gealekman O, Abassi Z, Rubinstein I, Winaver J, Binah ORole of myocardial inducible nitric oxide synthase in contractile dysfunction and beta-adrenergic hyporesponsiveness in rats with experimental volume-overload heart failure. Circulation. 2002;105:236–243.[PubMed][Google Scholar]
• 440. Geha RM, Rebrin I, Chen K, Shih JCSubstrate and inhibitor specificities for human monoamine oxidase A and B are influenced by a single amino acid. J Biol Chem. 2001;276:9877–9882.[PubMed][Google Scholar]
• 441. Gentleman SM, Leclercq PD, Moyes L, Graham DI, Smith C, Griffin WS, Nicoll JALong-term intracerebral inflammatory response after traumatic brain injury. Forensic Sci Int. 2004;146:97–104.[PubMed][Google Scholar]
• 442. Ghosh S, Karin MMissing pieces in the NF-kappaB puzzle. Cell. 2002;109(Suppl):S81–S96.[PubMed][Google Scholar]
• 443. Giasson BI, Duda JE, Murray IV, Chen Q, Souza JM, Hurtig HI, Ischiropoulos H, Trojanowski JQ, Lee VMOxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions. Science. 2000;290:985–989.[PubMed][Google Scholar]
• 444. Gilad E, Zingarelli B, Salzman AL, Szabo CProtection by inhibition of poly(ADP-ribose) synthetase against oxidant injury in cardiac myoblasts In vitro. J Mol Cell Cardiol. 1997;29:2585–2597.[PubMed][Google Scholar]
• 445. Giovannoni GCerebrospinal fluid and serum nitric oxide metabolites in patients with multiple sclerosis. Mult Scler. 1998;4:27–30.[PubMed][Google Scholar]
• 446. Giovannoni G, Heales SJ, Land JM, Thompson EJThe potential role of nitric oxide in multiple sclerosis. Mult Scler. 1998;4:212–216.[PubMed][Google Scholar]
• 447. Giovannoni G, Heales SJ, Silver NC, O’Riordan J, Miller RF, Land JM, Clark JB, Thompson EJRaised serum nitrate and nitrite levels in patients with multiple sclerosis. J Neurol Sci. 1997;145:77–81.[PubMed][Google Scholar]
• 448. Giovannoni G, Silver NC, O’Riordan J, Miller RF, Heales SJ, Land JM, Elliot M, Feldmann M, Miller DH, Thompson EJIncreased urinary nitric oxide metabolites in patients with multiple sclerosis correlates with early and relapsing disease. Mult Scler. 1999;5:335–341.[PubMed][Google Scholar]
• 449. Gloire G, Legrand-Poels S, Piette JNF-kB activation by reactive oxygen species: fifteen years later. Biochem Pharmacol. In press. [[PubMed]
• 450. Go YM, Patel RP, Maland MC, Park H, Beckman JS, Darley-Usmar VM, Jo HEvidence for peroxynitrite as a signaling molecule in flow-dependent activation of c-Jun NH(2)-terminal kinase. Am J Physiol Heart Circ Physiol. 1999;277:H1647–H1653.[PubMed][Google Scholar]
• 451. Goldfarb RD, Marton A, Szabo E, Virag L, Salzman AL, Glock D, Akhter I, McCarthy R, Parrillo JE, Szabo CProtective effect of a novel, potent inhibitor of poly(adenosine 5′-diphosphate-ribose) synthetase in a porcine model of severe bacterial sepsis. Crit Care Med. 2002;30:974–980.[PubMed][Google Scholar]
• 452. Goldstein S, Czapski G, Lind J, Merenyi GEffect of *NO on the decomposition of peroxynitrite: reaction of N₂O₃ with ONOO. Chem Res Toxicol. 1999;12:132–136.[PubMed][Google Scholar]
• 453. Golfetti R, VanDyke K, Rork T, Spiler N, Merrill GAcetaminophen in the post-ischemia reperfused myocardium. Exp Biol Med. 2002;227:1031–1037.[PubMed][Google Scholar]
• 454. Goligorsky MS, Brodsky SV, Noiri ENitric oxide in acute renal failure: NOS versus NOS. Kidney Int. 2002;61:855–861.[PubMed][Google Scholar]
• 455. Gomez CB, del Valle HF, Bertolotti A, Negroni JA, Cuniberti L, Martinez V, Osses J, Laguens RP, Favaloro RREffects of short-term inhaled nitric oxide on interleukin-8 release after single-lung transplantation in pigs. J Heart Lung Transplant. 2005;24:714–722.[PubMed][Google Scholar]
• 456. Good PF, Hsu A, Werner P, Perl DP, Olanow CWProtein nitration in Parkinson’s disease. J Neuropathol Exp Neurol. 1998;57:338–342.[PubMed][Google Scholar]
• 457. Good PF, Werner P, Hsu A, Olanow CW, Perl DPEvidence of neuronal oxidative damage in Alzheimer’s disease. Am J Pathol. 1996;149:21–28.[Google Scholar]
• 458. Gopalakrishna R, Jaken SProtein kinase C signaling and oxidative stress. Free Radic Biol Med. 2000;28:1349–1361.[PubMed][Google Scholar]
• 459. Gorg B, Bidmon HJ, Keitel V, Foster N, Goerlich R, Schliess F, Haussinger DInflammatory cytokines induce protein tyrosine nitration in rat astrocytes. Arch Biochem Biophys. 2006;449:104–114.[PubMed][Google Scholar]
• 460. Gorg B, Wettstein M, Metzger S, Schliess F, Haussinger DLipopolysaccharide-induced tyrosine nitration and inactivation of hepatic glutamine synthetase in the rat. Hepatology. 2005;41:1065–1073.[PubMed][Google Scholar]
• 461. Gori T, Parker JDNitrate tolerance: a unifying hypothesis. Circulation. 2002;106:2510–2513.[PubMed][Google Scholar]
• 462. Gouge RC, Marshburn P, Gordon BE, Nunley W, Huet-Hudson YMNitric oxide as a regulator of embryonic development. Biol Reprod. 1998;58:875–879.[PubMed][Google Scholar]
• 463. Gow AJ, Duran D, Malcolm S, Ischiropoulos HEffects of peroxynitrite-induced protein modifications on tyrosine phosphorylation and degradation. FEBS Lett. 1996;385:63–66.[PubMed][Google Scholar]
• 464. Gow AJ, Farkouh CR, Munson DA, Posencheg MA, Ischiropoulos HBiological significance of nitric oxide-mediated protein modifications. Am J Physiol Lung Cell Mol Physiol. 2004;287:L262–L268.[PubMed][Google Scholar]
• 465. Graham A, Hogg N, Kalyanaraman B, O’Leary V, Darley-Usmar V, Moncada SPeroxynitrite modification of low-density lipoprotein leads to recognition by the macrophage scavenger receptor. FEBS Lett. 1993;330:181–185.[PubMed][Google Scholar]
• 466. Grandati M, Verrecchia C, Revaud ML, Allix M, Boulu RG, Plotkine MCalcium-independent NO-synthase activity and nitrites/nitrates production in transient focal cerebral ischaemia in mice. Br J Pharmacol. 1997;122:625–630.[Google Scholar]
• 467. Granger DN, Rutili G, McCord JMSuperoxide radicals in feline intestinal ischemia. Gastroenterology. 1981;81:22–29.[PubMed][Google Scholar]
• 468. Grasemann H, Drazen JM, Deykin A, Israel E, DeSanctis GT, Pillari A, Yandava CNSimple tandem repeat polymorphisms in the neuronal nitric oxide synthase gene in different ethnic populations. Hum Hered. 1999;49:139–141.[PubMed][Google Scholar]
• 469. Graves JE, Bates JN, Kooy NW, Lewis SJVasodilator actions of the endothelium-derived relaxing factor L-S-nitrosocysteine in anaesthetized rats are markedly diminished by peroxynitrite. Clin Exp Pharmacol Physiol. 2005;32:1137–1141.[PubMed][Google Scholar]
• 470. Graves JE, Kooy NW, Lewis SJL-beta,beta-Dimethylcysteine attenuates the haemodynamic responses elicited by systemic injections of peroxynitrite in anaesthetized rats. Br J Pharmacol. In press.
• 471. Graves JE, Lewis SJ, Kooy NWLoss of K+ATP-channel-mediated vasodilation after induction of tachyphylaxis to peroxynitrite. J Cardiovasc Pharmacol. 2005;46:646–652.[PubMed][Google Scholar]
• 472. Graves JE, Lewis SJ, Kooy NWPeroxynitrite-mediated vasorelaxation: evidence against the formation of circulating S-nitrosothiols. Am J Physiol Heart Circ Physiol. 1998;274:H1001–H1008.[PubMed][Google Scholar]
• 473. Graves JE, Lewis SJ, Kooy NWRole of ATP-sensitive K^{-channels in hemodynamic effects of peroxynitrite in anesthetized rats.} J Cardiovasc Pharmacol. 2005;46:653–659.[PubMed][Google Scholar]
• 474. Green IC, Cunningham JM, Delaney CA, Elphick MR, Mabley JG, Green MHEffects of cytokines and nitric oxide donors on insulin secretion, cyclic GMP and DNA damage: relation to nitric oxide production. Biochem Soc Trans. 1994;22:30–37.[PubMed][Google Scholar]
• 475. Green LC, Ruiz de Luzuriaga K, Wagner DA, Rand W, Istfan N, Young VR, Tannenbaum SRNitrate biosynthesis in man. Proc Natl Acad Sci USA. 1981;78:7764–7768.[Google Scholar]
• 476. Greenacre SA, Ischiropoulos HTyrosine nitration: localisation, quantification, consequences for protein function and signal transduction. Free Radic Res. 2001;34:541–581.[PubMed][Google Scholar]
• 477. Greten FR, Eckmann L, Greten TF, Park JM, Li ZW, Egan LJ, Kagnoff MF, Karin MIKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell. 2004;118:285–296.[PubMed][Google Scholar]
• 478. Griendling KK, Sorescu D, Ushio-Fukai MNAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res. 2000;86:494–501.[PubMed][Google Scholar]
• 479. Griffith TM, Edwards DH, Davies RL, Harrison TJ, Evans KTEDRF coordinates the behaviour of vascular resistance vessels. Nature. 1987;329:442–445.[PubMed][Google Scholar]
• 480. Grishko V, Pastukh V, Solodushko V, Gillespie M, Azuma J, Schaffer SApoptotic cascade initiated by angiotensin II in neonatal cardiomyocytes: role of DNA damage. Am J Physiol Heart Circ Physiol. 2003;285:H2364–H2372.[PubMed][Google Scholar]
• 481. Groenendaal F, Lammers H, Smit D, Nikkels PGNitrotyrosine in brain tissue of neonates after perinatal asphyxia. Arch Dis Child Fetal Neonatal Ed. In press.
• 482. Grover AK, Samson SEEffect of superoxide radical on Ca ^{pumps of coronary artery.} Am J Physiol Cell Physiol. 1988;255:C297–C303.[PubMed][Google Scholar]
• 483. Grover AK, Samson SE, Robinson S, Kwan CYEffects of peroxynitrite on sarcoplasmic reticulum Ca ^{pump in pig coronary artery smooth muscle.} Am J Physiol Cell Physiol. 2003;284:C294–C301.[PubMed][Google Scholar]
• 484. Gryglewski RJ, Palmer RM, Moncada SSuperoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature. 1986;320:454–456.[PubMed][Google Scholar]
• 485. Gu X, El-Remessy AB, Brooks SE, Al-Shabrawey M, Tsai NT, Caldwell RBHyperoxia induces retinal vascular endothelial cell apoptosis through formation of peroxynitrite. Am J Physiol Cell Physiol. 2003;285:C546–C554.[PubMed][Google Scholar]
• 486. Gu ZY, Ling YL, Xu XH, Meng AH, Li SJEffect of peroxynitrite on the reactivity of rabbit pulmonary arteries in vitro. Sheng Li Xue Bao. 2003;55:469–474.[PubMed][Google Scholar]
• 487. Gu ZY, Ling YL, Xu XH, Zhu TN, Cong BEndogenous peroxynitrite mediates lipopolysaccharide-induced injury in cultured pulmonary artery endothelial cells. Sheng Li Xue Bao. 2003;55:475–480.[PubMed][Google Scholar]
• 488. Gugliucci AHuman plasminogen is highly susceptible to peroxynitrite inactivation. Clin Chem Lab Med. 2003;41:1064–1068.[PubMed][Google Scholar]
• 489. Guidarelli A, Fiorani M, Cantoni OEnhancing effects of intracellular ascorbic acid on peroxynitrite-induced U937 cell death are mediated by mitochondrial events resulting in enhanced sensitivity to peroxynitrite-dependent inhibition of complex III and formation of hydrogen peroxide. Biochem J. 2004;378:959–966.[Google Scholar]
• 490. Guittet O, Ducastel B, Salem JS, Henry Y, Rubin H, Lemaire G, Lepoivre MDifferential sensitivity of the tyrosyl radical of mouse ribonucleotide reductase to nitric oxide and peroxynitrite. J Biol Chem. 1998;273:22136–22144.[PubMed][Google Scholar]
• 491. Guix FX, Uribesalgo I, Coma M, Munoz FJThe physiology and pathophysiology of nitric oxide in the brain. Prog Neurobiol. 2005;76:126–152.[PubMed][Google Scholar]
• 492. Guo W, Adachi T, Matsui R, Xu S, Jiang B, Zou MH, Kirber M, Lieberthal W, Cohen RAQuantitative assessment of tyrosine nitration of manganese superoxide dismutase in angiotensin II-infused rat kidney. Am J Physiol Heart Circ Physiol. 2003;285:H1396–H1403.[PubMed][Google Scholar]
• 493. Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, Alexander DD, Caliendo J, Hentati A, Kwon YW, Deng HX, Chen W, Zhai P, Sufit RL, Siddique TMotor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science. 1994;264:1772–1775.[PubMed][Google Scholar]
• 494. Gursoy-Ozdemir Y, Bolay H, Saribas O, Dalkara TRole of endothelial nitric oxide generation and peroxynitrite formation in reperfusion injury after focal cerebral ischemia. Stroke. 2000;31:1974–1981.[PubMed][Google Scholar]
• 495. Gursoy-Ozdemir Y, Can A, Dalkara TReperfusion-induced oxidative/nitrative injury to neurovascular unit after focal cerebral ischemia. Stroke. 2004;35:1449–1453.[PubMed][Google Scholar]
• 496. Gutierrez-Martin Y, Martin-Romero FJ, Inesta-Vaquera FA, Gutierrez-Merino C, Henao FModulation of sarcoplasmic reticulum Ca(2+)-ATPase by chronic and acute exposure to peroxynitrite. Eur J Biochem. 2004;271:2647–2657.[PubMed][Google Scholar]
• 497. Gutkind JSRegulation of mitogen-activated protein kinase signaling networks by G protein-coupled receptors. Sci STKE 2000. 2000:RE1.[PubMed][Google Scholar]
• 498. Guy RA, Maguire GF, Crandall I, Connelly PW, Kain KCCharacterization of peroxynitrite-oxidized low density lipoprotein binding to human CD36. Atherosclerosis. 2001;155:19–28.[PubMed][Google Scholar]
• 499. Guyenet PGThe sympathetic control of blood pressure. Nat Rev Neurosci. 2006;7:335–346.[PubMed][Google Scholar]
• 500. Guzik TJ, Mussa S, Gastaldi D, Sadowski J, Ratnatunga C, Pillai R, Channon KMMechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase. Circulation. 2002;105:1656–1662.[PubMed][Google Scholar]
• 501. Ha HCDefective transcription factor activation for proinflammatory gene expression in poly(ADP-ribose) polymerase 1-deficient glia. Proc Natl Acad Sci USA. 2004;101:5087–5092.[Google Scholar]
• 502. Ha HC, Hester LD, Snyder SHPoly(ADP-ribose) polymerase-1 dependence of stress-induced transcription factors and associated gene expression in glia. Proc Natl Acad Sci USA. 2002;99:3270–3275.[Google Scholar]
• 503. Ha HC, Snyder SHPoly(ADP-ribose) polymerase is a mediator of necrotic cell death by ATP depletion. Proc Natl Acad Sci USA. 1999;96:13978–13982.[Google Scholar]
• 504. Hadjivassiliou V, Green MH, James RF, Swift SM, Clayton HA, Green ICInsulin secretion, DNA damage, and apoptosis in human and rat islets of Langerhans following exposure to nitric oxide, peroxynitrite, and cytokines. Nitric Oxide. 1998;2:429–441.[PubMed][Google Scholar]
• 505. Hafezi-Moghadam A, Simoncini T, Yang Z, Limbourg FP, Plumier JC, Rebsamen MC, Hsieh CM, Chui DS, Thomas KL, Prorock AJ, Laubach VE, Moskowitz MA, French BA, Ley K, Liao JKAcute cardiovascular protective effects of corticosteroids are mediated by non-transcriptional activation of endothelial nitric oxide synthase. Nat Med. 2002;8:473–479.[Google Scholar]
• 506. Hajjar I, Kotchen JM, Kotchen TAHypertension: trends in prevalence, incidence, and control. Annu Rev Public Health. 2006;27:465–490.[PubMed][Google Scholar]
• 507. Hall ED, Detloff MR, Johnson K, Kupina NCPeroxynitrite-mediated protein nitration and lipid peroxidation in a mouse model of traumatic brain injury. J Neurotrauma. 2004;21:9–20.[PubMed][Google Scholar]
• 508. Hall ED, Kupina NC, Althaus JSPeroxynitrite scavengers for the acute treatment of traumatic brain injury. Ann NY Acad Sci. 1999;890:462–468.[PubMed][Google Scholar]
• 509. Hamilton CA, Brosnan MJ, McIntyre M, Graham D, Dominiczak AFSuperoxide excess in hypertension and aging: a common cause of endothelial dysfunction. Hypertension. 2001;37:529–534.[PubMed][Google Scholar]
• 510. Hamilton ML, Van Remmen H, Drake JA, Yang H, Guo ZM, Kewitt K, Walter CA, Richardson ADoes oxidative damage to DNA increase with age? Proc Natl Acad Sci USA. 2001;98:10469–10474.[Google Scholar]
• 511. Han D, Canali R, Garcia J, Aguilera R, Gallaher TK, Cadenas ESites and mechanisms of aconitase inactivation by peroxynitrite: modulation by citrate and glutathione. Biochemistry. 2005;44:11986–11996.[PubMed][Google Scholar]
• 512. Hanada M, Feng J, Hemmings BAStructure, regulation and function of PKB/AKT—a major therapeutic target. Biochim Biophys Acta. 2004;1697:3–16.[PubMed][Google Scholar]
• 513. Hanauer SB, Sandborn WJ, Rutgeerts P, Fedorak RN, Lukas M, MacIntosh D, Panaccione R, Wolf D, Pollack PHuman anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn’s disease: the CLASSIC-I trial. Gastroenterology. 2006;130:323–333.[PubMed][Google Scholar]
• 514. Hansson GKInflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005;352:1685–1695.[PubMed][Google Scholar]
• 515. Haqqani AS, Kelly JF, Birnboim HCSelective nitration of histone tyrosine residues in vivo in mutatect tumors. J Biol Chem. 2002;277:3614–3621.[PubMed][Google Scholar]
• 516. Hare JM, Stamler JSNO/redox disequilibrium in the failing heart and cardiovascular system. J Clin Invest. 2005;115:509–517.[Google Scholar]
• 517. Harman DAging: a theory based on free radical and radiation chemistry. J Gerontol. 1956;11:298–300.[PubMed][Google Scholar]
• 518. Harrison D, Griendling KK, Landmesser U, Hornig B, Drexler HRole of oxidative stress in atherosclerosis. Am J Cardiol. 2003;91:7A–11A.[PubMed][Google Scholar]
• 519. Haskew RE, Mongin AA, Kimelberg HKPeroxynitrite enhances astrocytic volume-sensitive excitatory amino acid release via a src tyrosine kinase-dependent mechanism. J Neurochem. 2002;82:903–912.[PubMed][Google Scholar]
• 520. Hassa PO, Hottiger MOThe functional role of poly(ADP-ribose) polymerase 1 as novel coactivator of NF-kappaB in inflammatory disorders. Cell Mol Life Sci. 2002;59:1534–1553.[PubMed][Google Scholar]
• 521. Hatake K, Kakishita E, Wakabayashi I, Sakiyama N, Hishida SEffect of aging on endothelium-dependent vascular relaxation of isolated human basilar artery to thrombin and bradykinin. Stroke. 1990;21:1039–1043.[PubMed][Google Scholar]
• 522. Hattori N, Mizuno YPathogenetic mechanisms of parkin in Parkinson’s disease. Lancet. 2004;364:722–724.[PubMed][Google Scholar]
• 523. Hausladen A, Fridovich ISuperoxide and peroxynitrite inactivate aconitases, but nitric oxide does not. J Biol Chem. 1994;269:29405–29408.[PubMed][Google Scholar]
• 524. Hayashi T, Sumi D, Juliet PA, Matsui-Hirai H, Asai-Tanaka Y, Kano H, Fukatsu A, Tsunekawa T, Miyazaki A, Iguchi A, Ignarro LJGene transfer of endothelial NO synthase, but not eNOS plus inducible NOS, regressed atherosclerosis in rabbits. Cardiovasc Res. 2004;61:339–351.[PubMed][Google Scholar]
• 525. Hayashi Y, Sawa Y, Fukuyama N, Miyamoto Y, Takahashi T, Nakazawa H, Matsuda HLeukocyte-depleted terminal blood cardioplegia provides superior myocardial protective effects in association with myocardium-derived nitric oxide and peroxynitrite production for patients undergoing prolonged aortic cross-clamping for more than 120 minutes. J Thorac Cardiovasc Surg. 2003;126:1813–1821.[PubMed][Google Scholar]
• 526. Hayashi Y, Sawa Y, Ohtake S, Fukuyama N, Nakazawa H, Matsuda HPeroxynitrite formation from human myocardium after ischemia-reperfusion during open heart operation. Ann Thorac Surg. 2001;72:571–576.[PubMed][Google Scholar]
• 527. Hayat SA, Patel B, Khattar RS, Malik RADiabetic cardiomyopathy: mechanisms, diagnosis and treatment. Clin Sci. 2004;107:539–557.[PubMed][Google Scholar]
• 528. Haynes V, Elfering S, Traaseth N, Giulivi CMitochondrial nitric-oxide synthase: enzyme expression, characterization, and regulation. J Bioenerget Biomembr. 2004;36:341–346.[PubMed][Google Scholar]
• 529. Haywood GA, Tsao PS, von der Leyen HE, Mann MJ, Keeling PJ, Trindade PT, Lewis NP, Byrne CD, Rickenbacher PR, Bishopric NH, Cooke JP, McKenna WJ, Fowler MBExpression of inducible nitric oxide synthase in human heart failure. Circulation. 1996;93:1087–1094.[PubMed][Google Scholar]
• 530. Hazen SL, Zhang R, Shen Z, Wu W, Podrez EA, MacPherson JC, Schmitt D, Mitra SN, Mukhopadhyay C, Chen Y, Cohen PA, Hoff HF, Abu-Soud HMFormation of nitric oxide-derived oxidants by myeloperoxidase in monocytes: pathways for monocyte-mediated protein nitration and lipid peroxidation in vivo. Circ Res. 1999;85:950–958.[PubMed][Google Scholar]
• 531. He K, Nukada H, McMorran PD, Murphy MPProtein carbonyl formation and tyrosine nitration as markers of oxidative damage during ischaemia-reperfusion injury to rat sciatic nerve. Neuroscience. 1999;94:909–916.[PubMed][Google Scholar]
• 532. Heales SJ, Bolanos JP, Stewart VC, Brookes PS, Land JM, Clark JBNitric oxide, mitochondria and neurological disease. Biochim Biophys Acta. 1999;1410:215–228.[PubMed][Google Scholar]
• 533. Heck DE, Kagan VE, Shvedova AA, Laskin JDAn epigrammatic (abridged) recounting of the myriad tales of astonishing deeds and dire consequences pertaining to nitric oxide and reactive oxygen species in mitochondria with an ancillary missive concerning the origins of apoptosis. Toxicology. 2005;208:259–271.[PubMed][Google Scholar]
• 534. Heger J, Godecke A, Flogel U, Merx MW, Molojavyi A, Kuhn-Velten WN, Schrader JCardiac-specific overexpression of inducible nitric oxide synthase does not result in severe cardiac dysfunction. Circ Res. 2002;90:93–99.[PubMed][Google Scholar]
• 535. Heitzer T, Wenzel U, Hink U, Krollner D, Skatchkov M, Stahl RA, MacHarzina R, Brasen JH, Meinertz T, Munzel TIncreased NAD(P)H oxidase-mediated superoxide production in re-novascular hypertension: evidence for an involvement of protein kinase C. Kidney Int. 1999;55:252–260.[PubMed][Google Scholar]
• 536. Hellberg CB, Boggs SE, Lapetina EGPhosphatidylinositol 3-kinase is a target for protein tyrosine nitration. Biochem Biophys Res Commun. 1998;252:313–317.[PubMed][Google Scholar]
• 537. Henrotin YE, Bruckner P, Pujol JPThe role of reactive oxygen species in homeostasis and degradation of cartilage. Osteoarthritis Cartilage. 2003;11:747–755.[PubMed][Google Scholar]
• 538. Hensley K, Maidt ML, Yu Z, Sang H, Markesbery WR, Floyd RAElectrochemical analysis of protein nitrotyrosine and dityrosine in the Alzheimer brain indicates region-specific accumulation. J Neurosci. 1998;18:8126–8132.[Google Scholar]
• 539. Herceg Z, Wang ZFunctions of poly(ADP-ribose) polymerase (PARP) in DNA repair, genomic integrity and cell death. Mutat Res. 2001;477:97–110.[PubMed][Google Scholar]
• 540. Herold S, Exner M, Boccini FThe mechanism of the peroxynitrite-mediated oxidation of myoglobin in the absence and presence of carbon dioxide. Chem Res Toxicol. 2003;16:390–402.[PubMed][Google Scholar]
• 541. Herskowitz A, Choi S, Ansari AA, Wesselingh SCytokine mRNA expression in postischemic/reperfused myocardium. Am J Pathol. 1995;146:419–428.[Google Scholar]
• 542. Hibbs JB, Jr, Taintor RR, Vavrin ZMacrophage cytotoxicity: role of L-arginine deminiase and imino nitrogen oxidation to nitrite. Science. 1987;235:473–476.[PubMed][Google Scholar]
• 543. Hibbs JB, Jr, Taintor RR, Vavrin Z, Rachlin EMNitric oxide: a cytotoxic activated macrophage effector molecule. Biochem Biophys Res Commun. 1988;157:87–94.[PubMed][Google Scholar]
• 544. Hierholzer C, Billiar TRMolecular mechanisms in the early phase of hemorrhagic shock. Langenbecks Arch Surg. 2001;386:302–308.[PubMed][Google Scholar]
• 545. Higashi Y, Oshima T, Ozono R, Matsuura H, Kajiyama GAging and severity of hypertension attenuate endothelium-dependent renal vascular relaxation in humans. Hypertension. 1997;30:252–258.[PubMed][Google Scholar]
• 546. Hill KE, Zollinger LV, Watt HE, Carlson NG, Rose JWInducible nitric oxide synthase in chronic active multiple sclerosis plaques: distribution, cellular expression and association with myelin damage. J Neuroimmunol. 2004;151:171–179.[PubMed][Google Scholar]
• 547. Hillier BJ, Christopherson KS, Prehoda KE, Bredt DS, Lim WAUnexpected modes of PDZ domain scaffolding revealed by structure of nNOS-syntrophin complex. Science. 1999;284:812–815.[PubMed][Google Scholar]
• 548. Hines IN, Harada H, Bharwani S, Pavlick KP, Hoffman JM, Grisham MBEnhanced post-ischemic liver injury in iNOS-deficient mice: a cautionary note. Biochem Biophys Res Commun. 2001;284:972–976.[PubMed][Google Scholar]
• 549. Hink U, Oelze M, Kolb P, Bachschmid M, Zou MH, Daiber A, Mollnau H, August M, Baldus S, Tsilimingas N, Walter U, Ullrich V, Munzel TRole for peroxynitrite in the inhibition of prostacyclin synthase in nitrate tolerance. J Am Coll Cardiol. 2003;42:1826–1834.[PubMed][Google Scholar]
• 550. Hirabayashi H, Takizawa S, Fukuyama N, Nakazawa H, Shinohara Y7-Nitroindazole attenuates nitrotyrosine formation in the early phase of cerebral ischemia-reperfusion in mice. Neurosci Lett. 1999;268:111–113.[PubMed][Google Scholar]
• 551. Hirabayashi H, Takizawa S, Fukuyama N, Nakazawa H, Shinohara Y. N-methyl-D-aspartate receptor antagonist reduces nitrotyrosine formation in caudate-putamen in rat focal cerebral ischemia-reperfusion. Neurosci Lett. 2001;299:159–161.[PubMed]
• 552. Hirabayashi H, Takizawa S, Fukuyama N, Nakazawa H, Shinohara YNitrotyrosine generation via inducible nitric oxide synthase in vascular wall in focal ischemia-reperfusion. Brain Res. 2000;852:319–325.[PubMed][Google Scholar]
• 553. Hoeldtke RD, Bryner KD, McNeill DR, Hobbs GR, Baylis CPeroxynitrite versus nitric oxide in early diabetes. Am J Hypertens. 2003;16:761–766.[PubMed][Google Scholar]
• 554. Hoeldtke RD, Bryner KD, McNeill DR, Hobbs GR, Riggs JE, Warehime SS, Christie I, Ganser G, Van Dyke KNitrosative stress, uric acid, and peripheral nerve function in early type 1 diabetes. Diabetes. 2002;51:2817–2825.[PubMed][Google Scholar]
• 555. Hoeldtke RD, Bryner KD, McNeill DR, Warehime SS, Van Dyke K, Hobbs GOxidative stress and insulin requirements in patients with recent-onset type 1 diabetes. J Clin Endocrinol Metab. 2003;88:1624–1628.[PubMed][Google Scholar]
• 556. Hoffmann J, Haendeler J, Aicher A, Rossig L, Vasa M, Zeiher AM, Dimmeler SAging enhances the sensitivity of endothelial cells toward apoptotic stimuli: important role of nitric oxide. Circ Res. 2001;89:709–715.[PubMed][Google Scholar]
• 557. Hogaboam CM, Jacobson K, Collins SM, Blennerhassett MGThe selective beneficial effects of nitric oxide inhibition in experimental colitis. Am J Physiol Gastrointest Liver Physiol. 1995;268:G673–G684.[PubMed][Google Scholar]
• 558. Hogg N, Darley-Usmar VM, Graham A, Moncada SPeroxynitrite and atherosclerosis. Biochem Soc Trans. 1993;21:358–362.[PubMed][Google Scholar]
• 559. Hogg N, Darley-Usmar VM, Wilson MT, Moncada SProduction of hydroxyl radicals from the simultaneous generation of superoxide and nitric oxide. Biochem J. 1992;281:419–424.[Google Scholar]
• 560. Hogg N, Kalyanaraman BNitric oxide and lipid peroxidation. Biochim Biophys Acta. 1999;1411:378–384.[PubMed][Google Scholar]
• 561. Hogg N, Kalyanaraman B, Joseph J, Struck A, Parthasarathy S. Inhibition of low-density lipoprotein oxidation by nitric oxide. Potential role in atherogenesis. FEBS Lett. 1993;334:170–174.[PubMed]
• 562. Hokari R, Kato S, Matsuzaki K, Kuroki M, Iwai A, Kawaguchi A, Nagao S, Miyahara T, Itoh K, Sekizuka E, Nagata H, Ishii H, Miura SReduced sensitivity of inducible nitric oxide synthase-deficient mice to chronic colitis. Free Radic Biol Med. 2001;31:153–163.[PubMed][Google Scholar]
• 563. Holm L, Cassidy JD, Carroll LJ, Borg JSummary of the WHO collaborating centre for neurotrauma task force on mild traumatic brain injury. J Rehabil Med. 2005;37:137–141.[PubMed][Google Scholar]
• 564. Holscher CPossible causes of Alzheimer’s disease: amyloid fragments, free radicals, and calcium homeostasis. Neurobiol Dis. 1998;5:129–141.[PubMed][Google Scholar]
• 565. Hong HJ, Hsiao G, Cheng TH, Yen MHSupplemention with tetrahydrobiopterin suppresses the development of hypertension in spontaneously hypertensive rats. Hypertension. 2001;38:1044–1048.[PubMed][Google Scholar]
• 566. Hooper DC, Bagasra O, Marini JC, Zborek A, Ohnishi ST, Kean R, Champion JM, Sarker AB, Bobroski L, Farber JL, Akaike T, Maeda H, Koprowski HPrevention of experimental allergic encephalomyelitis by targeting nitric oxide and peroxynitrite: implications for the treatment of multiple sclerosis. Proc Natl Acad Sci USA. 1997;94:2528–2533.[Google Scholar]
• 567. Hooper DC, Spitsin S, Kean RB, Champion JM, Dickson GM, Chaudhry I, Koprowski HUric acid, a natural scavenger of peroxynitrite, in experimental allergic encephalomyelitis and multiple sclerosis. Proc Natl Acad Sci USA. 1998;95:675–680.[Google Scholar]
• 568. Hope BT, Michael GJ, Knigge KM, Vincent SRNeuronal NADPH diaphorase is a nitric oxide synthase. Proc Natl Acad Sci USA. 1991;88:2811–2814.[Google Scholar]
• 569. Hotchkiss RS, Karl IEThe pathophysiology and treatment of sepsis. N Engl J Med. 2003;348:138–150.[PubMed][Google Scholar]
• 570. Hsu CM, Wang JS, Liu CH, Chen LWKupffer cells protect liver from ischemia-reperfusion injury by an inducible nitric oxide synthase-dependent mechanism. Shock. 2002;17:280–285.[PubMed][Google Scholar]
• 571. Hsu HC, Zhou T, Kim H, Barnes S, Yang P, Wu Q, Zhou J, Freeman BA, Luo M, Mountz JDProduction of a novel class of polyreactive pathogenic autoantibodies in BXD2 mice causes glomerulonephritis and arthritis. Arthritis Rheum. 2006;54:343–355.[PubMed][Google Scholar]
• 572. Hu P, Ischiropoulos H, Beckman JS, Matalon SPeroxynitrite inhibition of oxygen consumption and sodium transport in alveolar type II cells. Am J Physiol Lung Cell Mol Physiol. 1994;266:L628–L634.[PubMed][Google Scholar]
• 573. Huang CH, Vatner SF, Peppas AP, Yang G, Kudej RKCardiac nerves affect myocardial stunning through reactive oxygen and nitric oxide mechanisms. Circ Res. 2003;93:866–873.[PubMed][Google Scholar]
• 574. Huang PL, Dawson TM, Bredt DS, Snyder SH, Fishman MCTargeted disruption of the neuronal nitric oxide synthase gene. Cell. 1993;75:1273–1286.[PubMed][Google Scholar]
• 575. Huang Z, Huang PL, Ma J, Meng W, Ayata C, Fishman MC, Moskowitz MAEnlarged infarcts in endothelial nitric oxide synthase knockout mice are attenuated by nitro-L-arginine. J Cereb Blood Flow Metab. 1996;16:981–987.[PubMed][Google Scholar]
• 576. Huang Z, Huang PL, Panahian N, Dalkara T, Fishman MC, Moskowitz MAEffects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science. 1994;265:1883–1885.[PubMed][Google Scholar]
• 577. Hubbard SR, Till JHProtein tyrosine kinase structure and function. Annu Rev Biochem. 2000;69:373–398.[PubMed][Google Scholar]
• 578. Huber W, Menander-Huber KB, Saifer MG, Williams LDBioavailability of superoxide dismutase: implications for the anti-inflammatory action mechanism of orgotein. Agents Actions Suppl. 1980;7:185–195.[PubMed][Google Scholar]
• 579. Hucks D, Thuraisingham RC, Raftery MJ, Yaqoob MMHomocysteine induced impairment of nitric oxide-dependent vasorelaxation is reversible by the superoxide dismutase mimetic TEM-POL. Nephrol Dial Transplant. 2004;19:1999–2005.[PubMed][Google Scholar]
• 580. Hughes MN, Nicklin HG. The chemistry of peroxonitrites. Part II. Copper (II)-catalysed reaction between hydroxylamine and peroxonitrite in alkali. J Chem Soc. 1970;1970:925–928.[PubMed]
• 581. Hughes MN, Nicklin HGA possible role for the species peroxonitrite in nitrification. Biochim Biophys Acta. 1970;222:660–661.[PubMed][Google Scholar]
• 582. Huhmer AF, Nishida CR, Ortiz de Montellano PR, Schoneich CInactivation of the inducible nitric oxide synthase by peroxynitrite. Chem Res Toxicol. 1997;10:618–626.[PubMed][Google Scholar]
• 583. Huie RE, Padmaja SThe reaction rate of nitric oxide with superoxide. Free Rad Res Commun. 1993;18:195–199.[PubMed][Google Scholar]
• 584. Hunter GC, Henderson AM, Westerband A, Kobayashi H, Suzuki F, Yan ZQ, Sirsjo A, Putnam CW, Hansson GKThe contribution of inducible nitric oxide and cytomegalovirus to the stability of complex carotid plaque. J Vasc Surg. 1999;30:36–50.[PubMed][Google Scholar]
• 585. Hussain SP, Trivers GE, Hofseth LJ, He P, Shaikh I, Mechanic LE, Doja S, Jiang W, Subleski J, Shorts L, Haines D, Laubach VE, Wiltrout RH, Djurickovic D, Harris CCNitric oxide, a mediator of inflammation, suppresses tumorigenesis. Cancer Res. 2004;64:6849–6853.[PubMed][Google Scholar]
• 586. Hutchinson FThe distance that a radical formed by ionizing radiation can diffuse in a yeast cell. Radiat Res. 1957;7:473–483.[PubMed][Google Scholar]
• 587. Iadecola C, Alexander MCerebral ischemia and inflammation. Curr Opin Neurol. 2001;14:89–94.[PubMed][Google Scholar]
• 588. Iadecola C, Xu X, Zhang F, el-Fakahany EE, Ross MEMarked induction of calcium-independent nitric oxide synthase activity after focal cerebral ischemia. J Cereb Blood Flow Metab. 1995;15:52–59.[PubMed][Google Scholar]
• 589. Iadecola C, Zhang F, Casey R, Clark HB, Ross MEInducible nitric oxide synthase gene expression in vascular cells after transient focal cerebral ischemia. Stroke. 1996;27:1373–1380.[PubMed][Google Scholar]
• 590. Iadecola C, Zhang F, Casey R, Nagayama M, Ross MEDelayed reduction of ischemic brain injury and neurological deficits in mice lacking the inducible nitric oxide synthase gene. J Neurosci. 1997;17:9157–9164.[Google Scholar]
• 591. Iadecola C, Zhang F, Xu XInhibition of inducible nitric oxide synthase ameliorates cerebral ischemic damage. Am J Physiol Regul Integr Comp Physiol. 1995;268:R286–R292.[PubMed][Google Scholar]
• 592. Ialenti A, Ianaro A, Moncada S, Di Rosa MModulation of acute inflammation by endogenous nitric oxide. Eur J Pharmacol. 1992;211:177–182.[PubMed][Google Scholar]
• 593. Ichinose F, Roberts JD, Jr, Zapol WMInhaled nitric oxide: a selective pulmonary vasodilator: current uses and therapeutic potential. Circulation. 2004;109:3106–3111.[PubMed][Google Scholar]
• 594. Ignarro LJHeme-dependent activation of soluble guanylate cyclase by nitric oxide: regulation of enzyme activity by porphyrins and metalloporphyrins. Semin Hematol. 1989;26:63–76.[PubMed][Google Scholar]
• 595. Ignarro LJNitric oxide: a unique endogenous signaling molecule in vascular biology. Biosci Rep. 1999;19:51–71.[PubMed][Google Scholar]
• 596. Ignarro LJ, Adams JB, Horwitz PM, Wood KSActivation of soluble guanylate cyclase by NO-hemoproteins involves NO-heme exchange. J Biol Chem. 1986;261:4997–5002.[PubMed][Google Scholar]
• 597. Ignarro LJ, Harbison RG, Wood KS, Kadowitz PJActivation of purified soluble guanylate cyclase by endothelium-derived relaxing factor from intrapulmonary artery and vein: stimulation by acetylcholine, bradykinin and arachidonic acid. J Pharmacol Exp Ther. 1986;237:893–900.[PubMed][Google Scholar]
• 598. Ilnytska O, Lyzogubov VV, Stevens MJ, Drel VR, Mashtalir N, Pacher P, Yorek MA, Obrosova IGPoly(ADP-ribose) polymerase inhibition alleviates experimental diabetic sensory neuropathy. Diabetes. 2006;55:1686–1694.[Google Scholar]
• 599. Imai H, Graham DI, Masayasu H, Macrae IMAntioxidant ebselen reduces oxidative damage in focal cerebral ischemia. Free Radic Biol Med. 2003;34:56–63.[PubMed][Google Scholar]
• 600. Inauen W, Granger DN, Meininger CJ, Schelling ME, Granger HJ, Kvietys PRAnoxia-reoxygenation-induced, neutrophil-mediated endothelial cell injury: role of elastase. Am J Physiol Heart Circ Physiol. 1990;259:H925–H931.[PubMed][Google Scholar]
• 601. Inoue M, Inoue KRole of free radicals in and around vascular endothelial cells in the mechanism of aging. Ann NY Acad Sci. 1996;786:224–232.[PubMed][Google Scholar]
• 602. Inoue T, Kato T, Hikichi Y, Hashimoto S, Hirase T, Morooka T, Imoto Y, Takeda Y, Sendo F, Node KStent-induced neutrophil activation is associated with an oxidative burst in the inflammatory process, leading to neointimal thickening. Thromb Haemost. 2006;95:43–48.[PubMed][Google Scholar]
• 603. Ip JH, Fuster V, Badimon L, Badimon J, Taubman MB, Chesebro JHSyndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation. J Am Coll Cardiol. 1990;15:1667–1687.[PubMed][Google Scholar]
• 604. Iqbal M, Cohen RI, Marzouk K, Liu SFTime course of nitric oxide, peroxynitrite, antioxidants in the endotoxemic heart. Crit Care Med. 2002;30:1291–1296.[PubMed][Google Scholar]
• 605. Ischiropoulos HBiological selectivity and functional aspects of protein tyrosine nitration. Biochem Biophys Res Commun. 2003;305:776–783.[PubMed][Google Scholar]
• 606. Ischiropoulos HBiological tyrosine nitration: a pathophysiological function of nitric oxide and reactive oxygen species. Arch Biochem Biophys. 1998;356:1–11.[PubMed][Google Scholar]
• 607. Ischiropoulos H, al-Mehdi AB, Fisher ABReactive species in ischemic rat lung injury: contribution of peroxynitrite. Am J Physiol Lung Cell Mol Physiol. 1995;269:L158–L164.[PubMed][Google Scholar]
• 608. Ischiropoulos H, Beckman JSOxidative stress and nitration in neurodegeneration: cause, effect, or association? J Clin Invest. 2003;111:163–169.[Google Scholar]
• 609. Ischiropoulos H, Chen J, Tsai JHM, Martin JC, Smith CD, Beckman JSPeroxynitrite (ONOO^{) reacts with superoxide dismutase to give the reactive nitronium ion (Abstract)} Free Rad Biol Med. 1990;9:131.[PubMed][Google Scholar]
• 610. Ischiropoulos H, Gow A, Thom SR, Kooy NW, Royall JA, Crow JPDetection of reactive nitrogen species using 2,7-dichlorodihydrofluorescein and dihydrorhodamine 123. Methods Enzymol. 1999;301:367–373.[PubMed][Google Scholar]
• 611. Ischiropoulos H, Zhu L, Beckman JSPeroxynitrite formation from macrophage-derived nitric oxide. Arch Biochem Biophys. 1992;298:446–451.[PubMed][Google Scholar]
• 612. Ischiropoulos H, Zhu L, Chen J, Tsai M, Martin JC, Smith CD, Beckman JSPeroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase. Arch Biochem Biophys. 1992;298:431–437.[PubMed][Google Scholar]
• 613. Ishida H, Genka C, Nakazawa HApplication of authentic peroxynitrite to biological materials. Methods Enzymol. 1999;301:402–409.[PubMed][Google Scholar]
• 614. Ishida H, Ichimori K, Hirota Y, Fukahori M, Nakazawa HPeroxynitrite-induced cardiac myocyte injury. Free Radic Biol Med. 1996;20:343–350.[PubMed][Google Scholar]
• 615. Ishii N, Patel KP, Lane PH, Taylor T, Bian K, Murad F, Pollock JS, Carmines PKNitric oxide synthesis and oxidative stress in the renal cortex of rats with diabetes mellitus. J Am Soc Nephrol. 2001;12:1630–1639.[PubMed][Google Scholar]
• 616. Ishiyama S, Hiroe M, Nishikawa T, Abe S, Shimojo T, Ito H, Ozasa S, Yamakawa K, Matsuzaki M, Mohammed MU, Nakazawa H, Kasajima T, Marumo FNitric oxide contributes to the progression of myocardial damage in experimental autoimmune myocarditis in rats. Circulation. 1997;95:489–496.[PubMed][Google Scholar]
• 617. Ito K, Hanazawa T, Tomita K, Barnes PJ, Adcock IMOxidative stress reduces histone deacetylase 2 activity and enhances IL-8 gene expression: role of tyrosine nitration. Biochem Biophys Res Commun. 2004;315:240–245.[PubMed][Google Scholar]
• 618. Jacobson GM, Dourron HM, Liu J, Carretero OA, Reddy DJ, Andrzejewski T, Pagano PJNovel NAD(P)H oxidase inhibitor suppresses angioplasty-induced superoxide and neointimal hyperplasia of rat carotid artery. Circ Res. 2003;92:637–643.[PubMed][Google Scholar]
• 619. Jadeski LC, Chakraborty C, Lala PKNitric oxide-mediated promotion of mammary tumour cell migration requires sequential activation of nitric oxide synthase, guanylate cyclase and mitogen-activated protein kinase. Int J Cancer. 2003;106:496–504.[PubMed][Google Scholar]
• 620. Jaeschke HGlutathione disulfide formation and oxidant stress during acetaminophen-induced hepatotoxicity in mice in vivo: the protective effect of allopurinol. J Pharmacol Exp Ther. 1990;255:935–941.[PubMed][Google Scholar]
• 621. Jaeschke HMolecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning. Am J Physiol Gastrointest Liver Physiol. 2003;284:G15–G26.[PubMed][Google Scholar]
• 622. Jaeschke H, Bajt MLIntracellular signaling mechanisms of acetaminophen-induced liver cell death. Toxicol Sci. 2006;89:31–41.[PubMed][Google Scholar]
• 623. Jagtap P, Soriano FG, Virag L, Liaudet L, Mabley J, Szabo E, Hasko G, Marton A, Lorigados CB, Gallyas F, Jr, Sumegi B, Hoyt DG, Baloglu E, VanDuzer J, Salzman AL, Southan GJ, Szabo CNovel phenanthridinone inhibitors of poly (adenosine 5′-diphosphate-ribose) synthetase: potent cytoprotective and antishock agents. Crit Care Med. 2002;30:1071–1082.[PubMed][Google Scholar]
• 624. Jagtap PG, Baloglu E, Southan GJ, Mabley JG, Li H, Zhou J, van Duzer J, Salzman AL, Szabo CDiscovery of potent poly-(ADP-ribose) polymerase-1 inhibitors from the modification of indeno[1,2-c]isoquinolinone. J Med Chem. 2005;48:5100–5103.[PubMed][Google Scholar]
• 625. Jaiswal M, LaRusso NF, Nishioka N, Nakabeppu Y, Gores GJHuman Ogg1, a protein involved in the repair of 8-oxoguanine, is inhibited by nitric oxide. Cancer Res. 2001;61:6388–6393.[PubMed][Google Scholar]
• 626. Jaiswal M, LaRusso NF, Shapiro RA, Billiar TR, Gores GJNitric oxide-mediated inhibition of DNA repair potentiates oxidative DNA damage in cholangiocytes. Gastroenterology. 2001;120:190–199.[PubMed][Google Scholar]
• 627. Jang B, Han SBiochemical properties of cytochrome c nitrated by peroxynitrite. Biochimie. 2006;88:53–58.[PubMed][Google Scholar]
• 628. Janssen-Heininger YM, Persinger RL, Korn SH, Pantano C, McElhinney B, Reynaert NL, Langen RC, Ckless K, Shrivastava P, Poynter MEReactive nitrogen species and cell signaling: implications for death or survival of lung epithelium. Am J Respir Crit Care Med. 2002;166:S9–S16.[PubMed][Google Scholar]
• 629. Javesghani D, Hussain SN, Scheidel J, Quinn MT, Magder SASuperoxide production in the vasculature of lipopolysaccharide-treated rats and pigs. Shock. 2003;19:486–493.[PubMed][Google Scholar]
• 630. Jay D, Hitomi H, Griendling KKOxidative stress and diabetic cardiovascular complications. Free Radic Biol Med. 2006;40:183–192.[PubMed][Google Scholar]
• 631. Jenkins DC, Charles IG, Thomsen LL, Moss DW, Holmes LS, Baylis SA, Rhodes P, Westmore K, Emson PC, Moncada SRoles of nitric oxide in tumor growth. Proc Natl Acad Sci USA. 1995;92:4392–4396.[Google Scholar]
• 632. Jenner POxidative stress in Parkinson’s disease. Ann Neurol. 2003;53(Suppl 3):S26–S36.[PubMed][Google Scholar]
• 633. Ji Y, Neverova I, Van Eyk JE, Bennett BMNitration of tyrosine 92 mediates the activation of rat microsomal glutathione S-transferase by peroxynitrite. J Biol Chem. 2006;281:1986–1991.[PubMed][Google Scholar]
• 634. Jijon HB, Churchill T, Malfair D, Wessler A, Jewell LD, Parsons HG, Madsen KLInhibition of poly(ADP-ribose) polymerase attenuates inflammation in a model of chronic colitis. Am J Physiol Gastrointest Liver Physiol. 2000;279:G641–G651.[PubMed][Google Scholar]
• 635. Jin L, Abou-Mohamed G, Caldwell RB, Caldwell RWEndothelial cell dysfunction in a model of oxidative stress. Med Sci Monit. 2001;7:585–591.[PubMed][Google Scholar]
• 636. Jones SP, Bolli RThe ubiquitous role of nitric oxide in cardioprotection. J Mol Cell Cardiol. 2006;40:16–23.[PubMed][Google Scholar]
• 637. Jones SP, Greer JJ, Ware PD, Yang J, Walsh K, Lefer DJDeficiency of iNOS does not attenuate severe congestive heart failure in mice. Am J Physiol Heart Circ Physiol. 2005;288:H365–H370.[PubMed][Google Scholar]
• 638. Jope RS, Zhang L, Song LPeroxynitrite modulates the activation of p38 and extracellular regulated kinases in PC12 cells. Arch Biochem Biophys. 2000;376:365–370.[PubMed][Google Scholar]
• 639. Joshi MS, Ferguson TB, Jr, Han TH, Hyduke DR, Liao JC, Rassaf T, Bryan N, Feelisch M, Lancaster JR., Jr Nitric oxide is consumed, rather than conserved, by reaction with oxyhemoglobin under physiological conditions. Proc Natl Acad Sci USA. 2002;99:10341–10346.
• 640. Jozsef L, Khreiss T, El Kebir D, Filep JGActivation of TLR-9 induces IL-8 secretion through peroxynitrite signaling in human neutrophils. J Immunol. 2006;176:1195–1202.[PubMed][Google Scholar]
• 641. Jozsef L, Zouki C, Petasis NA, Serhan CN, Filep JGLipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit peroxynitrite formation, NF-kappa B and AP-1 activation, and IL-8 gene expression in human leukocytes. Proc Natl Acad Sci USA. 2002;99:13266–13271.[Google Scholar]
• 642. Kacimi R, Karliner JS, Koudssi F, Long CSExpression and regulation of adhesion molecules in cardiac cells by cytokines: response to acute hypoxia. Circ Res. 1998;82:576–586.[PubMed][Google Scholar]
• 643. Kagota S, Yamaguchi Y, Tanaka N, Kubota Y, Kobayashi K, Nejime N, Nakamura K, Kunitomo M, Shinozuka KDisturbances in nitric oxide/cyclic guanosine monophosphate system in SHR/NDmcr-cp rats, a model of metabolic syndrome. Life Sci. 2006;78:1187–1196.[PubMed][Google Scholar]
• 644. Kahl KG, Zielasek J, Uttenthal LO, Rodrigo J, Toyka KV, Schmidt HHProtective role of the cytokine-inducible isoform of nitric oxide synthase induction and nitrosative stress in experimental autoimmune encephalomyelitis of the DA rat. J Neurosci Res. 2003;73:198–205.[PubMed][Google Scholar]
• 645. Kaji T, Kaieda I, Hisatsune T, Kaminogawa S3-Morpholino-sydnonimine hydrochloride induces p53-dependent apoptosis in murine primary neural cells: a critical role for p21(ras)-MAPK-p19(ARF) pathway. Nitric Oxide. 2002;6:125–134.[PubMed][Google Scholar]
• 646. Kajstura J, Fiordaliso F, Andreoli AM, Li B, Chimenti S, Medow MS, Limana F, Nadal-Ginard B, Leri A, Anversa PIGF-1 overexpression inhibits the development of diabetic cardiomyopathy and angiotensin II-mediated oxidative stress. Diabetes. 2001;50:1414–1424.[PubMed][Google Scholar]
• 647. Kalb RG, Agostini JMolecular evidence for nitric oxide-mediated motor neuron development. Neuroscience. 1993;57:1–8.[PubMed][Google Scholar]
• 648. Kalia N, Pockley AG, Wood RF, Brown NJEffects of FK409 on intestinal ischemia-reperfusion injury and ischemia-induced changes in the rat mucosal villus microcirculation. Transplantation. 2001;72:1875–1880.[PubMed][Google Scholar]
• 649. Kameoka M, Ota K, Tetsuka T, Tanaka Y, Itaya A, Okamoto T, Yoshihara KEvidence for regulation of NF-kappaB by poly-(ADP-ribose) polymerase. Biochem J. 2000;346:641–649.[Google Scholar]
• 650. Kamisaki Y, Waldman SA, Murad FThe involvement of catalytic site thiol groups in the activation of soluble guanylate cyclase by sodium nitroprusside. Arch Biochem Biophys. 1986;251:709–714.[PubMed][Google Scholar]
• 651. Kaneto H, Fujii J, Seo HG, Suzuki K, Matsuoka T, Nakamura M, Tatsumi H, Yamasaki Y, Kamada T, Taniguchi NApoptotic cell death triggered by nitric oxide in pancreatic beta-cells. Diabetes. 1995;44:733–738.[PubMed][Google Scholar]
• 652. Kang KW, Choi SH, Kim SGPeroxynitrite activates NF-E2-related factor 2/antioxidant response element through the pathway of phosphatidylinositol 3-kinase: the role of nitric oxide synthase in rat glutathione S-transferase A2 induction. Nitric Oxide. 2002;7:244–253.[PubMed][Google Scholar]
• 653. Kano H, Hayashi T, Sumi D, Matusi-Hirai H, Tsunekawa T, Endo H, Iguchi AEstriol retards and stabilizes atherosclerosis through an NO-mediated system. Life Sci. 2002;71:31–42.[PubMed][Google Scholar]
• 654. Kanski J, Behring A, Pelling J, Schoneich CProteomic identification of 3-nitrotyrosine-containing rat cardiac proteins: effects of biological aging. Am J Physiol Heart Circ Physiol. 2005;288:H371–H381.[PubMed][Google Scholar]
• 655. Kanski J, Hong SJ, Schoneich CProteomic analysis of protein nitration in aging skeletal muscle and identification of nitrotyrosine-containing sequences in vivo by nanoelectrospray ionization tandem mass spectrometry. J Biol Chem. 2005;280:24261–24266.[PubMed][Google Scholar]
• 656. Kase H, Hashikabe Y, Uchida K, Nakanishi N, Hattori YSupplementation with tetrahydrobiopterin prevents the cardiovascular effects of angiotensin II-induced oxidative and nitrosative stress. J Hypertens. 2005;23:1375–1382.[PubMed][Google Scholar]
• 657. Kashiwagi S, Izumi Y, Gohongi T, Demou ZN, Xu L, Huang PL, Buerk DG, Munn LL, Jain RK, Fukumura DNO mediates mural cell recruitment and vessel morphogenesis in murine melanomas and tissue-engineered blood vessels. J Clin Invest. 2005;115:1816–1827.[Google Scholar]
• 658. Kasina S, Rizwani W, Radhika KV, Singh SSNitration of profilin effects its interaction with poly (L-proline) and actin. J Biochem. 2005;138:687–695.[PubMed][Google Scholar]
• 659. Kasina S, Wasia R, Fasim A, Radhika KV, Singh SSPhorbol ester mediated activation of inducible nitric oxide synthase results in platelet profilin nitration. Nitric Oxide. 2006;14:65–71.[PubMed][Google Scholar]
• 660. Kawachi S, Hines IN, Laroux FS, Hoffman J, Bharwani S, Gray L, Leffer D, Grisham MBNitric oxide synthase and post-ischemic liver injury. Biochem Biophys Res Commun. 2000;276:851–854.[PubMed][Google Scholar]
• 661. Kawano T, Anrather J, Zhou P, Park L, Wang G, Frys KA, Kunz A, Cho S, Orio M, Iadecola CProstaglandin E₂ EP1 receptors: downstream effectors of COX-2 neurotoxicity. Nat Med. 2006;12:225–229.[PubMed][Google Scholar]
• 662. Keel M, Trentz OPathophysiology of polytrauma. Injury. 2005;36:691–709.[PubMed][Google Scholar]
• 663. Keira N, Tatsumi T, Matoba S, Shiraishi J, Yamanaka S, Akashi K, Kobara M, Asayama J, Fushiki S, Fliss H, Nakagawa MLethal effect of cytokine-induced nitric oxide and peroxynitrite on cultured rat cardiac myocytes. J Mol Cell Cardiol. 2002;34:583–596.[PubMed][Google Scholar]
• 664. Keller JN, Kindy MS, Holtsberg FW, St Clair DK, Yen HC, Germeyer A, Steiner SM, Bruce-Keller AJ, Hutchins JB, Mattson MPMitochondrial manganese superoxide dismutase prevents neural apoptosis and reduces ischemic brain injury: suppression of peroxynitrite production, lipid peroxidation, mitochondrial dysfunction. J Neurosci. 1998;18:687–697.[Google Scholar]
• 665. Keller JN, Mattson MPRoles of lipid peroxidation in modulation of cellular signaling pathways, cell dysfunction, death in the nervous system. Rev Neurosci. 1998;9:105–116.[PubMed][Google Scholar]
• 666. Kennedy M, Denenberg AG, Szabo C, Salzman ALPoly(ADP-ribose) synthetase activation mediates increased permeability induced by peroxynitrite in Caco-2BBe cells. Gastroenterology. 1998;114:510–518.[PubMed][Google Scholar]
• 667. Kennedy S, Preston AA, McPhaden AR, Miller AM, Wainwright CL, Wadsworth RMCorrelation of changes in nitric oxide synthase, superoxide dismutase and nitrotyrosine with endothelial regeneration and neointimal hyperplasia in the balloon-injured rabbit subclavian artery. Coron Artery Dis. 2004;15:337–346.[PubMed][Google Scholar]
• 668. Kettle AJ, van Dalen CJ, Winterbourn CCPeroxynitrite and myeloperoxidase leave the same footprint in protein nitration. Redox Rep. 1997;3:257–258.[PubMed][Google Scholar]
• 669. Keyer K, Imlay JAInactivation of dehydratase [4Fe-4S] clusters and disruption of iron homeostasis upon cell exposure to peroxynitrite. J Biol Chem. 1997;272:27652–27659.[PubMed][Google Scholar]
• 670. Khadour FH, Panas D, Ferdinandy P, Schulze C, Csont T, Lalu MM, Wildhirt SM, Schulz REnhanced NO and superoxide generation in dysfunctional hearts from endotoxemic rats. Am J Physiol Heart Circ Physiol. 2002;283:H1108–H1115.[PubMed][Google Scholar]
• 671. Khan F, Ali RAntibodies against nitric oxide damaged poly L-tyrosine and 3-nitrotyrosine levels in systemic lupus erythematosus. J Biochem Mol Biol. 2006;39:189–196.[PubMed][Google Scholar]
• 672. Khan M, Jatana M, Elango C, Singh Paintlia A, Singh AK, Singh ICerebrovascular protection by various nitric oxide donors in rats after experimental stroke. Nitric Oxide. 2006;15:114–124.[PubMed][Google Scholar]
• 673. Khor HK, Fisher MT, Schoneich CPotential role of methionine sulfoxide in the inactivation of the chaperone GroEL by hypochlorous acid (HOCl) and peroxynitrite (ONOO⁾ J Biol Chem. 2004;279:19486–19493.[PubMed][Google Scholar]
• 674. Khreiss T, Jozsef L, Potempa LA, Filep JGLoss of pentameric symmetry in C-reactive protein induces interleukin-8 secretion through peroxynitrite signaling in human neutrophils. Circ Res. 2005;97:690–697.[PubMed][Google Scholar]
• 675. Killestein J, Polman CHCurrent trials in multiple sclerosis: established evidence and future hopes. Curr Opin Neurol. 2005;18:253–260.[PubMed][Google Scholar]
• 676. Kim CH, Zou Y, Kim DH, Kim ND, Yu BP, Chung HYProteomic analysis of nitrated and 4-hydroxy-2-nonenal-modified serum proteins during aging. J Gerontol A Biol Sci Med Sci. 2006;61:332–338.[PubMed][Google Scholar]
• 677. Kim GW, Kondo T, Noshita N, Chan PHManganese superoxide dismutase deficiency exacerbates cerebral infarction after focal cerebral ischemia/reperfusion in mice: implications for the production and role of superoxide radicals. Stroke. 2002;33:809–815.[PubMed][Google Scholar]
• 678. King PA, Anderson VE, Edwards JO, Gustafson G, Plumb RC, Suggs JWA stable solid that generates hydroxyl radical upon dissolution in aqueous solutions: reaction with proteins and nucleic acid. J Am Chem Soc. 1992;114:5430–5432.[PubMed][Google Scholar]
• 679. Kinobe R, Ji Y, Nakatsu KPeroxynitrite-mediated inactivation of heme oxygenases. BMC Pharmacol. 2004;4:26.[Google Scholar]
• 680. Kinsella JPInhaled nitric oxide therapy in premature newborns. Curr Opin Pediatr. 2006;18:107–111.[PubMed][Google Scholar]
• 681. Kinsella JP, Cutter GR, Walsh WF, Gerstmann DR, Bose CL, Hart C, Sekar KC, Auten RL, Bhutani VK, Gerdes JS, George TN, Southgate WM, Carriedo H, Couser RJ, Mammel MC, Hall DC, Pappagallo M, Sardesai S, Strain JD, Baier M, Abman SHEarly inhaled nitric oxide therapy in premature newborns with respiratory failure. N Engl J Med. 2006;355:354–364.[PubMed][Google Scholar]
• 682. Kisley LR, Barrett BS, Bauer AK, Dwyer-Nield LD, Barthel B, Meyer AM, Thompson DC, Malkinson AMGenetic ablation of inducible nitric oxide synthase decreases mouse lung tumorigenesis. Cancer Res. 2002;62:6850–6856.[PubMed][Google Scholar]
• 683. Kiss J, Lamarque D, Delchier JC, Whittle BJTime-dependent actions of nitric oxide synthase inhibition on colonic inflammation induced by trinitrobenzene sulphonic acid in rats. Eur J Pharmacol. 1997;336:219–224.[PubMed][Google Scholar]
• 684. Kiziltepe T, Yan A, Dong M, Jonnalagadda VS, Dedon PC, Engelward BPDelineation of the chemical pathways underlying nitric oxide-induced homologous recombination in mammalian cells. Chem Biol. 2005;12:357–369.[PubMed][Google Scholar]
• 685. Kleemann R, Rothe H, Kolb-Bachofen V, Xie QW, Nathan C, Martin S, Kolb HTranscription and translation of inducible nitric oxide synthase in the pancreas of prediabetic BB rats. FEBS Lett. 1993;328:9–12.[PubMed][Google Scholar]
• 686. Klein JA, Ackerman SLOxidative stress, cell cycle, neurodegeneration. J Clin Invest. 2003;111:785–793.[Google Scholar]
• 687. Klotz LO, Schieke SM, Sies H, Holbrook NJPeroxynitrite activates the phosphoinositide 3-kinase/Akt pathway in human skin primary fibroblasts. Biochem J. 2000;352:219–225.[Google Scholar]
• 688. Klug D, Rabani J, Fridovich IA direct demonstration of the catalytic action of superoxide dismutase through the use of pulse radiolysis. J Biol Chem. 1972;247:4839–4842.[PubMed][Google Scholar]
• 689. Knapp LT, Kanterewicz BI, Hayes EL, Klann EPeroxynitrite-induced tyrosine nitration and inhibition of protein kinase C. Biochem Biophys Res Commun. 2001;286:764–770.[PubMed][Google Scholar]
• 690. Knight TR, Kurtz A, Bajt ML, Hinson JA, Jaeschke HVascular and hepatocellular peroxynitrite formation during acetaminophen toxicity: role of mitochondrial oxidant stress. Toxicol Sci. 2001;62:212–220.[PubMed][Google Scholar]
• 691. Knight-Lozano CA, Young CG, Burow DL, Hu ZY, Uyeminami D, Pinkerton KE, Ischiropoulos H, Ballinger SWCigarette smoke exposure and hypercholesterolemia increase mitochondrial damage in cardiovascular tissues. Circulation. 2002;105:849–854.[PubMed][Google Scholar]
• 692. Knyushko TV, Sharov VS, Williams TD, Schoneich C, Bigelow DJ3-Nitrotyrosine modification of SERCA2a in the aging heart: a distinct signature of the cellular redox environment. Biochemistry. 2005;44:13071–13081.[PubMed][Google Scholar]
• 693. Kobayashi N, Horinaka S, Mita S, Yoshida K, Honda T, Kobayashi T, Hara K, Nishikimi T, Matsuoka HAminoguanidine inhibits mitogen-activated protein kinase and improves cardiac performance and cardiovascular remodeling in failing hearts of salt-sensitive hypertensive rats. J Hypertens. 2002;20:2475–2485.[PubMed][Google Scholar]
• 694. Koch M, De Keyser JUric acid in multiple sclerosis. Neurol Res. 2006;28:316–319.[PubMed][Google Scholar]
• 695. Koeck T, Levison B, Hazen SL, Crabb JW, Stuehr DJ, Aulak KSTyrosine nitration impairs mammalian aldolase A activity. Mol Cell Proteomics. 2004;3:548–557.[PubMed][Google Scholar]
• 696. Koh DW, Dawson TM, Dawson VLMediation of cell death by poly(ADP-ribose) polymerase-1. Pharmacol Res. 2005;52:5–14.[PubMed][Google Scholar]
• 697. Koh SH, Park Y, Song CW, Kim JG, Kim K, Kim J, Kim MH, Lee SR, Kim DW, Yu HJ, Chang DI, Hwang SJ, Kim SHThe effect of PARP inhibitor on ischaemic cell death, its related inflammation and survival signals. Eur J Neurosci. 2004;20:1461–1472.[PubMed][Google Scholar]
• 698. Koller ASignaling pathways of mechanotransduction in arteriolar endothelium and smooth muscle cells in hypertension. Microcirculation. 2002;9:277–294.[PubMed][Google Scholar]
• 699. Koller A, Huang AImpaired nitric oxide-mediated flow-induced dilation in arterioles of spontaneously hypertensive rats. Circ Res. 1994;74:416–421.[PubMed][Google Scholar]
• 700. Koller WCParaquat and Parkinson’s disease. Neurology. 1986;36:1147.[PubMed][Google Scholar]
• 701. Kondo T, Reaume AG, Huang TT, Carlson E, Murakami K, Chen SF, Hoffman EK, Scott RW, Epstein CJ, Chan PHReduction of CuZn-superoxide dismutase activity exacerbates neuronal cell injury and edema formation after transient focal cerebral ischemia. J Neurosci. 1997;17:4180–4189.[Google Scholar]
• 702. Kong SK, Yim MB, Stadtman ER, Chock PBPeroxynitrite disables the tyrosine phosphorylation regulatory mechanism: lymphocyte-specific tyrosine kinase fails to phosphorylate nitrated cdc2(6–20)NH2 peptide. Proc Natl Acad Sci USA. 1996;93:3377–3382.[Google Scholar]
• 703. Konorev EA, Hogg N, Kalyanaraman BRapid and irreversible inhibition of creatine kinase by peroxynitrite. FEBS Lett. 1998;427:171–174.[PubMed][Google Scholar]
• 704. Kooy NW, Lewis SJElevation in arterial blood pressure following the development of tachyphylaxis to peroxynitrite. Eur J Pharmacol. 1996;307:R5–R7.[PubMed][Google Scholar]
• 705. Kooy NW, Lewis SJNitrotyrosine attenuates the hemodynamic effects of adrenoceptor agonists in vivo: relevance to the pathophysiology of peroxynitrite. Eur J Pharmacol. 1996;310:155–161.[PubMed][Google Scholar]
• 706. Kooy NW, Lewis SJThe peroxynitrite product 3-nitro-L-tyrosine attenuates the hemodynamic responses to angiotensin II in vivo. Eur J Pharmacol. 1996;315:165–170.[PubMed][Google Scholar]
• 707. Kooy NW, Lewis SJ, Royall JA, Ye YZ, Kelly DR, Beckman JSExtensive tyrosine nitration in human myocardial inflammation: evidence for the presence of peroxynitrite. Crit Care Med. 1997;25:812–819.[PubMed][Google Scholar]
• 708. Koppenol WH100 years of peroxynitrite chemistry and 11 years of peroxynitrite biochemistry. Redox Rep. 2001;6:339–341.[PubMed][Google Scholar]
• 709. Koppenol WH, Moreno JJ, Pryor WA, Ischiropoulos H, Beckman JSPeroxynitrite, a cloaked oxidant formed by nitric oxide and superoxide. Chem Res Toxicol. 1992;5:834–842.[PubMed][Google Scholar]
• 710. Koprowski H, Spitsin SV, Hooper DCProspects for the treatment of multiple sclerosis by raising serum levels of uric acid, a scavenger of peroxynitrite. Ann Neurol. 2001;49:139.[PubMed][Google Scholar]
• 711. Kossenjans W, Eis A, Sahay R, Brockman D, Myatt LRole of peroxynitrite in altered fetal-placental vascular reactivity in diabetes or preeclampsia. Am J Physiol Heart Circ Physiol. 2000;278:H1311–H1319.[PubMed][Google Scholar]
• 712. Kowluru RAEffect of reinstitution of good glycemic control on retinal oxidative stress and nitrative stress in diabetic rats. Diabetes. 2003;52:818–823.[PubMed][Google Scholar]
• 713. Kowluru RA, Koppolu P, Chakrabarti S, Chen SDiabetes-induced activation of nuclear transcriptional factor in the retina, its inhibition by antioxidants. Free Radic Res. 2003;37:1169–1180.[PubMed][Google Scholar]
• 714. Krieglstein CF, Cerwinka WH, Laroux FS, Salter JW, Russell JM, Schuermann G, Grisham MB, Ross CR, Granger DNRegulation of murine intestinal inflammation by reactive metabolites of oxygen and nitrogen: divergent roles of superoxide and nitric oxide. J Exp Med. 2001;194:1207–1218.[Google Scholar]
• 715. Kroncke KD, Funda J, Berschick B, Kolb H, Kolb-Bachofen VMacrophage cytotoxicity towards isolated rat islet cells: neither lysis nor its protection by nicotinamide are beta-cell specific. Diabetologia. 1991;34:232–238.[PubMed][Google Scholar]
• 716. Krupinski J, Vodovotz Y, Li C, Slowik A, Beevers D, Flanders KC, Lip G, Kumar P, Szczudlik AInducible nitric oxide production and expression of transforming growth factor-beta1 in serum and CSF after cerebral ischaemic stroke in man. Nitric Oxide. 1998;2:442–453.[PubMed][Google Scholar]
• 717. Kubes PIschemia-reperfusion in feline small intestine: a role for nitric oxide. Am J Physiol Gastrointest Liver Physiol. 1993;264:G143–G149.[PubMed][Google Scholar]
• 718. Kuhn DM, Aretha CW, Geddes TJPeroxynitrite inactivation of tyrosine hydroxylase: mediation by sulfhydryl oxidation, not tyrosine nitration. J Neurosci. 1999;19:10289–10294.[Google Scholar]
• 719. Kuhn DM, Geddes TJ. Peroxynitrite inactivates tryptophan hydroxylase via sulfhydryl oxidation. Coincident nitration of enzyme tyrosyl residues has minimal impact on catalytic activity. J Biol Chem. 1999;274:29726–29732.[PubMed]
• 720. Kuhn DM, Geddes TJReduced nicotinamide nucleotides prevent nitration of tyrosine hydroxylase by peroxynitrite. Brain Res. 2002;933:85–89.[PubMed][Google Scholar]
• 721. Kuhn DM, Sadidi M, Liu X, Kreipke C, Geddes T, Borges C, Watson JTPeroxynitrite-induced nitration of tyrosine hydroxylase: identification of tyrosines 423, 428, 432 as sites of modification by matrix-assisted laser desorption ionization time-of-flight mass spectrometry and tyrosine-scanning mutagenesis. J Biol Chem. 2002;277:14336–14342.[PubMed][Google Scholar]
• 722. Kuroki I, Miyazaki T, Mizukami I, Matsumoto N, Matsumoto IEffect of sodium nitroprusside on ischemia-reperfusion injuries of the rat liver. Hepatogastroenterology. 2004;51:1404–1407.[PubMed][Google Scholar]
• 723. Kurzelewski M, Czarnowska E, Beresewicz ASuperoxide-and nitric oxide-derived species mediate endothelial dysfunction, endothelial glycocalyx disruption, enhanced neutrophil adhesion in the post-ischemic guinea-pig heart. J Physiol Pharmacol. 2005;56:163–178.[PubMed][Google Scholar]
• 724. Kuster GM, Kotlyar E, Rude MK, Siwik DA, Liao R, Colucci WS, Sam FMineralocorticoid receptor inhibition ameliorates the transition to myocardial failure and decreases oxidative stress and inflammation in mice with chronic pressure overload. Circulation. 2005;111:420–427.[PubMed][Google Scholar]
• 725. Kuzkaya N, Weissmann N, Harrison DG, Dikalov SInteractions of peroxynitrite, tetrahydrobiopterin, ascorbic acid, thiols: implications for uncoupling endothelial nitric-oxide synthase. J Biol Chem. 2003;278:22546–22554.[PubMed][Google Scholar]
• 726. Lakatta EG. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises. Part III: cellular and molecular clues to heart and arterial aging. Circulation. 2003;107:490–497.[PubMed]
• 727. Lakatta EG, Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises. Part II: the aging heart in health: links to heart disease. Circulation. 2003;107:346–354.[PubMed]
• 728. Lancaster JRSimulation of the diffusion and reaction of endogenously produced nitric oxide. Proc Natl Acad Sci USA. 1994;91:8137–8141.[Google Scholar]
• 729. Lancel S, Tissier S, Mordon S, Marechal X, Depontieu F, Scherpereel A, Chopin C, Neviere RPeroxynitrite decomposition catalysts prevent myocardial dysfunction and inflammation in endotoxemic rats. J Am Coll Cardiol. 2004;43:2348–2358.[PubMed][Google Scholar]
• 730. Landino LM, Iwig JS, Kennett KL, Moynihan KLRepair of peroxynitrite damage to tubulin by the thioredoxin reductase system. Free Radic Biol Med. 2004;36:497–506.[PubMed][Google Scholar]
• 731. Landmesser U, Drexler HThe clinical significance of endothelial dysfunction. Curr Opin Cardiol. 2005;20:547–551.[PubMed][Google Scholar]
• 732. Lanone S, Manivet P, Callebert J, Launay JM, Payen D, Aubier M, Boczkowski J, Mebazaa AInducible nitric oxide synthase (NOS2) expressed in septic patients is nitrated on selected tyrosine residues: implications for enzymic activity. Biochem J. 2002;366:399–404.[Google Scholar]
• 733. Lassegue B, Sorescu D, Szocs K, Yin Q, Akers M, Zhang Y, Grant SL, Lambeth JD, Griendling KKNovel gp91(phox) homologues in vascular smooth muscle cells: nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways. Circ Res. 2001;88:888–894.[PubMed][Google Scholar]
• 734. Laursen JB, Somers M, Kurz S, McCann L, Warnholtz A, Freeman BA, Tarpey M, Fukai T, Harrison DGEndothelial regulation of vasomotion in apoE-deficient mice: implications for interactions between peroxynitrite and tetrahydrobiopterin. Circulation. 2001;103:1282–1288.[PubMed][Google Scholar]
• 735. Lee C, Miura K, Liu X, Zweier JLBiphasic regulation of leukocyte superoxide generation by nitric oxide and peroxynitrite. J Biol Chem. 2000;275:38965–38972.[PubMed][Google Scholar]
• 736. Lee CI, Liu X, Zweier JLRegulation of xanthine oxidase by nitric oxide and peroxynitrite. J Biol Chem. 2000;275:9369–9376.[PubMed][Google Scholar]
• 737. Lee CK, Allison DB, Brand J, Weindruch R, Prolla TATranscriptional profiles associated with aging and middle age-onset caloric restriction in mouse hearts. Proc Natl Acad Sci USA. 2002;99:14988–14993.[Google Scholar]
• 738. Lee JH, Yang ES, Park JWInactivation of NADP^{-dependent isocitrate dehydrogenase by peroxynitrite. Implications for cytotoxicity and alcohol-induced liver injury.} J Biol Chem. 2003;278:51360–51371.[PubMed][Google Scholar]
• 739. Lee VG, Johnson ML, Baust J, Laubach VE, Watkins SC, Billiar TRThe roles of iNOS in liver ischemia-reperfusion injury. Shock. 2001;16:355–360.[PubMed][Google Scholar]
• 740. Lee WH, Gounarides JS, Roos ES, Wolin MSInfluence of peroxynitrite on energy metabolism and cardiac function in a rat ischemia-reperfusion model. Am J Physiol Heart Circ Physiol. 2003;285:H1385–H1395.[PubMed][Google Scholar]
• 741. Lees KR, Zivin JA, Ashwood T, Davalos A, Davis SM, Diener HC, Grotta J, Lyden P, Shuaib A, Hardemark HG, Wasiewski WWNXY-059 for acute ischemic stroke. N Engl J Med. 2006;354:588–600.[PubMed][Google Scholar]
• 742. Leeuwenburgh C, Hardy MM, Hazen SL, Wagner P, Ohishi S, Steinbrecher UP, Heinecke JWReactive nitrogen intermediates promote low density lipoprotein oxidation in human atherosclerotic intima. J Biol Chem. 1997;272:1433–1436.[PubMed][Google Scholar]
• 743. Lefer AM, Lefer DJThe role of nitric oxide and cell adhesion molecules on the microcirculation in ischaemia-reperfusion. Cardiovasc Res. 1996;32:743–751.[PubMed][Google Scholar]
• 744. Lefer DJ, Scalia R, Campbell B, Nossuli T, Hayward R, Salamon M, Grayson J, Lefer AMPeroxynitrite inhibits leukocyte-endothelial cell interactions and protects against ischemia-reperfusion injury in rats. J Clin Invest. 1997;99:684–691.[Google Scholar]
• 745. Lehnert M, Arteel GE, Smutney OM, Conzelmann LO, Zhong Z, Thurman RG, Lemasters JJDependence of liver injury after hemorrhage/resuscitation in mice on NADPH oxidase-derived superoxide. Shock. 2003;19:345–351.[PubMed][Google Scholar]
• 746. Lei SZ, Pan ZH, Aggarwal SK, Chen HS, Hartman J, Sucher NJ, Lipton SAEffect of nitric oxide production on the redox modulatory site of the NMDA receptor-channel complex. Neuron. 1992;8:1087–1099.[PubMed][Google Scholar]
• 747. Leite PF, Danilovic A, Moriel P, Dantas K, Marklund S, Dantas AP, Laurindo FRSustained decrease in superoxide dismutase activity underlies constrictive remodeling after balloon injury in rabbits. Arterioscler Thromb Vasc Biol. 2003;23:2197–2202.[PubMed][Google Scholar]
• 748. Lepoivre M, Houee-Levin C, Coeytaux K, Decottignies P, Auger G, Lemaire GNitration of the tyrosyl radical in ribonucleotide reductase by nitrogen dioxide: a gamma radiolysis study. Free Radic Biol Med. 2005;38:1511–1517.[PubMed][Google Scholar]
• 749. Levrand S, Pesse B, Feihl F, Waeber B, Pacher P, Rolli J, Schaller MD, Liaudet LPeroxynitrite is a potent inhibitor of NF-kappa B activation triggered by inflammatory stimuli in cardiac and endothelial cell lines. J Biol Chem. 2005;280:34878–34887.[Google Scholar]
• 750. Levrand S, Vannay-Bouchiche C, Pesse B, Pacher P, Feihl F, Waeber B, Liaudet LPeroxynitrite is a major trigger of cardiomyocyte apoptosis in vitro and in vivo. Free Radic Biol Med. 2006;41:886–895.[Google Scholar]
• 751. Lewis SJ, Hoque A, Sandock K, Robertson TP, Bates JN, Kooy NWDifferential effects of peroxynitrite on the function of arginine vasopressin V(1a) receptors and alpha(1)-adrenoceptors in vivo. Vasc Pharmacol. In press. [[PubMed]
• 752. Lewis SJ, Hoque A, Walton TM, Kooy NWPotential role of nitration and oxidation reactions in the effects of peroxynitrite on the function of beta-adrenoceptor sub-types in the rat. Eur J Pharmacol. 2005;518:187–194.[PubMed][Google Scholar]
• 753. Li F, Szabo C, Pacher P, Southan GJ, Abatan OI, Char-niauskaya T, Stevens MJ, Obrosova IGEvaluation of orally active poly(ADP-ribose) polymerase inhibitor in streptozotocin-diabetic rat model of early peripheral neuropathy. Diabetologia. 2004;47:710–717.[PubMed][Google Scholar]
• 754. Li H, Gutterman DD, Rusch NJ, Bubolz A, Liu YNitration and functional loss of voltage-gated K^{channels in rat coronary microvessels exposed to high glucose.} Diabetes. 2004;53:2436–2442.[PubMed][Google Scholar]
• 755. Li J, Li W, Su J, Liu W, Altura BT, Altura BMPeroxynitrite induces apoptosis in rat aortic smooth muscle cells: possible relation to vascular diseases. Exp Biol Med. 2004;229:264–269.[PubMed][Google Scholar]
• 756. Li J, Su J, Li W, Liu W, Altura BT, Altura BMPeroxynitrite induces apoptosis in canine cerebral vascular muscle cells: possible relation to neurodegenerative diseases and strokes. Neurosci Lett. 2003;350:173–177.[PubMed][Google Scholar]
• 757. Li JM, Shah AMEndothelial cell superoxide generation: regulation and relevance for cardiovascular pathophysiology. Am J Physiol Regul Integr Comp Physiol. 2004;287:R1014–R1030.[PubMed][Google Scholar]
• 758. Li MH, Cha YN, Surh YJCarbon monoxide protects PC12 cells from peroxynitrite-induced apoptotic death by preventing the depolarization of mitochondrial transmembrane potential. Biochem Biophys Res Commun. 2006;342:984–990.[PubMed][Google Scholar]
• 759. Li N, Karin MIs NF-kappaB the sensor of oxidative stress? FASEB J. 1999;13:1137–1143.[PubMed][Google Scholar]
• 760. Li X, De Sarno P, Song L, Beckman JS, Jope RSPeroxynitrite modulates tyrosine phosphorylation and phosphoinositide signalling in human neuroblastoma SH-SY5Y cells: attenuated effects in human 1321N1 astrocytoma cells. Biochem J. 1998;331:599–606.[Google Scholar]
• 761. Li Y, Huang TT, Carlson EJ, Melov S, Ursell PC, Olson JL, Noble LJ, Yoshimura MP, Berger C, Chan PH, Wallace DC, Epstein CJDilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nature Genet. 1995;11:376–381.[PubMed][Google Scholar]
• 762. Liaudet LPoly(adenosine 5′-diphosphate) ribose polymerase activation as a cause of metabolic dysfunction in critical illness. Curr Opin Clin Nutr Metab Care. 2002;5:175–184.[PubMed][Google Scholar]
• 763. Liaudet L, Mabley JG, Soriano FG, Pacher P, Marton A, Hasko G, Szabo CInosine reduces systemic inflammation and improves survival in septic shock induced by cecal ligation and puncture. Am J Respir Crit Care Med. 2001;164:1213–1220.[PubMed][Google Scholar]
• 764. Liaudet L, Murthy KG, Mabley JG, Pacher P, Soriano FG, Salzman AL, Szabo CComparison of inflammation, organ damage, oxidant stress induced by Salmonella enterica serovar Muenchen flagellin and serovar Enteritidis lipopolysaccharide. Infect Immun. 2002;70:192–198.[Google Scholar]
• 765. Liaudet L, Oddo MRole of poly(adenosine diphosphate-ribose) polymerase 1 in septic peritonitis. Curr Opin Crit Care. 2003;9:152–158.[PubMed][Google Scholar]
• 766. Liaudet L, Soriano FG, Szabo CBiology of nitric oxide signaling. Crit Care Med. 2000;28:N37–52.[PubMed][Google Scholar]
• 767. Liaudet L, Soriano FG, Szabo E, Virag L, Mabley JG, Salz-man AL, Szabo CProtection against hemorrhagic shock in mice genetically deficient in poly(ADP-ribose)polymerase. Proc Natl Acad Sci USA. 2000;97:10203–10208.[Google Scholar]
• 768. Liaudet L, Szabo A, Soriano FG, Zingarelli B, Szabo C, Salzman ALPoly(ADP-ribose) synthetase mediates intestinal mucosal barrier dysfunction after mesenteric ischemia. Shock. 2000;14:134–141.[PubMed][Google Scholar]
• 769. Liaudet L, Szabo G, Szabo COxidative stress and regional ischemia-reperfusion injury: the peroxynitrite-poly(ADP-ribose) polymerase connection. Coron Artery Dis. 2003;14:115–122.[PubMed][Google Scholar]
• 770. Liaudet L, Yang Z, Al-Affar EB, Szabo CMyocardial ischemic preconditioning in rodents is dependent on poly (ADP-ribose) synthetase. Mol Med. 2001;7:406–417.[Google Scholar]
• 771. Libermann TA, Baltimore DActivation of interleukin-6 gene expression through the NF-kappa B transcription factor. Mol Cell Biol. 1990;10:2327–2334.[Google Scholar]
• 772. Lin HL, Kent UM, Zhang H, Waskell L, Hollenberg PFMutation of tyrosine 190 to alanine eliminates the inactivation of cytochrome P450 2B1 by peroxynitrite. Chem Res Toxicol. 2003;16:129–136.[PubMed][Google Scholar]
• 773. Lin KT, Xue JY, Nomen M, Spur B, Wong PYPeroxynitrite-induced apoptosis in HL-60 cells. J Biol Chem. 1995;270:16487–16490.[PubMed][Google Scholar]
• 774. Ling H, Gengaro PE, Edelstein CL, Martin PY, Wangsiripaisan A, Nemenoff R, Schrier RWEffect of hypoxia on proximal tubules isolated from nitric oxide synthase knockout mice. Kidney Int. 1998;53:1642–1646.[PubMed][Google Scholar]
• 775. Linke A, Recchia F, Zhang X, Hintze THAcute and chronic endothelial dysfunction: implications for the development of heart failure. Heart Fail Rev. 2003;8:87–97.[PubMed][Google Scholar]
• 776. Linz W, Itter G, Dobrucki LW, Malinski T, Wiemer GRamipril improves nitric oxide availability in hypertensive rats with failing hearts after myocardial infarction. J Renin Angiotensin Aldosterone Syst. 2003;4:180–185.[PubMed][Google Scholar]
• 777. Liochev SI, Fridovich IReversal of the superoxide dismutase reaction revisited. Free Radic Biol Med. 2003;34:908–910.[PubMed][Google Scholar]
• 778. Lipton PIschemic cell death in brain neurons. Physiol Rev. 1999;79:1431–1568.[PubMed][Google Scholar]
• 779. Lipton SA, Choi YB, Pan ZH, Lei SZ, Chen HS, Sucher NJ, Loscalzo J, Singel DJ, Stamler JSA redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature. 1993;364:626–632.[PubMed][Google Scholar]
• 780. Liu JS, Zhao ML, Brosnan CF, Lee SCExpression of inducible nitric oxide synthase and nitrotyrosine in multiple sclerosis lesions. Am J Pathol. 2001;158:2057–2066.[Google Scholar]
• 781. Liu P, Hock CE, Nagele R, Wong PYFormation of nitric oxide, superoxide, peroxynitrite in myocardial ischemia-reperfusion injury in rats. Am J Physiol Heart Circ Physiol. 1997;272:H2327–H2336.[PubMed][Google Scholar]
• 782. Liu P, Xu B, Quilley J, Wong PYPeroxynitrite attenuates hepatic ischemia-reperfusion injury. Am J Physiol Cell Physiol. 2000;279:C1970–C1977.[PubMed][Google Scholar]
• 783. Liu S, Beckman JS, Ku DDPeroxynitrite, a product of superoxide and nitric oxide, produces coronary vasorelaxation in dogs. J Pharmacol Exp Ther. 1994;268:1114–1121.[PubMed][Google Scholar]
• 784. Liu X, Miller MJ, Joshi MS, Thomas DD, Lancaster JR., Jr Accelerated reaction of nitric oxide with O₂ within the hydrophobic interior of biological membranes. Proc Natl Acad Sci USA. 1998;95:2175–2179.
• 785. Liu Y, Gutterman DDOxidative stress and potassium channel function. Clin Exp Pharmacol Physiol. 2002;29:305–311.[PubMed][Google Scholar]
• 786. Liu Y, Terata K, Chai Q, Li H, Kleinman LH, Gutterman DDPeroxynitrite inhibits Ca^{-activated Kchannel activity in smooth muscle of human coronary arterioles.} Circ Res. 2002;91:1070–1076.[PubMed][Google Scholar]
• 787. Lo CC, Chen JC, Chen HM, Shyr MH, Lau YT, Lin JN, Chen MFAminoguanidine attenuates hemodynamic and microcirculatory derangement in rat intestinal ischemia and reperfusion. J Trauma. 1999;47:1108–1113.[PubMed][Google Scholar]
• 788. Loehe F, Preissler G, Annecke T, Bittmann I, Jauch KW, Messmer KContinuous infusion of nitroglycerin improves pulmonary graft function of non-heart-beating donor lungs. Transplantation. 2004;77:1803–1808.[PubMed][Google Scholar]
• 789. Lokuta AJ, Maertz NA, Meethal SV, Potter KT, Kamp TJ, Valdivia HH, Haworth RAIncreased nitration of sarcoplasmic reticulum Ca^{-ATPase in human heart failure.} Circulation. 2005;111:988–995.[PubMed][Google Scholar]
• 790. Lopez BL, Liu GL, Christopher TA, Ma XLPeroxynitrite, the product of nitric oxide and superoxide, causes myocardial injury in the isolated perfused rat heart. Coron Artery Dis. 1997;8:149–153.[PubMed][Google Scholar]
• 791. Lopez CJ, Qayyum I, Mishra OP, Delivoria-Papadopoulos MEffect of nitration on protein tyrosine phosphatase and protein phosphatase activity in neuronal cell membranes of newborn piglets. Neurosci Lett. 2005;386:78–81.[PubMed][Google Scholar]
• 792. Los M, Mozoluk M, Ferrari D, Stepczynska A, Stroh C, Renz A, Herceg Z, Wang ZQ, Schulze-Osthoff KActivation and caspase-mediated inhibition of PARP: a molecular switch between fibroblast necrosis and apoptosis in death receptor signaling. Mol Biol Cell. 2002;13:978–988.[Google Scholar]
• 793. Love S, Barber R, Wilcock GKNeuronal accumulation of poly-(ADP-ribose) after brain ischaemia. Neuropathol Appl Neurobiol. 1999;25:98–103.[PubMed][Google Scholar]
• 794. Love S, Barber R, Wilcock GKNeuronal death in brain infarcts in man. Neuropathol Appl Neurobiol. 2000;26:55–66.[PubMed][Google Scholar]
• 795. Low SY, Sabetkar M, Bruckdorfer KR, Naseem KMThe role of protein nitration in the inhibition of platelet activation by peroxynitrite. FEBS Lett. 2002;511:59–64.[PubMed][Google Scholar]
• 796. Lowell CASrc-family kinases: rheostats of immune cell signaling. Mol Immunol. 2004;41:631–643.[PubMed][Google Scholar]
• 797. Lowenstein CJ, Hill SL, Lafond-Walker A, Wu J, Allen G, Landavere M, Rose NR, Herskowitz ANitric oxide inhibits viral replication in murine myocarditis. J Clin Invest. 1996;97:1837–1843.[Google Scholar]
• 798. Lu Y, Wang X, Cederbaum AILipopolysaccharide-induced liver injury in rats treated with the CYP2E1 inducer pyrazole. Am J Physiol Gastrointest Liver Physiol. 2005;289:G308–G319.[PubMed][Google Scholar]
• 799. Lucchesi BRModulation of leukocyte-mediated myocardial reperfusion injury. Annu Rev Physiol. 1990;52:561–576.[PubMed][Google Scholar]
• 800. Lucchesi BRMyocardial ischemia, reperfusion and free radical injury. Am J Cardiol. 1990;65:14I–23I.[PubMed][Google Scholar]
• 801. Lundberg JO, Hellstrom PM, Lundberg JM, Alving KGreatly increased luminal nitric oxide in ulcerative colitis. Lancet. 1994;344:1673–1674.[PubMed][Google Scholar]
• 802. Luoma JS, Stralin P, Marklund SL, Hiltunen TP, Sarkioja T, Yla-Herttuala SExpression of extracellular SOD and iNOS in macrophages and smooth muscle cells in human and rabbit atherosclerotic lesions: colocalization with epitopes characteristic of oxidized LDL and peroxynitrite-modified proteins. Arterioscler Thromb Vasc Biol. 1998;18:157–167.[PubMed][Google Scholar]
• 803. Lush CW, Cepinskas G, Kvietys PRRegulation of intestinal nuclear factor-kappaB activity and E-selectin expression during sepsis: a role for peroxynitrite. Gastroenterology. 2003;124:118–128.[PubMed][Google Scholar]
• 804. Luth HJ, Holzer M, Gartner U, Staufenbiel M, Arendt TExpression of endothelial and inducible NOS-isoforms is increased in Alzheimer’s disease, in APP23 transgenic mice and after experimental brain lesion in rat: evidence for an induction by amyloid pathology. Brain Res. 2001;913:57–67.[PubMed][Google Scholar]
• 805. Luth HJ, Holzer M, Gertz HJ, Arendt TAberrant expression of nNOS in pyramidal neurons in Alzheimer’s disease is highly co-localized with p21ras and p16INK4a. Brain Res. 2000;852:45–55.[PubMed][Google Scholar]
• 806. Luth HJ, Munch G, Arendt TAberrant expression of NOS isoforms in Alzheimer’s disease is structurally related to nitrotyrosine formation. Brain Res. 2002;953:135–143.[PubMed][Google Scholar]
• 807. Lyall F, Gibson JL, Greer IA, Brockman DE, Eis AL, Myatt LIncreased nitrotyrosine in the diabetic placenta: evidence for oxidative stress. Diabetes Care. 1998;21:1753–1758.[PubMed][Google Scholar]
• 808. Lymar S, Wishart JReactivity of peroxynitrite: implications for hanford waste management and remediation. Environmental Management Science Program Project. 1998:59982.[PubMed][Google Scholar]
• 809. Lymar SV, Hurst JKCarbon dioxide: physiological catalyst for peroxynitrite-mediated cellular damage or cellular protectant? Chem Res Toxicol. 1996;9:845–850.[PubMed][Google Scholar]
• 810. Lymar SV, Hurst JKRole of compartmentation in promoting toxicity of leukocyte-generated strong oxidants. Chem Res Toxicol. 1995;8:833–840.[PubMed][Google Scholar]
• 811. Lymar SV, Jiang Q, Hurst JKMechanism of carbon dioxide-catalyzed oxidation of tyrosine by peroxynitrite. Biochemistry. 1996;35:7855–7861.[PubMed][Google Scholar]
• 812. Lymar SV, Khairutdinov RF, Hurst JKHydroxyl radical formation by O-O bond homolysis in peroxynitrous acid. Inorg Chem. 2003;42:5259–5266.[PubMed][Google Scholar]
• 813. Ma N, Adachi Y, Hiraku Y, Horiki N, Horiike S, Imoto I, Pinlaor S, Murata M, Semba R, Kawanishi SAccumulation of 8-nitroguanine in human gastric epithelium induced by Helicobacter pylori infection. Biochem Biophys Res Commun. 2004;319:506–510.[PubMed][Google Scholar]
• 814. Ma N, Tagawa T, Hiraku Y, Murata M, Ding X, Kawanishi S8-Nitroguanine formation in oral leukoplakia, a premalignant lesion. Nitric Oxide. 2006;14:137–143.[PubMed][Google Scholar]
• 815. Ma XL, Gao F, Nelson AH, Lopez BL, Christopher TA, Yue TL, Barone FCOxidative inactivation of nitric oxide and endothelial dysfunction in stroke-prone spontaneous hypertensive rats. J Pharmacol Exp Ther. 2001;298:879–885.[PubMed][Google Scholar]
• 816. Ma XL, Lopez BL, Liu GL, Christopher TA, Ischiropoulos HPeroxynitrite aggravates myocardial reperfusion injury in the isolated perfused rat heart. Cardiovasc Res. 1997;36:195–204.[PubMed][Google Scholar]
• 817. Maas AI, Marmarou A, Murray GD, Steyerberg EWClinical trials in traumatic brain injury: current problems and future solutions. Acta Neurochir Suppl. 2004;89:113–118.[PubMed][Google Scholar]
• 818. Mabley JG, Jagtap P, Perretti M, Getting SJ, Salzman AL, Virag L, Szabo E, Soriano FG, Liaudet L, Abdelkarim GE, Hasko G, Marton A, Southan GJ, Szabo CAnti-inflammatory effects of a novel, potent inhibitor of poly(ADP-ribose) polymerase. Inflamm Res. 2001;50:561–569.[PubMed][Google Scholar]
• 819. Mabley JG, Liaudet L, Pacher P, Southan GJ, Groves JT, Salzman AL, Szabo CPart II: beneficial effects of the peroxynitrite decomposition catalyst FP15 in murine models of arthritis and colitis. Mol Med. 2002;8:581–590.[Google Scholar]
• 820. Mabley JG, Pacher P, Bai P, Wallace R, Goonesekera S, Virag L, Southan GJ, Szabo CSuppression of intestinal polyposis in Apcmin/+mice by targeting the nitric oxide or poly(ADP-ribose) pathways. Mutat Res. 2004;548:107–116.[PubMed][Google Scholar]
• 821. Mabley JG, Soriano FGRole of nitrosative stress and poly-(ADP-ribose) polymerase activation in diabetic vascular dysfunction. Curr Vasc Pharmacol. 2005;3:247–252.[PubMed][Google Scholar]
• 822. Mabley JG, Southan GJ, Salzman AL, Szabo CThe combined inducible nitric oxide synthase inhibitor and free radical scavenger guanidinoethyldisulfide prevents multiple low-dose streptozotocin-induced diabetes in vivo and interleukin-1beta-induced suppression of islet insulin secretion in vitro. Pancreas. 2004;28:E39–44.[PubMed][Google Scholar]
• 823. Maccaglia A, Mallozzi C, Minetti MDifferential effects of quercetin and resveratrol on Band 3 tyrosine phosphorylation signalling of red blood cells. Biochem Biophys Res Commun. 2003;305:541–547.[PubMed][Google Scholar]
• 824. Macfadyen AJ, Reiter C, Zhuang Y, Beckman JSA novel superoxide dismutase-based trap for peroxynitrite used to detect entry of peroxynitrite into erythrocyte ghosts. Chem Res Toxicol. 1999;12:223–229.[PubMed][Google Scholar]
• 825. MacMicking JD, Nathan C, Hom G, Chartrain N, Fletcher DS, Trumbauer M, Stevens K, Xie QW, Sokol K, Hutchinson N, Chen H, Mudget JSAltered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell. 1995;81:641–650.[PubMed][Google Scholar]
• 826. MacMillan-Crow LA, Crow JP, Kerby JD, Beckman JS, Thompson JANitration and inactivation of manganese superoxide dismutase in chronic rejection of human renal allografts. Proc Natl Acad Sci USA. 1996;93:11853–11858.[Google Scholar]
• 827. MacMillan-Crow LA, Cruthirds DLInvited review: manganese superoxide dismutase in disease. Free Radic Res. 2001;34:325–336.[PubMed][Google Scholar]
• 828. MacMillan-Crow LA, Cruthirds DL, Ahki KM, Sanders PW, Thompson JAMitochondrial tyrosine nitration precedes chronic allograft nephropathy. Free Radic Biol Med. 2001;31:1603–1608.[PubMed][Google Scholar]
• 829. MacMillan-Crow LA, Greendorfer JS, Vickers SM, Thompson JATyrosine nitration of c-SRC tyrosine kinase in human pancreatic ductal adenocarcinoma. Arch Biochem Biophys. 2000;377:350–356.[PubMed][Google Scholar]
• 830. MacMillan-Crow LA, Thompson JATyrosine modifications and inactivation of active site manganese superoxide dismutase mutant (Y34F) by peroxynitrite. Arch Biochem Biophys. 1999;366:82–88.[PubMed][Google Scholar]
• 831. Madesh M, Ramachandran A, Pulimood A, Vadranam M, Balasubramanian KAAttenuation of intestinal ischemia/reperfusion injury with sodium nitroprusside: studies on mitochondrial function and lipid changes. Biochim Biophys Acta. 2000;1500:204–216.[PubMed][Google Scholar]
• 832. Mahoney LREvidence for the formation of hydroxyl radical in the isomerization of pernitrous acid to nitric acid in aqueous solution. J Am Chem Soc. 1970;92:5262–5263.[PubMed][Google Scholar]
• 833. Maiese K, Boccone LNeuroprotection by peptide growth factors against anoxia and nitric oxide toxicity requires modulation of protein kinase C. J Cereb Blood Flow Metab. 1995;15:440–449.[PubMed][Google Scholar]
• 834. Malinski T, Bailey F, Zhang ZG, Chopp MNitric oxide measured by a porphyrinic microsensor in rat brain after transient middle cerebral artery occlusion. J Cereb Blood Flow Metab. 1993;13:355–358.[PubMed][Google Scholar]
• 835. Malle E, Waeg G, Schreiber R, Grone EF, Sattler W, Grone HJImmunohistochemical evidence for the myeloperoxidase/H₂O₂/halide system in human atherosclerotic lesions: colocalization of myeloperoxidase and hypochlorite-modified proteins. Eur J Biochem. 2000;267:4495–4503.[PubMed][Google Scholar]
• 836. Mallozzi C, De Franceschi L, Brugnara C, Di Stasi AMProtein phosphatase 1alpha is tyrosine-phosphorylated and inactivated by peroxynitrite in erythrocytes through the src family kinase fgr. Free Radic Biol Med. 2005;38:1625–1636.[PubMed][Google Scholar]
• 837. Mallozzi C, Di Stasi AM, Minetti MActivation of src tyrosine kinases by peroxynitrite. FEBS Lett. 1999;456:201–206.[PubMed][Google Scholar]
• 838. Mallozzi C, Di Stasi AM, Minetti MNitrotyrosine mimics phosphotyrosine binding to the SH2 domain of the src family tyrosine kinase lyn. FEBS Lett. 2001;503:189–195.[PubMed][Google Scholar]
• 839. Mallozzi C, Di Stasi AM, Minetti MPeroxynitrite modulates tyrosine-dependent signal transduction pathway of human erythrocyte band 3. FASEB J. 1997;11:1281–1290.[PubMed][Google Scholar]
• 840. Mallozzi C, Di Stasi MA, Minetti MPeroxynitrite-dependent activation of src tyrosine kinases lyn and hck in erythrocytes is under mechanistically different pathways of redox control. Free Radic Biol Med. 2001;30:1108–1117.[PubMed][Google Scholar]
• 841. Maneen MI, Hannah R, Vitullo L, Delance N, Cipolla MJPeroxynitrite diminishes myogenic activity and is associated with decreased vascular smooth muscle F-actin in rat posterior cerebral arteries. Stroke. 2006;37:894–899.[PubMed][Google Scholar]
• 842. Mapp PI, Klocke R, Walsh DA, Chana JK, Stevens CR, Gallagher PJ, Blake DRLocalization of 3-nitrotyrosine to rheumatoid and normal synovium. Arthritis Rheum. 2001;44:1534–1539.[PubMed][Google Scholar]
• 843. Marcillat O, Zhang Y, Davies KJOxidative and non-oxidative mechanisms in the inactivation of cardiac mitochondrial electron transport chain components by doxorubicin. Biochem J. 1989;259:181–189.[Google Scholar]
• 844. Marcondes S, Turko IV, Murad FNitration of succinyl-CoA:3-oxoacid CoA-transferase in rats after endotoxin administration. Proc Natl Acad Sci USA. 2001;98:7146–7151.[Google Scholar]
• 845. Markesbery WROxidative stress hypothesis in Alzheimer’s disease. Free Radic Biol Med. 1997;23:134–147.[PubMed][Google Scholar]
• 846. Marks DS, Vita JA, Folts JD, Keaney JF, Jr, Welch GN, Loscalzo JInhibition of neointimal proliferation in rabbits after vascular injury by a single treatment with a protein adduct of nitric oxide. J Clin Invest. 1995;96:2630–2638.[Google Scholar]
• 847. Marshall KA, Reist M, Jenner P, Halliwell BThe neuronal toxicity of sulfite plus peroxynitrite is enhanced by glutathione depletion: implications for Parkinson’s disease. Free Radic Biol Med. 1999;27:515–520.[PubMed][Google Scholar]
• 848. Martindale JL, Holbrook NJCellular response to oxidative stress: signaling for suicide and survival. J Cell Physiol. 2002;192:1–15.[PubMed][Google Scholar]
• 849. Massion PB, Feron O, Dessy C, Balligand JLNitric oxide and cardiac function: ten years after, continuing. Circ Res. 2003;93:388–398.[PubMed][Google Scholar]
• 850. Matata BM, Galinanes MCardiopulmonary bypass exacerbates oxidative stress but does not increase proinflammatory cytokine release in patients with diabetes compared with patients without diabetes: regulatory effects of exogenous nitric oxide. J Thorac Cardiovasc Surg. 2000;120:1–11.[PubMed][Google Scholar]
• 851. Matata BM, Galinanes MPeroxynitrite is an essential component of cytokines production mechanism in human monocytes through modulation of nuclear factor-kappa B DNA binding activity. J Biol Chem. 2002;277:2330–2335.[PubMed][Google Scholar]
• 852. Mathru M, Lang JDEndothelial dysfunction in trauma patients: a preliminary communication. Shock. 2005;24:210–213.[PubMed][Google Scholar]
• 853. Matsushita H, Chang E, Glassford AJ, Cooke JP, Chiu CP, Tsao PSeNOS activity is reduced in senescent human endothelial cells: preservation by hTERT immortalization. Circ Res. 2001;89:793–798.[PubMed][Google Scholar]
• 854. Mayer B, Schrammel A, Klatt P, Koesling D, Schmidt K. Peroxynitrite-induced accumulation of cyclic GMP in endothelial cells and stimulation of purified soluble guanylyl cyclase. Dependence on glutathione and possible role of S-nitrosation. J Biol Chem. 1995;270:17355–17360.[PubMed]
• 855. McCall TB, Boughton-Smith NK, Palmer RMJ, Whittle BJR, Moncada SSynthesis of nitric oxide from L-arginine by neutrophils. Biochem J. 1989;261:293–296.[Google Scholar]
• 856. McCartney-Francis N, Allen JB, Mizel DE, Albina JE, Xie QW, Nathan CF, Wahl SMSuppression of arthritis by an inhibitor of nitric oxide synthase. J Exp Med. 1993;178:749–754.[Google Scholar]
• 857. McCartney-Francis NL, Song XY, Mizel DE, Wahl CL, Wahl SMHemoglobin protects from streptococcal cell wall-induced arthritis. Arthritis Rheum. 1999;42:1119–1127.[PubMed][Google Scholar]
• 858. McCord JMOxygen-derived free radicals in postischemic tissue injury. N Engl J Med. 1985;312:159–163.[PubMed][Google Scholar]
• 859. McCord JM, Fridovich ISuperoxide dismutase: an enzymic function for erythrocuprein (hemocuprein) J Biol Chem. 1969;244:6049–6055.[PubMed][Google Scholar]
• 860. McInnes IB, Leung BP, Field M, Wei XQ, Huang FP, Sturrock RD, Kinninmonth A, Weidner J, Mumford R, Liew FYProduction of nitric oxide in the synovial membrane of rheumatoid and osteoarthritis patients. J Exp Med. 1996;184:1519–1524.[Google Scholar]
• 861. McLean GW, Carragher NO, Avizienyte E, Evans J, Brunton VG, Frame MCThe role of focal-adhesion kinase in cancer: a new therapeutic opportunity. Nat Rev Cancer. 2005;5:505–515.[PubMed][Google Scholar]
• 862. Meade MO, Granton JT, Matte-Martyn A, McRae K, Weaver B, Cripps P, Keshavjee SHA randomized trial of inhaled nitric oxide to prevent ischemia-reperfusion injury after lung transplantation. Am J Respir Crit Care Med. 2003;167:1483–1489.[PubMed][Google Scholar]
• 863. Meguro M, Katsuramaki T, Kimura H, Isobe M, Nagayama M, Kukita K, Nui A, Hirata KApoptosis and necrosis after warm ischemia-reperfusion injury of the pig liver and their inhibition by ONO-1714. Transplantation. 2003;75:703–710.[PubMed][Google Scholar]
• 864. Mehlhorn U, Krahwinkel A, Geissler HJ, LaRosee K, Fischer UM, Klass O, Suedkamp M, Hekmat K, Tossios P, Bloch WNitrotyrosine and 8-isoprostane formation indicate free radical-mediated injury in hearts of patients subjected to cardioplegia. J Thorac Cardiovasc Surg. 2003;125:178–183.[PubMed][Google Scholar]
• 865. Melichar VO, Behr-Roussel D, Zabel U, Uttenthal LO, Rodrigo J, Rupin A, Verbeuren TJ, Kumar HSA, Schmidt HHReduced cGMP signaling associated with neointimal proliferation and vascular dysfunction in late-stage atherosclerosis. Proc Natl Acad Sci USA. 2004;101:16671–16676.[Google Scholar]
• 866. Melone MA, Jori FP, Peluso GHuntington’s disease: new frontiers for molecular and cell therapy. Curr Drug Targets. 2005;6:43–56.[PubMed][Google Scholar]
• 867. Menconi MJ, Unno N, Smith M, Aguirre DE, Fink MPNitric oxide donor-induced hyperpermeability of cultured intestinal epithelial monolayers: role of superoxide radical, hydroxyl radical, peroxynitrite. Biochim Biophys Acta. 1998;1425:189–203.[PubMed][Google Scholar]
• 868. Merényi G, Lind J, Goldstein S, Czapski GMechanism and thermochemistry of peroxynitrite decomposition in water. J Phys Chem. 1999;103:3085–3091.[PubMed][Google Scholar]
• 869. Merrill G, McConnell P, Vandyke K, Powell SCoronary and myocardial effects of acetaminophen: protection during ischemia-reperfusion. Am J Physiol Heart Circ Physiol. 2001;280:H2631–H2638.[PubMed][Google Scholar]
• 870. Merrill GFAcetaminophen and low-flow myocardial ischemia: efficacy and antioxidant mechanisms. Am J Physiol Heart Circ Physiol. 2002;282:H1341–H1349.[PubMed][Google Scholar]
• 871. Merrill GF, Goldberg EAntioxidant properties of acetaminophen and cardioprotection. Basic Res Cardiol. 2001;96:423–430.[PubMed][Google Scholar]
• 872. Mhatre M, Floyd RA, Hensley KOxidative stress and neuroinflammation in Alzheimer’s disease and amyotrophic lateral sclerosis: common links and potential therapeutic targets. J Alzheimers Dis. 2004;6:147–157.[PubMed][Google Scholar]
• 873. Michelson AM, Maral JCarbonate anions: effects on the oxidation of luminol, oxidative hemolysis, γ-irradiation and the reaction of activated oxygen species with enzymes containing various active centres. Biochomie. 1983;65:95–104.[PubMed][Google Scholar]
• 874. Middleton SJ, Shorthouse M, Hunter JOIncreased nitric oxide synthesis in ulcerative colitis. Lancet. 1993;341:465–466.[PubMed][Google Scholar]
• 875. Miesel R, Kurpisz M, Kroger HModulation of inflammatory arthritis by inhibition of poly(ADP ribose) polymerase. Inflammation. 1995;19:379–387.[PubMed][Google Scholar]
• 876. Migita KNitric oxide in rheumatoid arthritis. Nippon Rinsho. 2005;63(Suppl 1):106–109.[PubMed][Google Scholar]
• 877. Mihm MJ, Bauer JAPeroxynitrite-induced inhibition and nitration of cardiac myofibrillar creatine kinase. Biochimie. 2002;84:1013–1019.[PubMed][Google Scholar]
• 878. Mihm MJ, Coyle CM, Schanbacher BL, Weinstein DM, Bauer JAPeroxynitrite induced nitration and inactivation of myofibrillar creatine kinase in experimental heart failure. Cardiovasc Res. 2001;49:798–807.[PubMed][Google Scholar]
• 879. Mihm MJ, Jing L, Bauer JANitrotyrosine causes selective vascular endothelial dysfunction and DNA damage. J Cardiovasc Pharmacol. 2000;36:182–187.[PubMed][Google Scholar]
• 880. Mihm MJ, Wattanapitayakul SK, Piao SF, Hoyt DG, Bauer JAEffects of angiotensin II on vascular endothelial cells: formation of receptor-mediated reactive nitrogen species. Biochem Pharmacol. 2003;65:1189–1197.[PubMed][Google Scholar]
• 881. Mihm MJ, Yu F, Carnes CA, Reiser PJ, McCarthy PM, Van Wagoner DR, Bauer JAImpaired myofibrillar energetics and oxidative injury during human atrial fibrillation. Circulation. 2001;104:174–180.[PubMed][Google Scholar]
• 882. Mihm MJ, Yu F, Reiser PJ, Bauer JAEffects of peroxynitrite on isolated cardiac trabeculae: selective impact on myofibrillar energetic controllers. Biochimie. 2003;85:587–596.[PubMed][Google Scholar]
• 883. Mihm MJ, Yu F, Weinstein DM, Reiser PJ, Bauer JAIntracellular distribution of peroxynitrite during doxorubicin cardiomyopathy: evidence for selective impairment of myofibrillar creatine kinase. Br J Pharmacol. 2002;135:581–588.[Google Scholar]
• 884. Mikami S, Kawashima S, Kanazawa K, Hirata K, Katayama Y, Hotta H, Hayashi Y, Ito H, Yokoyama MExpression of nitric oxide synthase in a murine model of viral myocarditis induced by coxsackievirus B3. Biochem Biophys Res Commun. 1996;220:983–989.[PubMed][Google Scholar]
• 885. Miller MJ, Thompson JH, Zhang XJ, Sadowska-Krowicka H, Kakkis JL, Munshi UK, Sandoval M, Rossi JL, Eloby-Childress S, Beckman JS, Ye YZ, Rodi CP, Manning PT, Currie MG, Clark DARole of inducible nitric oxide synthase expression and peroxynitrite formation in guinea pig ileitis. Gastroenterology. 1995;109:1475–1483.[PubMed][Google Scholar]
• 886. Minchenko AG, Stevens MJ, White L, Abatan OI, Komjati K, Pacher P, Szabo C, Obrosova IGDiabetes-induced overexpression of endothelin-1 and endothelin receptors in the rat renal cortex is mediated via poly(ADP-ribose) polymerase activation. FASEB J. 2003;17:1514–1516.[PubMed][Google Scholar]
• 887. Minetti M, Mallozzi C, Di Stasi AMPeroxynitrite activates kinases of the src family and upregulates tyrosine phosphorylation signaling. Free Radic Biol Med. 2002;33:744–754.[PubMed][Google Scholar]
• 888. Mohr S, Stamler JS, Brune BMechanism of covalent modification of glyceraldehyde-3-phosphate dehydrogenase at its active site thiol by nitric oxide, peroxynitrite and related nitrosating agents. FEBS Lett. 1994;348:223–227.[PubMed][Google Scholar]
• 889. Mollnau H, Wendt M, Szocs K, Lassegue B, Schulz E, Oelze M, Li H, Bodenschatz M, August M, Kleschyov AL, Tsilimingas N, Walter U, Forstermann U, Meinertz T, Griendling K, Munzel TEffects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling. Circ Res. 2002;90:E58–65.[PubMed][Google Scholar]
• 890. Moncada S, Bolanos JPNitric oxide, cell bioenergetics and neurodegeneration. J Neurochem. 2006;97:1676–1689.[PubMed][Google Scholar]
• 891. Moncada S, Erusalimsky JDDoes nitric oxide modulate mitochondrial energy generation and apoptosis? Nat Rev Mol Cell Biol. 2002;3:214–220.[PubMed][Google Scholar]
• 892. Moncada S, Herman AG, Vanhoutte PMEndothelium-derived relaxing factor is identified as nitric oxide. Trends Pharmacol Sci. 1987;8:365–368.[PubMed][Google Scholar]
• 893. Moncada S, Higgs EAThe discovery of nitric oxide and its role in vascular biology. Br J Pharmacol. 2006;147(Suppl 1):S193–S201.[Google Scholar]
• 894. Moncada S, Palmer RM, Gryglewski RJMechanism of action of some inhibitors of endothelium-derived relaxing factor. Proc Natl Acad Sci USA. 1986;83:9164–9168.[Google Scholar]
• 895. Moncada S, Palmer RMJ, Higgs EANitric oxide: physiology, pathophysiology, pharmacology. Pharmacol Rev. 1991;43:109–142.[PubMed][Google Scholar]
• 896. Mondoro TH, Shafer BC, Vostal JGPeroxynitrite-induced tyrosine nitration and phosphorylation in human platelets. Free Radic Biol Med. 1997;22:1055–1063.[PubMed][Google Scholar]
• 897. Montague PR, Gally JA, Edelman GMSpatial signaling in the development and function of neural connections. Cereb Cortex. 1991;1:199–220.[PubMed][Google Scholar]
• 898. Moochhala SM, Lu J, Xing MC, Anuar F, Ng KC, Yang KL, Whiteman M, Atan SMercaptoethylguanidine inhibition of inducible nitric oxide synthase and cyclooxygenase-2 expressions induced in rats after fluid-percussion brain injury. J Trauma. 2005;59:450–457.[PubMed][Google Scholar]
• 899. Moore KP, Darley-Usmar V, Morrow J, Roberts LJ., 2nd Formation of F2-isoprostanes during oxidation of human low-density lipoprotein and plasma by peroxynitrite. Circ Res. 1995;77:335–341.[PubMed]
• 900. Moreira PI, Siedlak SL, Aliev G, Zhu X, Cash AD, Smith MA, Perry GOxidative stress mechanisms and potential therapeutics in Alzheimer disease. J Neural Transm. 2005;112:921–932.[PubMed][Google Scholar]
• 901. Moreira PI, Smith MA, Zhu X, Nunomura A, Castellani RJ, Perry GOxidative stress and neurodegeneration. Ann NY Acad Sci. 2005;1043:545–552.[PubMed][Google Scholar]
• 902. Mori E, Haramaki N, Ikeda H, Imaizumi TIntra-coronary administration of L-arginine aggravates myocardial stunning through production of peroxynitrite in dogs. Cardiovasc Res. 1998;40:113–123.[PubMed][Google Scholar]
• 903. Moriel P, Abdalla DSNitrotyrosine bound to beta-VLDL-apoproteins: a biomarker of peroxynitrite formation in experimental atherosclerosis. Biochem Biophys Res Commun. 1997;232:332–335.[PubMed][Google Scholar]
• 904. Morisue A, Wakabayashi G, Shimazu M, Tanabe M, Mukai M, Matsumoto K, Kawachi S, Yoshida M, Yamamoto S, Kitajima MThe role of nitric oxide after a short period of liver ischemia-reperfusion. J Surg Res. 2003;109:101–109.[PubMed][Google Scholar]
• 905. Morita H, Seidman J, Seidman CEGenetic causes of human heart failure. J Clin Invest. 2005;115:518–526.[Google Scholar]
• 906. Moro MA, Almeida A, Bolanos JP, Lizasoain IMitochondrial respiratory chain and free radical generation in stroke. Free Radic Biol Med. 2005;39:1291–1304.[PubMed][Google Scholar]
• 907. Moro MA, Cardenas A, Hurtado O, Leza JC, Lizasoain IRole of nitric oxide after brain ischaemia. Cell Calcium. 2004;36:265–275.[PubMed][Google Scholar]
• 908. Moro MA, Darley-Usmar VM, Goodwin DA, Read NG, Zamora-Pino R, Feelisch M, Radomski MW, Moncada SParadoxical fate and biological action of peroxynitrite on human platelets. Proc Natl Acad Sci USA. 1994;91:6702–6706.[Google Scholar]
• 909. Moro MA, Darley-Usmar VM, Lizasoain I, Su Y, Knowles RG, Radomski MW, Moncada SThe formation of nitric oxide donors from peroxynitrite. Br J Pharmacol. 1995;116:1999–2004.[Google Scholar]
• 910. Morten KJ, Ackrell BA, Melov SMitochondrial reactive oxygen species in mice lacking superoxide dismutase 2: attenuation via antioxidant treatment. J Biol Chem. 2006;281:3354–3359.[PubMed][Google Scholar]
• 911. Mota-Filipe H, McDonald MC, Cuzzocrea S, Thiemermann CA membrane-permeable radical scavenger reduces the organ injury in hemorrhagic shock. Shock. 1999;12:255–261.[PubMed][Google Scholar]
• 912. Mujumdar VS, Aru GM, Tyagi SCInduction of oxidative stress by homocyst(e)ine impairs endothelial function. J Cell Biochem. 2001;82:491–500.[PubMed][Google Scholar]
• 913. Mungrue IN, Gros R, You X, Pirani A, Azad A, Csont T, Schulz R, Butany J, Stewart DJ, Husain MCardiomyocyte overexpression of iNOS in mice results in peroxynitrite generation, heart block, sudden death. J Clin Invest. 2002;109:735–743.[Google Scholar]
• 914. Mungrue IN, Stewart DJ, Husain MThe Janus faces of iNOS. Circ Res. 2003;93:e74.[PubMed][Google Scholar]
• 915. Murakami K, Kondo T, Kawase M, Li Y, Sato S, Chen SF, Chan PHMitochondrial susceptibility to oxidative stress exacerbates cerebral infarction that follows permanent focal cerebral ischemia in mutant mice with manganese superoxide dismutase deficiency. J Neurosci. 1998;18:205–213.[Google Scholar]
• 916. Muriel P, Castaneda G, Ortega M, Noel FInsights into the mechanism of erythrocyte Na^{/K-ATPase inhibition by nitric oxide and peroxynitrite anion.} J Appl Toxicol. 2003;23:275–278.[PubMed][Google Scholar]
• 917. Muriel P, Sandoval GHepatic basolateral plasma high-affinity Ca^{-ATPase is inhibited by nitric oxide and peroxynitrite anion.} J Appl Toxicol. 2000;20:435–439.[PubMed][Google Scholar]
• 918. Muriel P, Sandoval GNitric oxide and peroxynitrite anion modulate liver plasma membrane fluidity and Na(+)/K(+)-ATPase activity. Nitric Oxide. 2000;4:333–342.[PubMed][Google Scholar]
• 919. Murray J, Taylor SW, Zhang B, Ghosh SS, Capaldi RAOxidative damage to mitochondrial complex I due to peroxynitrite: identification of reactive tyrosines by mass spectrometry. J Biol Chem. 2003;278:37223–37230.[PubMed][Google Scholar]
• 920. Murry CE, Jennings RB, Reimer KAPreconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986;74:1124–1136.[PubMed][Google Scholar]
• 921. Muscoli C, Sacco I, Alecce W, Palma E, Nistico R, Costa N, Clementi F, Rotiroti D, Romeo F, Salvemini D, Mehta JL, Mollace VThe protective effect of superoxide dismutase mimetic M40401 on balloon injury-related neointima formation: role of the lectin-like oxidized low-density lipoprotein receptor-1. J Pharmacol Exp Ther. 2004;311:44–50.[PubMed][Google Scholar]
• 922. Nabeyrat E, Jones GE, Fenwick PS, Barnes PJ, Donnelly LEMitogen-activated protein kinases mediate peroxynitrite-induced cell death in human bronchial epithelial cells. Am J Physiol Lung Cell Mol Physiol. 2003;284:L1112–L1120.[PubMed][Google Scholar]
• 923. Nagayama T, Simon RP, Chen D, Henshall DC, Pei W, Stetler RA, Chen JActivation of poly(ADP-ribose) polymerase in the rat hippocampus may contribute to cellular recovery following sub-lethal transient global ischemia. J Neurochem. 2000;74:1636–1645.[PubMed][Google Scholar]
• 924. Naidu BV, Farivar AS, Woolley SM, Fraga C, Salzman AL, Szabo C, Groves JT, Mulligan MSEnhanced peroxynitrite decomposition protects against experimental obliterative bronchiolitis. Exp Mol Pathol. 2003;75:12–17.[PubMed][Google Scholar]
• 925. Naidu BV, Fraga C, Salzman AL, Szabo C, Verrier ED, Mulligan MSCritical role of reactive nitrogen species in lung ischemia-reperfusion injury. J Heart Lung Transplant. 2003;22:784–793.[PubMed][Google Scholar]
• 926. Naito Y, Takagi T, Ichikawa H, Tomatsuri N, Kuroda M, Isozaki Y, Katada K, Uchiyama K, Kokura S, Yoshida N, Okanoue T, Yoshikawa TA novel potent inhibitor of inducible nitric oxide inhibitor, ONO-1714, reduces intestinal ischemia-reperfusion injury in rats. Nitric Oxide. 2004;10:170–177.[PubMed][Google Scholar]
• 927. Najjar SS, Scuteri A, Lakatta EGArterial aging: is it an immutable cardiovascular risk factor? Hypertension. 2005;46:454–462.[PubMed][Google Scholar]
• 928. Nakajima A, Ueda K, Takaoka M, Yoshimi Y, Matsumura YOpposite effects of pre- and postischemic treatments with nitric oxide donor on ischemia/reperfusion-induced renal injury. J Pharmacol Exp Ther. 2006;316:1038–1046.[PubMed][Google Scholar]
• 929. Nakamura H, Tsukada H, Oya M, Onomura M, Saito T, Fukuda K, Kodama M, Taniguchi T, Tominaga M, Hosokawa M, Seino YAminoguanidine has both an anti-inflammatory effect on experimental colitis and a proliferative effect on colonic mucosal cells. Scand J Gastroenterol. 1999;34:1117–1122.[PubMed][Google Scholar]
• 930. Naoi M, Maruyama WFuture of neuroprotection in Parkinson’s disease. Parkinsonism Relat Disord. 2001;8:139–145.[PubMed][Google Scholar]
• 931. Napoli C, de Nigris F, Williams-Ignarro S, Pignalosa O, Sica V, Ignarro LJNitric oxide and atherosclerosis: an update. Nitric Oxide. In press. [PubMed]
• 932. Naruse K, Shimizu K, Muramatsu M, Toki Y, Miyazaki Y, Okumura K, Hashimoto H, Ito T. Long-term inhibition of NO synthesis promotes atherosclerosis in the hypercholesterolemic rabbit thoracic aorta. PGH₂ does not contribute to impaired endothelium-dependent relaxation. Arterioscler Thromb. 1994;14:746–752.[PubMed]
• 933. Nathan CSpecificity of a third kind: reactive oxygen and nitrogen intermediates in cell signaling. J Clin Invest. 2003;111:769–778.[Google Scholar]
• 934. Nathan C, Xie QWNitric oxide synthases: roles, tolls, controls. Cell. 1994;78:915–918.[PubMed][Google Scholar]
• 935. Nathan C, Xie QWRegulation of biosynthesis of nitric oxide. J Biol Chem. 1994;269:13725–13728.[PubMed][Google Scholar]
• 936. Nathan CF, Hibbs JBJRole of nitric oxide synthesis in macrophage antimicrobial activity. Curr Opin Immunol. 1991;3:65–70.[PubMed][Google Scholar]
• 937. Nauser T, Koppenol WHThe rate constant of the reaction of superoxide with nitrogen monoxide: approaching the diffusion limit. J Phys Chem A. 2002;106:4084–4086.[PubMed][Google Scholar]
• 938. Navarro A, Gomez C, Lopez-Cepero JM, Boveris ABeneficial effects of moderate exercise on mice aging: survival, behavior, oxidative stress, mitochondrial electron transfer. Am J Physiol Regul Integr Comp Physiol. 2004;286:R505–R511.[PubMed][Google Scholar]
• 939. Neeley WL, Delaney JC, Henderson PT, Essigmann JMIn vivo bypass efficiencies and mutational signatures of the guanine oxidation products 2-aminoimidazolone and 5-guanidino-4-nitro-imidazole. J Biol Chem. 2004;279:43568–43573.[PubMed][Google Scholar]
• 940. Neumann P, Gertzberg N, Vaughan E, Weisbrot J, Woodburn R, Lambert W, Johnson APeroxynitrite mediates TNF-α-induced endothelial barrier dysfunction and nitration of actin. Am J Physiol Lung Cell Mol Physiol. 2006;290:L674–L684.[PubMed][Google Scholar]
• 941. Newman DK, Hoffman S, Kotamraju S, Zhao T, Wakim B, Kalyanaraman B, Newman PJNitration of PECAM-1 ITIM tyrosines abrogates phosphorylation and SHP-2 binding. Biochem Biophys Res Commun. 2002;296:1171–1179.[PubMed][Google Scholar]
• 942. Newmeyer DD, Ferguson-Miller SMitochondria: releasing power for life and unleashing the machineries of death. Cell. 2003;112:481–490.[PubMed][Google Scholar]
• 943. Nielsen VG, Crow JP, Mogal A, Zhou F, Parks DAPeroxynitrite decreases hemostasis in human plasma in vitro. Anesth Analg. 2004;99:21–26.[PubMed][Google Scholar]
• 944. Nieuwenhuijzen GA, Goris RJThe gut: the “motor” of multiple organ dysfunction syndrome? Curr Opin Clin Nutr Metab Care. 1999;2:399–404.[PubMed][Google Scholar]
• 945. Niles JC, Wishnok JS, Tannenbaum SRPeroxynitrite-induced oxidation and nitration products of guanine and 8-oxoguanine: structures and mechanisms of product formation. Nitric Oxide. 2006;14:109–121.[PubMed][Google Scholar]
• 946. Nishikawa T, Edelstein D, Brownlee MThe missing link: a single unifying mechanism for diabetic complications. Kidney Int Suppl. 2000;77:S26–S30.[PubMed][Google Scholar]
• 947. Nohl HGeneration of superoxide radicals as byproduct of cellular respiration. Ann Biol Clin. 1994;52:199–204.[PubMed][Google Scholar]
• 948. Noiri E, Peresleni T, Miller F, Goligorsky MSIn vivo targeting of inducible NO synthase with oligodeoxynucleotides protects rat kidney against ischemia. J Clin Invest. 1996;97:2377–2383.[Google Scholar]
• 949. Nomiyama T, Igarashi Y, Taka H, Mineki R, Uchida T, Ogihara T, Choi JB, Uchino H, Tanaka Y, Maegawa H, Kashiwagi A, Murayama K, Kawamori R, Watada HReduction of insulin-stimulated glucose uptake by peroxynitrite is concurrent with tyrosine nitration of insulin receptor substrate-1. Biochem Biophys Res Commun. 2004;320:639–647.[PubMed][Google Scholar]
• 950. Nossuli TO, Hayward R, Jensen D, Scalia R, Lefer AMMechanisms of cardioprotection by peroxynitrite in myocardial ischemia and reperfusion injury. Am J Physiol Heart Circ Physiol. 1998;275:H509–H519.[PubMed][Google Scholar]
• 951. Nossuli TO, Hayward R, Scalia R, Lefer AMPeroxynitrite reduces myocardial infarct size and preserves coronary endothelium after ischemia and reperfusion in cats. Circulation. 1997;96:2317–2324.[PubMed][Google Scholar]
• 952. Nowak P, Kolodziejczyk J, Wachowicz BPeroxynitrite and fibrinolytic system: the effect of peroxynitrite on plasmin activity. Mol Cell Biochem. 2004;267:141–146.[PubMed][Google Scholar]
• 953. Nowak P, Wachowicz BPeroxynitrite-mediated modification of fibrinogen affects platelet aggregation and adhesion. Platelets. 2002;13:293–299.[PubMed][Google Scholar]
• 954. Oates JC, Gilkeson GSThe biology of nitric oxide and other reactive intermediates in systemic lupus erythematosus. Clin Immunol. In press.
• 955. Obermeier F, Kojouharoff G, Hans W, Scholmerich J, Gross V, Falk WInterferon-gamma (IFN-gamma)- and tumour necrosis factor (TNF)-induced nitric oxide as toxic effector molecule in chronic dextran sulphate sodium (DSS)-induced colitis in mice. Clin Exp Immunol. 1999;116:238–245.[Google Scholar]
• 956. Obrosova IGIncreased sorbitol pathway activity generates oxidative stress in tissue sites for diabetic complications. Antioxid Redox Signal. 2005;7:1543–1552.[PubMed][Google Scholar]
• 957. Obrosova IG, Drel VR, Pacher P, Ilnytska O, Wang ZQ, Stevens MJ, Yorek MAOxidative-nitrosative stress and poly-(ADP-ribose) polymerase (PARP) activation in experimental diabetic neuropathy: the relation is revisited. Diabetes. 2005;54:3435–3441.[Google Scholar]
• 958. Obrosova IG, Julius UARole for poly(ADP-ribose) polymerase activation in diabetic nephropathy, neuropathy and retinopathy. Curr Vasc Pharmacol. 2005;3:267–283.[PubMed][Google Scholar]
• 959. Obrosova IG, Li F, Abatan OI, Forsell MA, Komjati K, Pacher P, Szabo C, Stevens MJRole of poly(ADP-ribose) polymerase activation in diabetic neuropathy. Diabetes. 2004;53:711–720.[PubMed][Google Scholar]
• 960. Obrosova IG, Mabley JG, Zsengeller Z, Charniauskaya T, Abatan OI, Groves JT, Szabo CRole for nitrosative stress in diabetic neuropathy: evidence from studies with a peroxynitrite decomposition catalyst. FASEB J. 2005;19:401–403.[PubMed][Google Scholar]
• 961. Obrosova IG, Minchenko AG, Frank RN, Seigel GM, Zsengeller Z, Pacher P, Stevens MJ, Szabo CPoly(ADP-ribose) polymerase inhibitors counteract diabetes- and hypoxia-induced retinal vascular endothelial growth factor overexpression. Int J Mol Med. 2004;14:55–64.[PubMed][Google Scholar]
• 962. Obrosova IG, Pacher P, Szabo C, Zsengeller Z, Hirooka H, Stevens MJ, Yorek MAAldose reductase inhibition counteracts oxidative-nitrosative stress and poly(ADP-ribose) polymerase activation in tissue sites for diabetes complications. Diabetes. 2005;54:234–242.[Google Scholar]
• 963. O’Donnell VB, Eiserich JP, Chumley PH, Jablonsky MJ, Krishna NR, Kirk M, Barnes S, Darley-Usmar VM, Freeman BANitration of unsaturated fatty acids by nitric oxide-derived reactive nitrogen species peroxynitrite, nitrous acid, nitrogen dioxide, nitronium ion. Chem Res Toxicol. 1999;12:83–92.[PubMed][Google Scholar]
• 964. Oeckler RA, Wolin MSNew concepts in vascular nitric oxide signaling. Curr Atheroscler Rep. 2000;2:437–444.[PubMed][Google Scholar]
• 965. Oh-Hashi K, Maruyama W, Isobe KPeroxynitrite induces GADD34, 45, 153 VIA p38 MAPK in human neuroblastoma SH-SY5Y cells. Free Radic Biol Med. 2001;30:213–221.[PubMed][Google Scholar]
• 966. Ohmori H, Kanayama NImmunogenicity of an inflammation-associated product, tyrosine nitrated self-proteins. Autoimmun Rev. 2005;4:224–229.[PubMed][Google Scholar]
• 967. Ohshima H, Friesen M, Brouet I, Bartsch HNitrotyrosine as a new marker for endogenous nitrosation and nitration of proteins. Food Chem Toxicol. 1990;28:647–652.[PubMed][Google Scholar]
• 968. Ohtaki H, Funahashi H, Dohi K, Oguro T, Horai R, Asano M, Iwakura Y, Yin L, Matsunaga M, Goto N, Shioda SSuppression of oxidative neuronal damage after transient middle cerebral artery occlusion in mice lacking interleukin-1. Neurosci Res. 2003;45:313–324.[PubMed][Google Scholar]
• 969. Ohtsu H, Frank GD, Utsunomiya H, Eguchi SRedox-dependent protein kinase regulation by angiotensin II: mechanistic insights and its pathophysiology. Antioxid Redox Signal. 2005;7:1315–1326.[PubMed][Google Scholar]
• 970. Ohtsuka M, Konno F, Honda H, Oikawa T, Ishikawa M, Iwase N, Isomae K, Ishii F, Hemmi H, Sato SPPA250 [3-(2,4-diflu-orophenyl)-6-[2-[4-(1H-imidazol-1-ylmethyl) phenoxy]ethoxy]-2-phenylpyridine], a novel orally effective inhibitor of the dimerization of inducible nitric-oxide synthase, exhibits an anti-inflammatory effect in animal models of chronic arthritis. J Pharmacol Exp Ther. 2002;303:52–57.[PubMed][Google Scholar]
• 971. Okamoto T, Akaike T, Sawa T, Miyamoto Y, van der Vliet A, Maeda HActivation of matrix metalloproteinases by peroxynitrite-induced protein S-glutathiolation via disulfide S-oxide formation. J Biol Chem. 2001;276:29596–29602.[PubMed][Google Scholar]
• 972. Oleszak EL, Zaczynska E, Bhattacharjee M, Butunoi C, Legido A, Katsetos CDInducible nitric oxide synthase and nitrotyrosine are found in monocytes/macrophages and/or astrocytes in acute, but not in chronic, multiple sclerosis. Clin Diagn Lab Immunol. 1998;5:438–445.[Google Scholar]
• 973. Oliver FJ, Menissier-de Murcia J, Nacci C, Decker P, Andriantsitohaina R, Muller S, de la Rubia G, Stoclet JC, de Murcia GResistance to endotoxic shock as a consequence of defective NF-kappaB activation in poly (ADP-ribose) polymerase-1 deficient mice. EMBO J. 1999;18:4446–4454.[Google Scholar]
• 974. Onozato ML, Tojo A, Goto A, Fujita T, Wilcox CSOxidative stress and nitric oxide synthase in rat diabetic nephropathy: effects of ACEI and ARB. Kidney Int. 2002;61:186–194.[PubMed][Google Scholar]
• 975. Orucevic A, Bechberger J, Green AM, Shapiro RA, Billiar TR, Lala PKNitric-oxide production by murine mammary adenocarcinoma cells promotes tumor-cell invasiveness. Int J Cancer. 1999;81:889–896.[PubMed][Google Scholar]
• 976. Osuka K, Feustel PJ, Mongin AA, Tranmer BI, Kimelberg HKTamoxifen inhibits nitrotyrosine formation after reversible middle cerebral artery occlusion in the rat. J Neurochem. 2001;76:1842–1850.[PubMed][Google Scholar]
• 977. Ovechkin AV, Lominadze D, Sedoris KC, Gozal E, Robinson TW, Roberts AMInhibition of inducible nitric oxide synthase attenuates platelet adhesion in subpleural arterioles caused by lung ischemia-reperfusion in rabbits. J Appl Physiol. 2005;99:2423–2432.[PubMed][Google Scholar]
• 978. Oyama J, Shimokawa H, Momii H, Cheng X, Fukuyama N, Arai Y, Egashira K, Nakazawa H, Takeshita ARole of nitric oxide and peroxynitrite in the cytokine-induced sustained myocardial dysfunction in dogs in vivo. J Clin Invest. 1998;101:2207–2214.[Google Scholar]
• 979. Oyanagui YNitric oxide and superoxide radical are involved in both initiation and development of adjuvant arthritis in rats. Life Sci. 1994;54:PL285–289.[PubMed][Google Scholar]
• 980. Ozdulger A, Cinel I, Unlu A, Cinel L, Mavioglu I, Tamer L, Atik U, Oral UPoly(ADP-ribose) synthetase inhibition prevents lipopolysaccharide-induced peroxynitrite mediated damage in diaphragm. Pharmacol Res. 2002;46:67–73.[PubMed][Google Scholar]
• 981. Ozturk OH, Cetin A, Ozdem SS, Uysal N, Kayisli UA, Senturk UK, Yesilkaya APlasma levels of nitrites, PGF1alpha, nitrotyrosine in LPS-treated rats: functional and histochemical implications in aorta. J Physiol Biochem. 2006;62:27–34.[PubMed][Google Scholar]
• 982. Pacher P, Csordas G, Hajnoczky GMitochondrial Ca(2+) signaling and cardiac apoptosis. Biol Signals Recept. 2001;10:200–223.[PubMed][Google Scholar]
• 983. Pacher P, Cziraki A, Mabley JG, Liaudet L, Papp L, Szabo CRole of poly(ADP-ribose) polymerase activation in endotoxin-induced cardiac collapse in rodents. Biochem Pharmacol. 2002;64:1785–1791.[PubMed][Google Scholar]
• 984. Pacher P, Hajnoczky GPropagation of the apoptotic signal by mitochondrial waves. EMBO J. 2001;20:4107–4121.[Google Scholar]
• 985. Pacher P, Liaudet L, Bai P, Mabley JG, Kaminski PM, Virag L, Deb A, Szabo E, Ungvari Z, Wolin MS, Groves JT, Szabo CPotent metalloporphyrin peroxynitrite decomposition catalyst protects against the development of doxorubicin-induced cardiac dysfunction. Circulation. 2003;107:896–904.[PubMed][Google Scholar]
• 986. Pacher P, Liaudet L, Bai P, Virag L, Mabley JG, Hasko G, Szabo CActivation of poly(ADP-ribose) polymerase contributes to development of doxorubicin-induced heart failure. J Pharmacol Exp Ther. 2002;300:862–867.[PubMed][Google Scholar]
• 987. Pacher P, Liaudet L, Mabley J, Komjati K, Szabo CPharmacologic inhibition of poly(adenosine diphosphate-ribose) polymerase may represent a novel therapeutic approach in chronic heart failure. J Am Coll Cardiol. 2002;40:1006–1016.[PubMed][Google Scholar]
• 988. Pacher P, Liaudet L, Mabley JG, Cziraki A, Hasko G, Szabo CBeneficial effects of a novel ultrapotent poly(ADP-ribose) polymerase inhibitor in murine models of heart failure. Int J Mol Med. 2006;17:369–375.[Google Scholar]
• 989. Pacher P, Liaudet L, Soriano FG, Mabley JG, Szabo E, Szabo CThe role of poly(ADP-ribose) polymerase activation in the development of myocardial and endothelial dysfunction in diabetes. Diabetes. 2002;51:514–521.[PubMed][Google Scholar]
• 990. Pacher P, Mabley JG, Liaudet L, Evgenov OV, Marton A, Hasko G, Kollai M, Szabo CLeft ventricular pressure-volume relationship in a rat model of advanced aging-associated heart failure. Am J Physiol Heart Circ Physiol. 2004;287:H2132–H2137.[Google Scholar]
• 991. Pacher P, Mabley JG, Soriano FG, Liaudet L, Komjati K, Szabo CEndothelial dysfunction in aging animals: the role of poly(ADP-ribose) polymerase activation. Br J Pharmacol. 2002;135:1347–1350.[Google Scholar]
• 992. Pacher P, Mabley JG, Soriano FG, Liaudet L, Szabo CActivation of poly(ADP-ribose) polymerase contributes to the endothelial dysfunction associated with hypertension and aging. Int J Mol Med. 2002;9:659–664.[PubMed][Google Scholar]
• 993. Pacher P, Nivorozhkin A, Szabo CTherapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol. Pharmacol Rev. 2006;58:87–114.[Google Scholar]
• 994. Pacher P, Obrosova IG, Mabley JG, Szabo C. Role of nitrosative stress and peroxynitrite in the pathogenesis of diabetic complications. Emerging new therapeutical strategies. Curr Med Chem. 2005;12:267–275.
• 995. Pacher P, Schulz R, Liaudet L, Szabo CNitrosative stress and pharmacological modulation of heart failure. Trends Pharmacol Sci. 2005;26:302–310.[Google Scholar]
• 996. Pacher P, Szabo CRole of peroxynitrite in the pathogenesis of cardiovascular complications of diabetes. Curr Opin Pharmacol. 2006;6:136–141.[Google Scholar]
• 997. Pacher P, Szabo CRole of poly(ADP-ribose) polymerase-1 activation in the pathogenesis of diabetic complications: endothelial dysfunction, as a common underlying theme. Antioxid Redox Signal. 2005;7:1568–1580.[Google Scholar]
• 998. Pacher P, Vaslin A, Benko R, Mabley JG, Liaudet L, Hasko G, Marton A, Batkai S, Kollai M, Szabo CA new, potent poly-(ADP-ribose) polymerase inhibitor improves cardiac and vascular dysfunction associated with advanced aging. J Pharmacol Exp Ther. 2004;311:485–491.[Google Scholar]
• 999. Packer MA, Murphy MPPeroxynitrite causes calcium efflux from mitochondria which is prevented by cyclosporin A. FEBS Lett. 1994;345:237–240.[PubMed][Google Scholar]
• 1000. Packer MA, Murphy MPPeroxynitrite formed by simultaneous nitric oxide and superoxide generation causes cyclosporin-A-sensitive mitochondrial calcium efflux and depolarisation. Eur J Biochem. 1995;234:231–239.[PubMed][Google Scholar]
• 1001. Palacios-Callender M, Quintero M, Hollis VS, Springett RJ, Moncada SEndogenous NO regulates superoxide production at low oxygen concentrations by modifying the redox state of cytochrome c oxidase. Proc Natl Acad Sci USA. 2004;101:7630–7635.[Google Scholar]
• 1002. Pannala AS, Rice-Evans C, Sampson J, Singh SInteraction of peroxynitrite with carotenoids and tocopherols within low density lipoprotein. FEBS Lett. 1998;423:297–301.[PubMed][Google Scholar]
• 1003. Pannu R, Singh IPharmacological strategies for the regulation of inducible nitric oxide synthase: neurodegenerative versus neuroprotective mechanisms. Neurochem Int. 2006;49:170–182.[PubMed][Google Scholar]
• 1004. Paravicini TM, Touyz RMRedox signaling in hypertension. Cardiovasc Res. 2006;71:247–258.[PubMed][Google Scholar]
• 1005. Park S, Geddes TJ, Javitch JA, Kuhn DMDopamine prevents nitration of tyrosine hydroxylase by peroxynitrite and nitrogen dioxide: is nitrotyrosine formation an early step in dopamine neuronal damage? J Biol Chem. 2003;278:28736–28742.[PubMed][Google Scholar]
• 1006. Park SW, Huq MD, Hu X, Wei LNTyrosine nitration on p65: a novel mechanism to rapidly inactivate nuclear factor-kappaB. Mol Cell Proteomics. 2005;4:300–309.[PubMed][Google Scholar]
• 1007. Park SW, Wei LNRegulation of c-myc gene by nitric oxide via inactivating NF-kappa B complex in P19 mouse embryonal carcinoma cells. J Biol Chem. 2003;278:29776–29782.[PubMed][Google Scholar]
• 1008. Parmentier S, Bohme GA, Lerouet D, Damour D, Stutzmann JM, Margaill I, Plotkine MSelective inhibition of inducible nitric oxide synthase prevents ischaemic brain injury. Br J Pharmacol. 1999;127:546–552.[Google Scholar]
• 1009. Patel RP, Darley-Usmar VMUsing peroxynitrite as oxidant with low-density lipoprotein. Methods Enzymol. 1996;269:375–384.[PubMed][Google Scholar]
• 1010. Patel RP, Diczfalusy U, Dzeletovic S, Wilson MT, Darley-Usmar VMFormation of oxysterols during oxidation of low density lipoprotein by peroxynitrite, myoglobin, copper. J Lipid Res. 1996;37:2361–2371.[PubMed][Google Scholar]
• 1011. Patel RP, McAndrew J, Sellak H, White CR, Jo H, Freeman BA, Darley-Usmar VMBiological aspects of reactive nitrogen species. Biochim Biophys Acta. 1999;1411:385–400.[PubMed][Google Scholar]
• 1012. Patel RP, Moellering D, Murphy-Ullrich J, Jo H, Beckman JS, Darley-Usmar VMCell signaling by reactive nitrogen and oxygen species in atherosclerosis. Free Radic Biol Med. 2000;28:1780–1794.[PubMed][Google Scholar]
• 1013. Pauling LThe discovery of the superoxide radical. Trends Biochem Sci. 1979;4:N270–N271.[PubMed][Google Scholar]
• 1014. Paulus WJ, Bronzwaer JGMyocardial contractile effects of nitric oxide. Heart Fail Rev. 2002;7:371–383.[PubMed][Google Scholar]
• 1015. Pearce LL, Kanai AJ, Birder LA, Pitt BR, Peterson JThe catabolic fate of nitric oxide: the nitric oxide oxidase and peroxynitrite reductase activities of cytochrome oxidase. J Biol Chem. 2002;277:13556–13562.[PubMed][Google Scholar]
• 1016. Pearce LL, Kanai AJ, Epperly MW, Peterson JNitrosative stress results in irreversible inhibition of purified mitochondrial complexes I and III without modification of cofactors. Nitric Oxide. 2005;13:254–263.[PubMed][Google Scholar]
• 1017. Pearce LL, Pitt BR, Peterson JThe peroxynitrite reductase activity of cytochrome c oxidase involves a two-electron redox reaction at the heme a(3)-Cu(B) site. J Biol Chem. 1999;274:35763–35767.[PubMed][Google Scholar]
• 1018. Pehar M, Cassina P, Vargas MR, Castellanos R, Viera L, Beckman JS, Estevez AG, Barbeito LAstrocytic production of nerve growth factor in motor neuron apoptosis: implications for amyotrophic lateral sclerosis. J Neurochem. 2004;89:464–473.[PubMed][Google Scholar]
• 1019. Pennathur S, Bergt C, Shao B, Byun J, Kassim SY, Singh P, Green PS, McDonald TO, Brunzell J, Chait A, Oram JF, O’Brien K, Geary RL, Heinecke JWHuman atherosclerotic intima and blood of patients with established coronary artery disease contain high density lipoprotein damaged by reactive nitrogen species. J Biol Chem. 2004;279:42977–42983.[PubMed][Google Scholar]
• 1020. Pennathur S, Jackson-Lewis V, Przedborski S, Heinecke JWMass spectrometric quantification of 3-nitrotyrosine, ortho-tyrosine, o,o′-dityrosine in brain tissue of 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-treated mice, a model of oxidative stress in Parkinson’s disease. J Biol Chem. 1999;274:34621–34628.[PubMed][Google Scholar]
• 1021. Pennathur S, Wagner JD, Leeuwenburgh C, Litwak KN, Heinecke JWA hydroxyl radical-like species oxidizes cynomolgus monkey artery wall proteins in early diabetic vascular disease. J Clin Invest. 2001;107:853–860.[Google Scholar]
• 1022. Perez-De La Cruz V, Gonzalez-Cortes C, Galvan-Arzate S, Medina-Campos ON, Perez-Severiano F, Ali SF, Pedraza-Chaverri J, Santamaria AExcitotoxic brain damage involves early peroxynitrite formation in a model of Huntington’s disease in rats: protective role of iron porphyrinate 5,10,15,20-tetrakis (4-sulfonatophenyl)porphyrinate iron (III) Neuroscience. 2005;135:463–474.[PubMed][Google Scholar]
• 1023. Perez-Severiano F, Escalante B, Vergara P, Rios C, Segovia JAge-dependent changes in nitric oxide synthase activity and protein expression in striata of mice transgenic for the Huntington’s disease mutation. Brain Res. 2002;951:36–42.[PubMed][Google Scholar]
• 1024. Pesse B, Levrand S, Feihl F, Waeber B, Gavillet B, Pacher P, Liaudet LPeroxynitrite activates ERK via Raf-1 and MEK, independently from EGF receptor and p21Ras in H9C2 cardiomyocytes. J Mol Cell Cardiol. 2005;38:765–775.[Google Scholar]
• 1025. Peters O, Back T, Lindauer U, Busch C, Megow D, Dreier J, Dirnagl UIncreased formation of reactive oxygen species after permanent and reversible middle cerebral artery occlusion in the rat. J Cereb Blood Flow Metab. 1998;18:196–205.[PubMed][Google Scholar]
• 1026. Pick M, Rabani J, Yost F, Fridovich IThe catalytic mechanism of the manganese-containing superoxide dismutase of Escherichia coli studied by pulse radiolysis. J Am Chem Soc. 1974;96:7329–7332.[PubMed][Google Scholar]
• 1027. Pieper GM, Nilakantan V, Chen M, Zhou J, Khanna AK, Henderson JD, Jr, Johnson CP, Roza AM, Szabo CProtective mechanisms of a metalloporphyrinic peroxynitrite decomposition catalyst, WW85, in rat cardiac transplants. J Pharmacol Exp Ther. 2005;314:53–60.[PubMed][Google Scholar]
• 1028. Pierson KB, Evenson MA200 Kd neurofilament protein binds Al, Cu and Zn. Biochem Biophys Res Commun. 1988;152:598–604.[PubMed][Google Scholar]
• 1029. Pinlaor S, Ma N, Hiraku Y, Yongvanit P, Semba R, Oikawa S, Murata M, Sripa B, Sithithaworn P, Kawanishi SRepeated infection with Opisthorchis viverrini induces accumulation of 8-nitroguanine and 8-oxo-7,8-dihydro-2′-deoxyguanine in the bile duct of hamsters via inducible nitric oxide synthase. Carcinogenesis. 2004;25:1535–1542.[PubMed][Google Scholar]
• 1030. Piper HM, Garcia-Dorado D, Ovize MA fresh look at reperfusion injury. Cardiovasc Res. 1998;38:291–300.[PubMed][Google Scholar]
• 1031. Plumb RC, Tantayanon R, Libby M, Xu WWChemical model for Viking biology experiments: implications for the composition of the martian regolith. Nature. 1989;338:633–635.[PubMed][Google Scholar]
• 1032. Podgoreanu MV, Michelotti GA, Sato Y, Smith MP, Lin S, Morris RW, Grocott HP, Mathew JP, Schwinn DADifferential cardiac gene expression during cardiopulmonary bypass: ischemia-independent upregulation of proinflammatory genes. J Thorac Cardiovasc Surg. 2005;130:330–339.[PubMed][Google Scholar]
• 1033. Podrez EA, Schmitt D, Hoff HF, Hazen SLMyeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in vitro. J Clin Invest. 1999;103:1547–1560.[Google Scholar]
• 1034. Poladia DP, Bauer JAEarly cell-specific changes in nitric oxide synthases, reactive nitrogen species formation, ubiquitinylation during diabetes-related bladder remodeling. Diabetes Metab Res Rev. 2003;19:313–319.[PubMed][Google Scholar]
• 1035. Pollock DM, Pollock JSEndothelin and oxidative stress in the vascular system. Curr Vasc Pharmacol. 2005;3:365–367.[PubMed][Google Scholar]
• 1036. Polman CH, Uitdehaag BMDrug treatment of multiple sclerosis. BMJ. 2000;321:490–494.[Google Scholar]
• 1037. Pong KOxidative stress in neurodegenerative diseases: therapeutic implications for superoxide dismutase mimetics. Expert Opin Biol Ther. 2003;3:127–139.[PubMed][Google Scholar]
• 1038. Potashkin JA, Meredith GEThe role of oxidative stress in the dysregulation of gene expression and protein metabolism in neurodegenerative disease. Antioxid Redox Signal. 2006;8:144–151.[PubMed][Google Scholar]
• 1039. Pozza M, Bettelli C, Magnani F, Mascia MT, Manzini E, Calza LIs neuronal nitric oxide involved in adjuvant-induced joint inflammation? Eur J Pharmacol. 1998;359:87–93.[PubMed][Google Scholar]
• 1040. Pricci F, Leto G, Amadio L, Iacobini C, Cordone S, Catalano S, Zicari A, Sorcini M, Di Mario U, Pugliese GOxidative stress in diabetes-induced endothelial dysfunction involvement of nitric oxide and protein kinase C. Free Radic Biol Med. 2003;35:683–694.[PubMed][Google Scholar]
• 1041. Pryor WA, Squadrito GLThe chemistry of peroxynitrite: a product from the reaction of nitric oxide with superoxide. Am J Physiol Lung Cell Mol Physiol. 1995;268:L699–L722.[PubMed][Google Scholar]
• 1042. Przedborski S, Chen Q, Vila M, Giasson BI, Djaldatti R, Vukosavic S, Souza JM, Jackson-Lewis V, Lee VM, Ischiropoulos HOxidative post-translational modifications of alpha-synuclein in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson’s disease. J Neurochem. 2001;76:637–640.[PubMed][Google Scholar]
• 1043. Przedborski S, Jackson-Lewis V, Djaldetti R, Liberatore G, Vila M, Vukosavic S, Almer GThe parkinsonian toxin MPTP: action and mechanism. Restor Neurol Neurosci. 2000;16:135–142.[PubMed][Google Scholar]
• 1044. Przedborski S, Jackson-Lewis V, Yokoyama R, Shibata T, Dawson VL, Dawson TMRole of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity. Proc Natl Acad Sci USA. 1996;93:4565–4571.[Google Scholar]
• 1045. Pu M, Akhand AA, Kato M, Hamaguchi M, Koike T, Iwata H, Sabe H, Suzuki H, Nakashima IEvidence of a novel redox-linked activation mechanism for the Src kinase which is independent of tyrosine 527-mediated regulation. Oncogene. 1996;13:2615–2622.[PubMed][Google Scholar]
• 1046. Pulido EJ, Shames BD, Selzman CH, Barton HA, Banerjee A, Bensard DD, McIntyre RC., Jr Inhibition of PARS attenuates endotoxin-induced dysfunction of pulmonary vasorelaxation. Am J Physiol Lung Cell Mol Physiol. 1999;277:L769–L776.[PubMed]
• 1047. Qayyum I, Zubrow AB, Ashraf QM, Kubin J, Delivoria-Papadopoulos M, Mishra OPNitration as a mechanism of Na^{,K-ATPase modification during hypoxia in the cerebral cortex of the guinea pig fetus.} Neurochem Res. 2001;26:1163–1169.[PubMed][Google Scholar]
• 1048. Qi M, Elion EAMAP kinase pathways. J Cell Sci. 2005;118:3569–3572.[PubMed][Google Scholar]
• 1049. Quagliaro L, Piconi L, Assaloni R, Martinelli L, Motz E, Ceriello AIntermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: the role of protein kinase C and NAD(P)H-oxidase activation. Diabetes. 2003;52:2795–2804.[PubMed][Google Scholar]
• 1050. Rabini RA, Vignini A, Salvolini E, Staffolani R, Martarelli D, Moretti N, Mazzanti LActivation of human aortic endothelial cells by LDL from Type 1 diabetic patients: an in vitro study. Atherosclerosis. 2002;165:69–77.[PubMed][Google Scholar]
• 1051. Rabinovitch A, Suarez-Pinzon WL, Sorensen O, Bleackley RCInducible nitric oxide synthase (iNOS) in pancreatic islets of nonobese diabetic mice: identification of iNOS-expressing cells and relationships to cytokines expressed in the islets. Endocrinology. 1996;137:2093–2099.[PubMed][Google Scholar]
• 1052. Rachmilewitz D, Stamler JS, Karmeli F, Mullins ME, Singel DJ, Loscalzo J, Xavier RJ, Podolsky DKPeroxynitrite-induced rat colitis: a new model of colonic inflammation. Gastroenterology. 1993;105:1681–1688.[PubMed][Google Scholar]
• 1053. Radi RNitric oxide, oxidants, protein tyrosine nitration. Proc Natl Acad Sci USA. 2004;101:4003–4008.[Google Scholar]
• 1054. Radi RPeroxynitrite reactions and diffusion in biology. Chem Res Toxicol. 1998;11:720–721.[PubMed][Google Scholar]
• 1055. Radi R, Beckman JS, Bush KM, Freeman BAPeroxynitrite-induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide. Arch Biochem Biophys. 1991;288:481–487.[PubMed][Google Scholar]
• 1056. Radi R, Beckman JS, Bush KM, Freeman BAPeroxynitrite-mediated sulfhydryl oxidation: the cytotoxic potential of superoxide and nitric oxide. J Biol Chem. 1991;266:4244–4250.[PubMed][Google Scholar]
• 1057. Radi R, Beckman JS, Bush KM, Freeman BA. Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide. J Biol Chem. 1991;266:4244–4250.[PubMed]
• 1058. Radi R, Cassina A, Hodara RNitric oxide and peroxynitrite interactions with mitochondria. Biol Chem. 2002;383:401–409.[PubMed][Google Scholar]
• 1059. Radi R, Cassina A, Hodara R, Quijano C, Castro LPeroxynitrite reactions and formation in mitochondria. Free Radic Biol Med. 2002;33:1451–1464.[PubMed][Google Scholar]
• 1060. Radi R, Cosgrove TP, Beckman JS, Freeman BAPeroxynitrite-induced luminol chemiluminescence. Biochem J. 1993;290:51–57.[Google Scholar]
• 1061. Radi R, Peluffo G, Alvarez MN, Naviliat M, Cayota AUnraveling peroxynitrite formation in biological systems. Free Radic Biol Med. 2001;30:463–488.[PubMed][Google Scholar]
• 1062. Radi R, Rodriguez M, Castro L, Telleri RInhibition of mitochondrial electron transport by peroxynitrite. Arch Biochem Biophys. 1994;308:89–95.[PubMed][Google Scholar]
• 1063. Radons J, Heller B, Burkle A, Hartmann B, Rodriguez ML, Kroncke KD, Burkart V, Kolb HNitric oxide toxicity in islet cells involves poly(ADP-ribose) polymerase activation and concomitant NAD ^depletion. Biochem Biophys Res Commun. 1994;199:1270–1277.[PubMed][Google Scholar]
• 1064. Raghuram N, Fortenberry JD, Owens ML, Brown LAEffects of exogenous nitric oxide and hyperoxia on lung fibroblast viability and DNA fragmentation. Biochem Biophys Res Commun. 1999;262:685–691.[PubMed][Google Scholar]
• 1065. Rajagopalan S, Kurz S, Munzel T, Tarpey M, Freeman BA, Griendling KK, Harrison DG. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest. 1996;97:1916–1923.
• 1066. Rajfer J, Aronson WJ, Bush PA, Dorey FJ, Ignarro LJNitric oxide as a mediator of relaxation of the corpus cavernosum in response to nonadrenergic, noncholinergic neurotransmission. N Engl J Med. 1992;326:90–94.[PubMed][Google Scholar]
• 1067. Rakesh K, Agrawal DKControlling cytokine signaling by constitutive inhibitors. Biochem Pharmacol. 2005;70:649–657.[PubMed][Google Scholar]
• 1068. Raoul C, Estevez AG, Nishimune H, Cleveland DW, deLapeyriere O, Henderson CE, Haase G, Pettmann B. Motoneuron death triggered by a specific pathway downstream of Fas. Potentiation by ALS-linked SOD1 mutations. Neuron. 2002;35:1067–1083.[PubMed]
• 1069. Ravalli S, Albala A, Ming M, Szabolcs M, Barbone A, Michler RE, Cannon PJInducible nitric oxide synthase expression in smooth muscle cells and macrophages of human transplant coronary artery disease. Circulation. 1998;97:2338–2345.[PubMed][Google Scholar]
• 1070. Reaume AG, Elliott JL, Hoffman EK, Kowall NW, Ferrante RJ, Siwek DF, Wilcox HM, Flood DG, Beal MF, Brown RH, Jr, Scott RW, Snider WDMotor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury. Nat Genet. 1996;13:43–47.[PubMed][Google Scholar]
• 1071. Reid AB, Kurten RC, McCullough SS, Brock RW, Hinson JAMechanisms of acetaminophen-induced hepatotoxicity: role of oxidative stress and mitochondrial permeability transition in freshly isolated mouse hepatocytes. J Pharmacol Exp Ther. 2005;312:509–516.[PubMed][Google Scholar]
• 1072. Reinehr R, Gorg B, Hongen A, Haussinger DCD95-tyrosine nitration inhibits hyperosmotic and CD95 ligand-induced CD95 activation in rat hepatocytes. J Biol Chem. 2004;279:10364–10373.[PubMed][Google Scholar]
• 1073. Reynolds MR, Berry RW, Binder LISite-specific nitration and oxidative dityrosine bridging of the tau protein by peroxynitrite: implications for Alzheimer’s disease. Biochemistry. 2005;44:1690–1700.[PubMed][Google Scholar]
• 1074. Reynolds MR, Lukas TJ, Berry RW, Binder LIPeroxynitrite-mediated tau modifications stabilize preformed filaments and destabilize microtubules through distinct mechanisms. Biochemistry. 2006;45:4314–4326.[PubMed][Google Scholar]
• 1075. Richter CBiophysical consequences of lipid peroxidation in membranes. Chem Phys Lipids. 1987;44:175–189.[PubMed][Google Scholar]
• 1076. Ridnour LA, Isenberg JS, Espey MG, Thomas DD, Roberts DD, Wink DANitric oxide regulates angiogenesis through a functional switch involving thrombospondin-1. Proc Natl Acad Sci USA. 2005;102:13147–13152.[Google Scholar]
• 1077. Roberts CK, Vaziri ND, Ni Z, Barnard RJCorrection of long-term diet-induced hypertension and nitrotyrosine accumulation by diet modification. Atherosclerosis. 2002;163:321–327.[PubMed][Google Scholar]
• 1078. Robinson VK, Sato E, Nelson DK, Camhi SL, Robbins RA, Hoyt JCPeroxynitrite inhibits inducible (type 2) nitric oxide synthase in murine lung epithelial cells in vitro. Free Radic Biol Med. 2001;30:986–991.[PubMed][Google Scholar]
• 1079. Rodrigo J, Fernandez AP, Serrano J, Peinado MA, Martinez AThe role of free radicals in cerebral hypoxia and ischemia. Free Radic Biol Med. 2005;39:26–50.[PubMed][Google Scholar]
• 1080. Rodriguez-Iturbe B, Zhan CD, Quiroz Y, Sindhu RK, Vaziri NDAntioxidant-rich diet relieves hypertension and reduces renal immune infiltration in spontaneously hypertensive rats. Hypertension. 2003;41:341–346.[PubMed][Google Scholar]
• 1081. Rodriguez-Martinez MA, Alonso MJ, Redondo J, Salaices M, Marin JRole of lipid peroxidation and the glutathione-dependent antioxidant system in the impairment of endothelium-dependent relaxations with age. Br J Pharmacol. 1998;123:113–121.[Google Scholar]
• 1082. Rojas J, Paya M, Dominguez JN, Ferrandiz MLttCH, a selective inhibitor of inducible nitric oxide synthase expression with antiarthritic properties. Eur J Pharmacol. 2003;465:183–189.[PubMed][Google Scholar]
• 1083. Ronson RS, Nakamura M, Vinten-Johansen JThe cardiovascular effects and implications of peroxynitrite. Cardiovasc Res. 1999;44:47–59.[PubMed][Google Scholar]
• 1084. Ronson RS, Thourani VH, Ma XL, Katzmark SL, Han D, Zhao ZQ, Nakamura M, Guyton RA, Vinten-Johansen JPeroxynitrite, the breakdown product of nitric oxide, is beneficial in blood cardioplegia but injurious in crystalloid cardioplegia. Circulation. 1999;100(Suppl II):II-384–II-391.[PubMed][Google Scholar]
• 1085. Rork TH, Hadzimichalis NM, Kappil MA, Merrill GFAcetaminophen attenuates peroxynitrite-activated matrix metalloproteinase-2-mediated troponin I cleavage in the isolated guinea pig myocardium. J Mol Cell Cardiol. 2006;40:553–561.[PubMed][Google Scholar]
• 1086. Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, Donaldson D, Goto J, O’Regan JP, Deng HX, Rahmani Z, Krizus A, McKenna-Yasek D, Cayabyab A, Gaston SM, Berger R, Tanzi RE, Halperin JJ, Herzfeldt B, Van den Bergh R, Hung WY, Bird T, Deng G, Mulder DW, Smyth C, Laing NG, Soriano E, Pericak-Vance MA, Haines J, Rouleau GA, Gusella JS, Horvitz HR, Brown RH., Jr Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362:59–62.[PubMed]
• 1087. Roskoski R., Jr Src kinase regulation by phosphorylation and dephosphorylation. Biochem Biophys Res Commun. 2005;331:1–14.[PubMed]
• 1088. Rowland LP, Shneider NAAmyotrophic lateral sclerosis. N Engl J Med. 2001;344:1688–1700.[PubMed][Google Scholar]
• 1089. Rubanyi GM, Vanhoutte PMSuperoxide anions and hyperoxia inactivate endothelium-derived relaxing factor. Am J Physiol Heart Circ Physiol. 1986;250:H822–H827.[PubMed][Google Scholar]
• 1090. Rubbo H, Batthyany C, Radi RNitric oxide-oxygen radicals interactions in atherosclerosis. Biol Res. 2000;33:167–175.[PubMed][Google Scholar]
• 1091. Rubbo H, Darley-Usmar V, Freeman BANitric oxide regulation of tissue free radical injury. Chem Res Toxicol. 1996;9:809–820.[PubMed][Google Scholar]
• 1092. Rubbo H, Denicola A, Radi RPeroxynitrite inactivates thiol-containing enzymes of Trypanosoma cruzi energetic metabolism and inhibits cell respiration. Arch Biochem Biophys. 1994;308:96–102.[PubMed][Google Scholar]
• 1093. Rubbo H, O’Donnell VNitric oxide, peroxynitrite and lipoxygenase in atherogenesis: mechanistic insights. Toxicology. 2005;208:305–317.[PubMed][Google Scholar]
• 1094. Rubbo H, Trostchansky A, Botti H, Batthyany CInteractions of nitric oxide and peroxynitrite with low-density lipoprotein. Biol Chem. 2002;383:547–552.[PubMed][Google Scholar]
• 1095. Ryberg H, Soderling AS, Davidsson P, Blennow K, Caidahl K, Persson LICerebrospinal fluid levels of free 3-nitrotyrosine are not elevated in the majority of patients with amyotrophic lateral sclerosis or Alzheimer’s disease. Neurochem Int. 2004;45:57–62.[PubMed][Google Scholar]
• 1096. Ryu JK, Kim SU, McLarnon JGBlockade of quinolinic acid-induced neurotoxicity by pyruvate is associated with inhibition of glial activation in a model of Huntington’s disease. Exp Neurol. 2004;187:150–159.[PubMed][Google Scholar]
• 1097. Sabetkar M, Low SY, Naseem KM, Bruckdorfer KRThe nitration of proteins in platelets: significance in platelet function. Free Radic Biol Med. 2002;33:728–736.[PubMed][Google Scholar]
• 1098. Sacksteder CA, Qian WJ, Knyushko TV, Wang H, Chin MH, Lacan G, Melega WP, Camp DG, 2nd, Smith RD, Smith DJ, Squier TC, Bigelow DJEndogenously nitrated proteins in mouse brain: links to neurodegenerative disease. Biochemistry. 2006;45:8009–8022.[PubMed][Google Scholar]
• 1099. Saeki M, Kamisaki Y, Maeda SInvolvement of mitogen-activated protein kinase in peroxynitrite-induced cell death of human neuroblastoma SH-SY5Y cells. Neurosci Res. 2000;38:213–216.[PubMed][Google Scholar]
• 1100. Saeki M, Maeda Sp130cas is a cellular target protein for tyrosine nitration induced by peroxynitrite. Neurosci Res. 1999;33:325–328.[PubMed][Google Scholar]
• 1101. Saeki M, Maeda S, Kamisaki YVanadate protects human neuroblastoma SH-SY5Y cells against peroxynitrite-induced cell death. J Cell Biochem. 2002;85:721–727.[PubMed][Google Scholar]
• 1102. Saez TE, Pehar M, Vargas M, Barbeito L, Maccioni RBAstrocytic nitric oxide triggers tau hyperphosphorylation in hippocampal neurons. In Vivo. 2004;18:275–280.[PubMed][Google Scholar]
• 1103. Sakurai H, Kohsaka H, Liu MF, Higashiyama H, Hirata Y, Kanno K, Saito I, Miyasaka NNitric oxide production and inducible nitric oxide synthase expression in inflammatory arthritides. J Clin Invest. 1995;96:2357–2363.[Google Scholar]
• 1104. Sakurai M, Fukuyama N, Iguchi A, Akimoto H, Ohmi M, Yokoyama H, Nakazawa H, Tabayashi KQuantitative analysis of cardiac 3-L-nitrotyrosine during acute allograft rejection in an experimental heart transplantation. Transplantation. 1999;68:1818–1822.[PubMed][Google Scholar]
• 1105. Salgo MG, Squadrito GL, Pryor WAPeroxynitrite causes apoptosis in rat thymocytes. Biochem Biophys Res Commun. 1995;215:1111–1118.[PubMed][Google Scholar]
• 1106. Salom JB, Orti M, Centeno JM, Torregrosa G, Alborch EReduction of infarct size by the NO donors sodium nitroprusside and spermine/NO after transient focal cerebral ischemia in rats. Brain Res. 2000;865:149–156.[PubMed][Google Scholar]
• 1107. Salvemini D, Cuzzocrea SOxidative stress in septic shock and disseminated intravascular coagulation. Free Radic Biol Med. 2002;33:1173–1185.[PubMed][Google Scholar]
• 1108. Salvemini D, Mazzon E, Dugo L, Serraino I, De Sarro A, Caputi AP, Cuzzocrea SAmelioration of joint disease in a rat model of collagen-induced arthritis by M40403, a superoxide dismutase mimetic. Arthritis Rheum. 2001;44:2909–2921.[PubMed][Google Scholar]
• 1109. Salvemini D, Riley DP, Lennon PJ, Wang ZQ, Currie MG, Macarthur H, Misko TPProtective effects of a superoxide dismutase mimetic and peroxynitrite decomposition catalysts in endotoxin-induced intestinal damage. Br J Pharmacol. 1999;127:685–692.[Google Scholar]
• 1110. Salvemini D, Wang ZQ, Bourdon DM, Stern MK, Currie MG, Manning PTEvidence of peroxynitrite involvement in the carrageenan-induced rat paw edema. Eur J Pharmacol. 1996;303:217–220.[PubMed][Google Scholar]
• 1111. Salvemini D, Wang ZQ, Stern MK, Currie MG, Misko TPPeroxynitrite decomposition catalysts: therapeutics for peroxynitrite-mediated pathology. Proc Natl Acad Sci USA. 1998;95:2659–2663.[Google Scholar]
• 1112. Sampson JB, Rosen H, Beckman JSPeroxynitrite-dependent tyrosine nitration catalyzed by superoxide dismutase, myeloperoxidase, horseradish peroxidase. Methods Enzymol. 1996;269:210–218.[PubMed][Google Scholar]
• 1113. Sampson JB, Ye Y, Rosen H, Beckman JSMyeloperoxidase and horseradish peroxidase catalyze tyrosine nitration in proteins from nitrite and hydrogen peroxide. Arch Biochem Biophys. 1998;356:207–213.[PubMed][Google Scholar]
• 1114. Sanchez-Ramos JR, Hefti F, Weiner WJParaquat and Parkinson’s disease. Neurology. 1987;37:728.[PubMed][Google Scholar]
• 1115. Sandhu JK, Robertson S, Birnboim HC, Goldstein RDistribution of protein nitrotyrosine in synovial tissues of patients with rheumatoid arthritis and osteoarthritis. J Rheumatol. 2003;30:1173–1181.[PubMed][Google Scholar]
• 1116. Sangha OEpidemiology of rheumatic diseases. Rheumatology. 2000;39(Suppl 2):3–12.[PubMed][Google Scholar]
• 1117. Santiago-Lopez D, Vazquez-Roman B, Perez-de La Cruz V, Barrera D, Rembao D, Salinas-Lara C, Pedraza-Chaverri J, Galvan-Arzate S, Ali SF, Santamaria APeroxynitrite decomposition catalyst, iron metalloporphyrin, reduces quinolinate-induced neurotoxicity in rats. Synapse. 2004;54:233–238.[PubMed][Google Scholar]
• 1118. Saraswathi V, Wu G, Toborek M, Hennig BLinoleic acid-induced endothelial activation: role of calcium and peroxynitrite signaling. J Lipid Res. 2004;45:794–804.[PubMed][Google Scholar]
• 1119. Sarchielli P, Galli F, Floridi A, Floridi A, Gallai VRelevance of protein nitration in brain injury: a key pathophysiological mechanism in neurodegenerative, autoimmune, or inflammatory CNS diseases and stroke. Amino Acids. 2003;25:427–436.[PubMed][Google Scholar]
• 1120. Sarker KP, Nakata M, Kitajima I, Nakajima T, Maruyama IInhibition of caspase-3 activation by SB 203580, p38 mitogen-activated protein kinase inhibitor in nitric oxide-induced apoptosis of PC-12 cells. J Mol Neurosci. 2000;15:243–250.[PubMed][Google Scholar]
• 1121. Sasaki S, Warita H, Abe K, Iwata MInducible nitric oxide synthase (iNOS) and nitrotyrosine immunoreactivity in the spinal cords of transgenic mice with a G93A mutant SOD1 gene. J Neuropathol Exp Neurol. 2001;60:839–846.[PubMed][Google Scholar]
• 1122. Sase K, Michel TExpression and regulation of endothelial nitric oxide synthase. Trends Cardiovasc Med. 1997;7:28–37.[PubMed][Google Scholar]
• 1123. Satsangi J, Silverberg MS, Vermeire S, Colombel JFThe Montreal classification of inflammatory bowel disease: controversies, consensus, implications. Gut. 2006;55:749–753.[Google Scholar]
• 1124. Sawa T, Ohshima HNitrative DNA damage in inflammation and its possible role in carcinogenesis. Nitric Oxide. 2006;14:91–100.[PubMed][Google Scholar]
• 1125. Sawyer DT, Valentine JHow super is superoxide? Acct Chem Res. 1981;14:393–400.[PubMed][Google Scholar]
• 1126. Saxena M, Mustelin TExtracellular signals and scores of phosphatases: all roads lead to MAP kinase. Semin Immunol. 2000;12:387–396.[PubMed][Google Scholar]
• 1127. Scarlett JL, Packer MA, Porteous CM, Murphy MPAlterations to glutathione and nicotinamide nucleotides during the mitochondrial permeability transition induced by peroxynitriten. Biochem Pharmacol. 1996;52:1047–1055.[PubMed][Google Scholar]
• 1128. Schieke SM, Briviba K, Klotz LO, Sies HActivation pattern of mitogen-activated protein kinases elicited by peroxynitrite: attenuation by selenite supplementation. FEBS Lett. 1999;448:301–303.[PubMed][Google Scholar]
• 1129. Schlessinger JCell signaling by receptor tyrosine kinases. Cell. 2000;103:211–225.[PubMed][Google Scholar]
• 1130. Schmidt P, Youhnovski N, Daiber A, Balan A, Arsic M, Bachschmid M, Przybylski M, Ullrich VSpecific nitration at tyrosine 430 revealed by high resolution mass spectrometry as basis for redox regulation of bovine prostacyclin synthase. J Biol Chem. 2003;278:12813–12819.[PubMed][Google Scholar]
• 1131. Schoneich C, Viner RI, Ferrington DA, Bigelow DJAge-related chemical modification of the skeletal muscle sarcoplasmic reticulum Ca-ATPase of the rat. Mech Ageing Dev. 1999;107:221–231.[PubMed][Google Scholar]
• 1132. Schopfer FJ, Baker PR, Freeman BANO-dependent protein nitration: a cell signaling event or an oxidative inflammatory response? Trends Biochem Sci. 2003;28:646–654.[PubMed][Google Scholar]
• 1133. Schroeder P, Klotz LO, Buchczyk DP, Sadik CD, Schewe T, Sies HEpicatechin selectively prevents nitration but not oxidation reactions of peroxynitrite. Biochem Biophys Res Commun. 2001;285:782–787.[PubMed][Google Scholar]
• 1134. Schroeder P, Zhang H, Klotz LO, Kalyanaraman B, Sies H(−)-Epicatechin inhibits nitration and dimerization of tyrosine in hydrophilic as well as hydrophobic environments. Biochem Biophys Res Commun. 2001;289:1334–1338.[PubMed][Google Scholar]
• 1135. Schulz JB, Matthews RT, Klockgether T, Dichgans J, Beal MFThe role of mitochondrial dysfunction and neuronal nitric oxide in animal models of neurodegenerative diseases. Mol Cell Biochem. 1997;174:193–197.[PubMed][Google Scholar]
• 1136. Schulz R, Dodge KL, Lopaschuk GD, Clanachan ASPeroxynitrite impairs cardiac contractile function by decreasing cardiac efficiency. Am J Physiol Heart Circ Physiol. 1997;272:H1212–H1219.[PubMed][Google Scholar]
• 1137. Schuman EM, Madison DVA requirement for the intercellular messenger nitric oxide in long-term potentiation. Science. 1991;254:1503–1506.[PubMed][Google Scholar]
• 1138. Schutte H, Mayer K, Burger H, Witzenrath M, Gessler T, Seeger W, Grimminger FEndogenous nitric oxide synthesis and vascular leakage in ischemic-reperfused rabbit lungs. Am J Respir Crit Care Med. 2001;164:412–418.[PubMed][Google Scholar]
• 1139. Schutte H, Witzenrath M, Mayer K, Rosseau S, Seeger W, Grimminger FShort-term “preconditioning” with inhaled nitric oxide protects rabbit lungs against ischemia-reperfusion injury. Transplantation. 2001;72:1363–1370.[PubMed][Google Scholar]
• 1140. Scott DJ, Hull MA, Cartwright EJ, Lam WK, Tisbury A, Poulsom R, Markham AF, Bonifer C, Coletta PLLack of inducible nitric oxide synthase promotes intestinal tumorigenesis in the Apc(Min/+) mouse. Gastroenterology. 2001;121:889–899.[PubMed][Google Scholar]
• 1141. Scott GS, Hooper DCThe role of uric acid in protection against peroxynitrite-mediated pathology. Med Hypotheses. 2001;56:95–100.[PubMed][Google Scholar]
• 1142. Scott GS, Kean RB, Southan GJ, Szabo C, Hooper DCEffect of mercaptoethylguanidine scavengers of peroxynitrite on the development of experimental allergic encephalomyelitis in PLSJL mice. Neurosci Lett. 2001;311:125–128.[PubMed][Google Scholar]
• 1143. Sekar KInhaled nitric oxide in term and preterm infants. J Perinatol. 2006;26(Suppl 1):S4–S23.[PubMed][Google Scholar]
• 1144. Seki J, Nishio M, Kato Y, Motoyama Y, Yoshida KFK409, a new nitricoxide donor, suppresses smooth muscle proliferation in the rat model of balloon angioplasty. Atherosclerosis. 1995;117:97–106.[PubMed][Google Scholar]
• 1145. Senftleben U, Cao Y, Xiao G, Greten FR, Krahn G, Bonizzi G, Chen Y, Hu Y, Fong A, Sun SC, Karin MActivation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway. Science. 2001;293:1495–1499.[PubMed][Google Scholar]
• 1146. Serracino-Inglott F, Virlos IT, Habib NA, Williamson RC, Mathie RTDifferential nitric oxide synthase expression during hepatic ischemia-reperfusion. Am J Surg. 2003;185:589–595.[PubMed][Google Scholar]
• 1147. Serrano F, Kolluri NS, Wientjes FB, Card JP, Klann ENADPH oxidase immunoreactivity in the mouse brain. Brain Res. 2003;988:193–198.[PubMed][Google Scholar]
• 1148. Shacka JJ, Sahawneh MA, Gonzalez JD, Ye YZ, D’Alessandro TL, Estevez AGTwo distinct signaling pathways regulate peroxynitrite-induced apoptosis in PC12 cells. Cell Death Differ. 2006;13:1506–1514.[PubMed][Google Scholar]
• 1149. Shah AM, MacCarthy PAParacrine and autocrine effects of nitric oxide on myocardial function. Pharmacol Ther. 2000;86:49–86.[PubMed][Google Scholar]
• 1150. Shall S, de Murcia GPoly(ADP-ribose) polymerase-1: what have we learned from the deficient mouse model? Mutat Res. 2000;460:1–15.[PubMed][Google Scholar]
• 1151. Sharma VS, Traylor TG, Gardiner R, Mizukami HReaction of nitric oxide with heme proteins and model compounds of hemoglobin. Biochemistry. 1987;26:3837–3843.[PubMed][Google Scholar]
• 1152. Shears LL, 2nd, Kibbe MR, Murdock AD, Billiar TR, Lizonova A, Kovesdi I, Watkins SC, Tzeng EEfficient inhibition of intimal hyperplasia by adenovirus-mediated inducible nitric oxide synthase gene transfer to rats and pigs in vivo. J Am Coll Surg. 1998;187:295–306.[PubMed][Google Scholar]
• 1153. Sheng H, Enghild JJ, Bowler R, Patel M, Batinic-Haberle I, Calvi CL, Day BJ, Pearlstein RD, Crapo JD, Warner DSEffects of metalloporphyrin catalytic antioxidants in experimental brain ischemia. Free Radic Biol Med. 2002;33:947–961.[PubMed][Google Scholar]
• 1154. Sherman MP, Griscavage JM, Ignarro LJNitric oxide-mediated neuronal injury in multiple sclerosis. Med Hypotheses. 1992;39:143–146.[PubMed][Google Scholar]
• 1155. Shi H, Noguchi N, Xu Y, Niki EFormation of phospholipid hydroperoxides and its inhibition by alpha-tocopherol in rat brain synaptosomes induced by peroxynitrite. Biochem Biophys Res Commun. 1999;257:651–656.[PubMed][Google Scholar]
• 1156. Shibata M, Araki N, Hamada J, Sasaki T, Shimazu K, Fukuu-chi YBrain nitrite production during global ischemia and reperfusion: an in vivo microdialysis study. Brain Res. 1996;734:86–90.[PubMed][Google Scholar]
• 1157. Shibuya A, Wada K, Nakajima A, Saeki M, Katayama K, Mayumi T, Kadowaki T, Niwa H, Kamisaki YNitration of PPARgamma inhibits ligand-dependent translocation into the nucleus in a macrophage-like cell line, RAW 264. FEBS Lett. 2002;525:43–47.[PubMed][Google Scholar]
• 1158. Shimizu K, Rajapakse N, Horiguchi T, Payne RM, Busija DWNeuroprotection against hypoxia-ischemia in neonatal rat brain by novel superoxide dismutase mimetics. Neurosci Lett. 2003;346:41–44.[PubMed][Google Scholar]
• 1159. Shimosawa T, Shibagaki Y, Ishibashi K, Kitamura K, Kangawa K, Kato S, Ando K, Fujita TAdrenomedullin, an endogenous peptide, counteracts cardiovascular damage. Circulation. 2002;105:106–111.[PubMed][Google Scholar]
• 1160. Shin T, Tanuma N, Kim S, Jin J, Moon C, Kim K, Kohyama K, Matsumoto Y, Hyun BAn inhibitor of inducible nitric oxide synthase ameliorates experimental autoimmune myocarditis in Lewis rats. J Neuroimmunol. 1998;92:133–138.[PubMed][Google Scholar]
• 1161. Shiva S, Brookes PS, Patel RP, Anderson PG, Darley-Usmar VMNitric oxide partitioning into mitochondrial membranes and the control of respiration at cytochrome c oxidase. Proc Natl Acad Sci USA. 2001;98:7212–7217.[Google Scholar]
• 1162. Shrivastava P, Pantano C, Watkin R, McElhinney B, Guala A, Poynter ML, Persinger RL, Budd R, Janssen-Heininger YReactive nitrogen species-induced cell death requires Fas-dependent activation of c-Jun N-terminal kinase. Mol Cell Biol. 2004;24:6763–6772.[Google Scholar]
• 1163. Siegert A, Rosenberg C, Schmitt WD, Denkert C, Hauptmann SNitric oxide of human colorectal adenocarcinoma cell lines promotes tumour cell invasion. Br J Cancer. 2002;86:1310–1315.[Google Scholar]
• 1164. Silvagno F, Xia H, Bredt DSNeuronal nitricoxide synthase-μ, an alternatively spliced isoform expressed in differentiated skeletal muscle. J Biol Chem. 1996;271:11204–11208.[PubMed][Google Scholar]
• 1165. Simbulan-Rosenthal CM, Ly DH, Rosenthal DS, Konopka G, Luo R, Wang ZQ, Schultz PG, Smulson EMisregulation of gene expression in primary fibroblasts lacking poly(ADP-ribose) polymerase. Proc Natl Acad Sci USA. 2000;97:11274–11279.[Google Scholar]
• 1166. Simic G, Lucassen PJ, Krsnik Z, Kruslin B, Kostovic I, Winblad B, Bogdanovi nNOS expression in reactive astrocytes correlates with increased cell death related DNA damage in the hippocampus and entorhinal cortex in Alzheimer’s disease. Exp Neurol. 2000;165:12–26.[PubMed]
• 1167. Simonian NA, Coyle JTOxidative stress in neurodegenerative diseases. Annu Rev Pharmacol Toxicol. 1996;36:83–106.[PubMed][Google Scholar]
• 1168. Simpson EPAntioxidant treatment for amyotrophic lateral sclerosis. Lancet Neurol. 2005;4:266.[PubMed][Google Scholar]
• 1169. Sims NR, Anderson MFMitochondrial contributions to tissue damage in stroke. Neurochem Int. 2002;40:511–526.[PubMed][Google Scholar]
• 1170. Singer II, Kawka DW, Scott S, Weidner JR, Mumford RA, Riehl TE, Stenson WFExpression of inducible nitric oxide synthase and nitrotyrosine in colonic epithelium in inflammatory bowel disease. Gastroenterology. 1996;111:871–885.[PubMed][Google Scholar]
• 1171. Singh IN, Sullivan PG, Deng Y, Mbye LH, Hall EDTime course of post-traumatic mitochondrial oxidative damage and dysfunction in a mouse model of focal traumatic brain injury: implications for neuroprotective therapy. J Cereb Blood Flow Metab. In press. [[PubMed]
• 1172. Sinnaeve P, Chiche JD, Nong Z, Varenne O, Van Pelt N, Gillijns H, Collen D, Bloch KD, Janssens SSoluble guanylate cyclase alpha(1) and beta(1) gene transfer increases NO responsiveness and reduces neointima formation after balloon injury in rats via antiproliferative and antimigratory effects. Circ Res. 2001;88:103–109.[PubMed][Google Scholar]
• 1173. Sironi L, Cimino M, Guerrini U, Calvio AM, Lodetti B, Asdente M, Balduini W, Paoletti R, Tremoli ETreatment with statins after induction of focal ischemia in rats reduces the extent of brain damage. Arterioscler Thromb Vasc Biol. 2003;23:322–327.[PubMed][Google Scholar]
• 1174. Smith CD, Carson M, van der Woerd M, Chen J, Ischiropoulos H, Beckman JSCrystal structure of peroxynitrite-modified bovine Cu,Zn superoxide dismutase. Arch Biochem Biophys. 1992;299:350–355.[PubMed][Google Scholar]
• 1175. Smith KJ, Kapoor R, Felts PADemyelination: the role of reactive oxygen and nitrogen species. Brain Pathol. 1999;9:69–92.[PubMed][Google Scholar]
• 1176. Smith MA, Richey Harris PL, Sayre LM, Beckman JS, Perry GWidespread peroxynitrite-mediated damage in Alzheimer’s disease. J Neurosci. 1997;17:2653–2657.[Google Scholar]
• 1177. Sobel BE, Schneider DJCardiovascular complications in diabetes mellitus. Curr Opin Pharmacol. 2005;5:143–148.[PubMed][Google Scholar]
• 1178. Sohn HY, Krotz F, Zahler S, Gloe T, Keller M, Theisen K, Schiele TM, Klauss V, Pohl UCrucial role of local peroxynitrite formation in neutrophil-induced endothelial cell activation. Cardiovasc Res. 2003;57:804–815.[PubMed][Google Scholar]
• 1179. Soloviev A, Stefanov A, Parshikov A, Khromov A, Moibenko A, Kvotchina L, Balavoine G, Geletii YArrhythmogenic peroxynitrite-induced alterations in mammalian heart contractility and its prevention with quercetin-filled liposomes. Cardiovasc Toxicol. 2002;2:129–139.[PubMed][Google Scholar]
• 1180. Somers MJ, Mavromatis K, Galis ZS, Harrison DGVascular superoxide production and vasomotor function in hypertension induced by deoxycorticosterone acetate-salt. Circulation. 2000;101:1722–1728.[PubMed][Google Scholar]
• 1181. Sood HS, Cox MJ, Tyagi SCGeneration of nitrotyrosine precedes activation of metalloproteinase in myocardium of hyperhomocysteinemic rats. Antioxid Redox Signal. 2002;4:799–804.[PubMed][Google Scholar]
• 1182. Sorescu D, Griendling KKReactive oxygen species, mitochondria, NAD(P)H oxidases in the development and progression of heart failure. Congest Heart Fail. 2002;8:132–140.[PubMed][Google Scholar]
• 1183. Soriano FG, Liaudet L, Szabo E, Virag L, Mabley JG, Pacher P, Szabo CResistance to acute septic peritonitis in poly(ADP-ribose) polymerase-1-deficient mice. Shock. 2002;17:286–292.[PubMed][Google Scholar]
• 1184. Soriano FG, Nogueira AC, Caldini EG, Lins MH, Teixeira AC, Cappi SB, Lotufo PA, Bernik MM, Zsengeller Z, Chen M, Szabo CPotential role of poly(adenosine 5′-diphosphate-ribose) polymerase activation in the pathogenesis of myocardial contractile dysfunction associated with human septic shock. Crit Care Med. 2006;34:1073–1079.[PubMed][Google Scholar]
• 1185. Soriano FG, Pacher P, Mabley J, Liaudet L, Szabo CRapid reversal of the diabetic endothelial dysfunction by pharmacological inhibition of poly(ADP-ribose) polymerase. Circ Res. 2001;89:684–691.[PubMed][Google Scholar]
• 1186. Soriano FG, Virag L, Szabo CDiabetic endothelial dysfunction: role of reactive oxygen and nitrogen species production and poly-(ADP-ribose) polymerase activation. J Mol Med. 2001;79:437–448.[PubMed][Google Scholar]
• 1187. Sospedra M, Martin RImmunology of multiple sclerosis. Annu Rev Immunol. 2005;23:683–747.[PubMed][Google Scholar]
• 1188. Southam E, East SJ, Garthwaite JExcitatory amino acid receptors coupled to the nitric oxide/cyclic GMP pathway in rat cerebellum during development. J Neurochem. 1991;56:2072–2081.[PubMed][Google Scholar]
• 1189. Southern C, Schulster D, Green IC. Inhibition of insulin secretion from rat islets of Langerhans by interleukin-6. An effect distinct from that of interleukin-1. Biochem J. 1990;272:243–245.
• 1190. Souza JM, Daikhin E, Yudkoff M, Raman CS, Ischiropoulos HFactors determining the selectivity of protein tyrosine nitration. Arch Biochem Biophys. 1999;371:169–178.[PubMed][Google Scholar]
• 1191. Souza JM, Giasson BI, Chen Q, Lee VM, Ischiropoulos H. Dityrosine cross-linking promotes formation of stable alpha-synuclein polymers. Implication of nitrative and oxidative stress in the pathogenesis of neurodegenerative synucleinopathies. J Biol Chem. 2000;275:18344–18349.[PubMed]
• 1192. Souza JM, Radi RGlyceraldehyde-3-phosphate dehydrogenase inactivation by peroxynitrite. Arch Biochem Biophys. 1998;360:187–194.[PubMed][Google Scholar]
• 1193. Spear N, Estevez AG, Barbeito L, Beckman JS, Johnson GVNerve growth factor protects PC12 cells against peroxynitrite-induced apoptosis via a mechanism dependent on phosphatidylinositol 3-kinase. J Neurochem. 1997;69:53–59.[PubMed][Google Scholar]
• 1194. Spitaler MM, Graier WFVascular targets of redox signalling in diabetes mellitus. Diabetologia. 2002;45:476–494.[PubMed][Google Scholar]
• 1195. Spitsin S, Hooper DC, Mikheeva T, Koprowski HUric acid levels in patients with multiple sclerosis: analysis in mono- and dizygotic twins. Mult Scler. 2001;7:165–166.[PubMed][Google Scholar]
• 1196. St Clair EW, Wilkinson WE, Lang T, Sanders L, Misukonis MA, Gilkeson GS, Pisetsky DS, Granger DL, Weinberg JBIncreased expression of blood mononuclear cell nitric oxide synthase type 2 in rheumatoid arthritis patients. J Exp Med. 1996;184:1173–1178.[Google Scholar]
• 1197. Stachowiak O, Dolder M, Wallimann T, Richter CMitochondrial creatine kinase is a prime target of peroxynitrite-induced modification and inactivation. J Biol Chem. 1998;273:16694–16699.[PubMed][Google Scholar]
• 1198. Stadler K, Jenei V, von Bolcshazy G, Somogyi A, Jakus JIncreased nitric oxide levels as an early sign of premature aging in diabetes. Free Radic Biol Med. 2003;35:1240–1251.[PubMed][Google Scholar]
• 1199. Stadtman ER, Moskovitz J, Levine RLOxidation of methionine residues of proteins: biological consequences. Antioxid Redox Signal. 2003;5:577–582.[PubMed][Google Scholar]
• 1200. Stamler JS, Lamas S, Fang FCNitrosylation, the prototypic redox-based signaling mechanism. Cell. 2001;106:675–683.[PubMed][Google Scholar]
• 1201. Stamler JS, Singel DJ, Loscalzo JBiochemistry of nitric oxide and its redox-activated forms. Science. 1992;258:1898–1902.[PubMed][Google Scholar]
• 1202. Stanger O, Weger MInteractions of homocysteine, nitric oxide, folate and radicals in the progressively damaged endothelium. Clin Chem Lab Med. 2003;41:1444–1454.[PubMed][Google Scholar]
• 1203. Stefanovic-Racic M, Meyers K, Meschter C, Coffey JW, Hoffman RA, Evans CHComparison of the nitric oxide synthase inhibitors methylarginine and aminoguanidine as prophylactic and therapeutic agents in rat adjuvant arthritis. J Rheumatol. 1995;22:1922–1928.[PubMed][Google Scholar]
• 1204. Stevens MJOxidative-nitrosative stress as a contributing factor to cardiovascular disease in subjects with diabetes. Curr Vasc Pharmacol. 2005;3:253–266.[PubMed][Google Scholar]
• 1205. Stewart VC, Heales SJNitric oxide-induced mitochondrial dysfunction: implications for neurodegeneration. Free Radic Biol Med. 2003;34:287–303.[PubMed][Google Scholar]
• 1206. Stoker AWProtein tyrosine phosphatases and signalling. J Endocrinol. 2005;185:19–33.[PubMed][Google Scholar]
• 1207. Strong JP, Malcom GT, McMahan CA, Tracy RE, Newman WP, 3rd, Herderick EE, Cornhill JFPrevalence and extent of atherosclerosis in adolescents and young adults: implications for prevention from the Pathobiological Determinants of Atherosclerosis in Youth Study. JAMA. 1999;281:727–735.[PubMed][Google Scholar]
• 1208. Stuehr DJ, Nathan CF. Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumor cells. J Exp Med. 1989;169:1543–1555.
• 1209. Suarez-Pinzon WL, Mabley JG, Strynadka K, Power RF, Szabo C, Rabinovitch AAn inhibitor of inducible nitric oxide synthase and scavenger of peroxynitrite prevents diabetes development in NOD mice. J Autoimmun. 2001;16:449–455.[PubMed][Google Scholar]
• 1210. Suarez-Pinzon WL, Szabo C, Rabinovitch ADevelopment of autoimmune diabetes in NOD mice is associated with the formation of peroxynitrite in pancreatic islet beta-cells. Diabetes. 1997;46:907–911.[PubMed][Google Scholar]
• 1211. Sucu N, Unlu A, Tamer L, Aytacoglu B, Ercan B, Dikmengil M, Atik U3-Nitrotyrosine in atherosclerotic blood vessels. Clin Chem Lab Med. 2003;41:23–25.[PubMed][Google Scholar]
• 1212. Suh JH, Shigeno ET, Morrow JD, Cox B, Rocha AE, Frei B, Hagen TMOxidative stress in the aging rat heart is reversed by dietary supplementation with (R)-(alpha)-lipoic acid. FASEB J. 2001;15:700–706.[Google Scholar]
• 1213. Sun D, Huang A, Yan EH, Wu Z, Yan C, Kaminski PM, Oury TD, Wolin MS, Kaley GReduced release of nitric oxide to shear stress in mesenteric arteries of aged rats. Am J Physiol Heart Circ Physiol. 2004;286:H2249–H2256.[Google Scholar]
• 1214. Sun Y, Zhang J, Lu L, Chen SS, Quinn MT, Weber KTAldosterone-induced inflammation in the rat heart: role of oxidative stress. Am J Pathol. 2002;161:1773–1781.[Google Scholar]
• 1215. Suschek C, Fehsel K, Kroncke KD, Sommer A, Kolb-Bachofen V. Primary cultures of rat islet capillary endothelial cells. Constitutive and cytokine-inducible macrophagelike nitric oxide synthases are expressed and activities regulated by glucose concentration. Am J Pathol. 1994;145:685–695.
• 1216. Susin SA, Lorenzo HK, Zamzami N, Marzo I, Snow BE, Brothers GM, Mangion J, Jacotot E, Costantini P, Loeffler M, Larochette N, Goodlett DR, Aebersold R, Siderovski DP, Penninger JM, Kroemer GMolecular characterization of mitochondrial apoptosis-inducing factor. Nature. 1999;397:441–446.[PubMed][Google Scholar]
• 1217. Suzuki A, Yamamoto N, Jokura H, Yamamoto M, Fujii A, Tokimitsu I, Saito IChlorogenic acid attenuates hypertension and improves endothelial function in spontaneously hypertensive rats. J Hypertens. 2006;24:1065–1073.[PubMed][Google Scholar]
• 1218. Suzuki M, Tabuchi M, Ikeda M, Tomita TConcurrent formation of peroxynitrite with the expression of inducible nitric oxide synthase in the brain during middle cerebral artery occlusion and reperfusion in rats. Brain Res. 2002;951:113–120.[PubMed][Google Scholar]
• 1219. Suzuki N, Yasui M, Geacintov NE, Shafirovich V, Shibutani SMiscoding events during DNA synthesis past the nitration-damaged base 8-nitroguanine. Biochemistry. 2005;44:9238–9245.[PubMed][Google Scholar]
• 1220. Suzuki Y, Deitch EA, Mishima S, Lu Q, Xu DInducible nitric oxide synthase gene knockout mice have increased resistance to gut injury and bacterial translocation after an intestinal ischemia-reperfusion injury. Crit Care Med. 2000;28:3692–3696.[PubMed][Google Scholar]
• 1221. Suzuki YJ, Forman HJ, Sevanian AOxidants as stimulators of signal transduction. Free Radic Biol Med. 1997;22:269–285.[PubMed][Google Scholar]
• 1222. Symmons D, Turner G, Webb R, Asten P, Barrett E, Lunt M, Scott D, Silman AThe prevalence of rheumatoid arthritis in the United Kingdom: new estimates for a new century. Rheumatology. 2002;41:793–800.[PubMed][Google Scholar]
• 1223. Szabo A, Hake P, Salzman AL, Szabo C3-Aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase, improves hemodynamics and prolongs survival in a porcine model of hemorrhagic shock. Shock. 1998;10:347–353.[PubMed][Google Scholar]
• 1224. Szabo A, Hake P, Salzman AL, Szabo CBeneficial effects of mercaptoethylguanidine, an inhibitor of the inducible isoform of nitric oxide synthase and a scavenger of peroxynitrite, in a porcine model of delayed hemorrhagic shock. Crit Care Med. 1999;27:1343–1350.[PubMed][Google Scholar]
• 1225. Szabo A, Salzman AL, Szabo CPoly(ADP-ribose) synthetase activation mediates pulmonary microvascular and intestinal mucosal dysfunction in endotoxin shock. Life Sci. 1998;63:2133–2139.[PubMed][Google Scholar]
• 1226. Szabo CAlterations in nitric oxide production in various forms of circulatory shock. New Horizons. 1995;3:2–32.[PubMed][Google Scholar]
• 1227. Szabo CMultiple pathways of peroxynitrite cytotoxicity. Toxicol Lett. 2003;140–141:105–112.[PubMed][Google Scholar]
• 1228. Szabo CPharmacological inhibition of poly(ADP-ribose) polymerase in cardiovascular disorders: future directions. Curr Vasc Pharmacol. 2005;3:301–303.[PubMed][Google Scholar]
• 1229. Szabo CPhysiological and pathophysiological roles of nitric oxide in the central nervous system. Brain Res Bull. 1996;41:131–141.[PubMed][Google Scholar]
• 1230. Szabo CPoly(ADP-ribose) polymerase activation by reactive nitrogen species-Relevance for the pathogenesis of inflammation. Nitric Oxide. 2006;14:169–179.[PubMed][Google Scholar]
• 1231. Szabo CPotential role of the peroxynitrate-poly(ADP-ribose) synthetase pathway in a rat model of severe hemorrhagic shock. Shock. 1998;9:341–344.[PubMed][Google Scholar]
• 1232. Szabo CRoles of poly(ADP-ribose) polymerase activation in the pathogenesis of diabetes mellitus and its complications. Pharmacol Res. 2005;52:60–71.[PubMed][Google Scholar]
• 1233. Szabo C, Cuzzocrea S, Zingarelli B, O’Connor M, Salzman AL. Endothelial dysfunction in a rat model of endotoxic shock. Importance of the activation of poly (ADP-ribose) synthetase by peroxynitrite. J Clin Invest. 1997;100:723–735.
• 1234. Szabo C, Mabley JG, Moeller SM, Shimanovich R, Pacher P, Virag L, Soriano FG, Van Duzer JH, Williams W, Salzman AL, Groves JTPart I: pathogenetic role of peroxynitrite in the development of diabetes and diabetic vascular complications: studies with FP15, a novel potent peroxynitrite decomposition catalyst. Mol Med. 2002;8:571–580.[Google Scholar]
• 1235. Szabo C, Ohshima HDNA damage induced by peroxynitrite: subsequent biological effects. Nitric Oxide. 1997;1:373–385.[PubMed][Google Scholar]
• 1236. Szabo C, Pacher P, Zsengeller Z, Vaslin A, Komjati K, Benko R, Chen M, Mabley JG, Kollai MAngiotensin II-mediated endothelial dysfunction: role of poly(ADP-ribose) polymerase activation. Mol Med. 2004;10:28–35.[Google Scholar]
• 1237. Szabo C, Salzman AL, Ischiropoulos HEndotoxin triggers the expression of an inducible isoform of nitric oxide synthase and the formation of peroxynitrite in the rat aorta in vivo. FEBS Lett. 1995;363:235–238.[PubMed][Google Scholar]
• 1238. Szabo C, Salzman AL, Ischiropoulos HPeroxynitrite-mediated oxidation of dihydrorhodamine 123 occurs in early stages of endotoxic and hemorrhagic shock and ischemia-reperfusion injury. FEBS Lett. 1995;372:229–232.[PubMed][Google Scholar]
• 1239. Szabo C, Saunders C, O’Connor M, Salzman ALPeroxynitrite causes energy depletion and increases permeability via activation of poly(ADP-ribose) synthetase in pulmonary epithelial cells. Am J Respir Cell Mol Biol. 1997;16:105–109.[PubMed][Google Scholar]
• 1240. Szabo C, Virag L, Cuzzocrea S, Scott GJ, Hake P, O’Connor MP, Zingarelli B, Salzman AL, Kun EProtection against peroxynitrite-induced fibroblast injury and arthritis development by inhibition of poly(ADP-ribose) synthetase. Proc Natl Acad Sci USA. 1998;95:3867–3872.[Google Scholar]
• 1241. Szabo C, Virag L, Cuzzocrea S, Scott GS, Hake P, O’Connor MP, Zingarelli B, Salzman A, Kun EProtection against peroxynitrite-induced fibroblast injury and arthritis development by inhibition of poly(ADP-ribose) synthase. Proc Natl Acad Sci USA. 1998;95:3867–3872.[Google Scholar]
• 1242. Szabo C, Zanchi A, Komjati K, Pacher P, Krolewski AS, Quist WC, LoGerfo FW, Horton ES, Veves APoly(ADP-ribose) polymerase is activated in subjects at risk of developing type 2 diabetes and is associated with impaired vascular reactivity. Circulation. 2002;106:2680–2686.[PubMed][Google Scholar]
• 1243. Szabo C, Zingarelli B, O’Connor M, Salzman ALDNA strand breakage, activation of poly (ADP-ribose) synthetase, cellular energy depletion are involved in the cytotoxicity of macrophages and smooth muscle cells exposed to peroxynitrite. Proc Natl Acad Sci USA. 1996;93:1753–1758.[Google Scholar]
• 1244. Szabo C, Zingarelli B, Salzman ALRole of poly-ADP ribosyl-transferase activation in the vascular contractile and energetic failure elicited by exogenous and endogenous nitric oxide and peroxynitrite. Circ Res. 1996;78:1051–1063.[PubMed][Google Scholar]
• 1245. Szabo G, Bahrle SRole of nitrosative stress and poly(ADP-ribose) polymerase activation in myocardial reperfusion injury. Curr Vasc Pharmacol. 2005;3:215–220.[PubMed][Google Scholar]
• 1246. Szabo G, Liaudet L, Hagl S, Szabo CPoly(ADP-ribose) polymerase activation in the reperfused myocardium. Cardiovasc Res. 2004;61:471–480.[PubMed][Google Scholar]
• 1247. Szabolcs M, Michler RE, Yang X, Aji W, Roy D, Athan E, Sciacca RR, Minanov OP, Cannon PJ. Apoptosis of cardiac myocytes during cardiac allograft rejection. Relation to induction of nitric oxide synthase. Circulation. 1996;94:1665–1673.[PubMed]
• 1248. Szabolcs MJ, Ma N, Athan E, Zhong J, Ming M, Sciacca RR, Husemann J, Albala A, Cannon PJAcute cardiac allograft rejection in nitric oxide synthase-2(−/−) and nitric oxide synthase-2(+/+) mice: effects of cellular chimeras on myocardial inflammation and cardiomyocyte damage and apoptosis. Circulation. 2001;103:2514–2520.[PubMed][Google Scholar]
• 1249. Szabolcs MJ, Ravalli S, Minanov O, Sciacca RR, Michler RE, Cannon PJApoptosis and increased expression of inducible nitric oxide synthase in human allograft rejection. Transplantation. 1998;65:804–812.[PubMed][Google Scholar]
• 1250. Szilvassy Z, Csont T, Pali T, Droy-Lefaix MT, Ferdinandy PNitric oxide, peroxynitrite and cGMP in atherosclerosis-induced hypertension in rabbits: beneficial effects of cicletanine. J Vasc Res. 2001;38:39–46.[PubMed][Google Scholar]
• 1251. Tabner BJ, El-Agnaf OM, German MJ, Fullwood NJ, Allsop DProtein aggregation, metals and oxidative stress in neurodegenerative diseases. Biochem Soc Trans. 2005;33:1082–1086.[PubMed][Google Scholar]
• 1252. Tabuchi M, Umegaki K, Ito T, Suzuki M, Tomita I, Ikeda M, Tomita T. Fluctuation of serum NO(x) concentration at stroke onset in a rat spontaneous stroke model (M-SHRSP). Peroxynitrite formation in brain lesions. Brain Res. 2002;949:147–156.[PubMed]
• 1253. Taddei S, Virdis A, Mattei P, Ghiadoni L, Gennari A, Fasolo CB, Sudano I, Salvetti AAging and endothelial function in normotensive subjects and patients with essential hypertension. Circulation. 1995;91:1981–1987.[PubMed][Google Scholar]
• 1254. Takakura K, Beckman JS, MacMillan-Crow LA, Crow JPRapid and irreversible inactivation of protein tyrosine phosphatases PTP1B, CD45, LAR by peroxynitrite. Arch Biochem Biophys. 1999;369:197–207.[PubMed][Google Scholar]
• 1255. Takakura K, Xiaohong W, Takeuchi K, Fukuda SPeroxynitrite decreases dopamine’s vasoconstrictive activity. Anesth Analg. 2003;97:1492–1496.[PubMed][Google Scholar]
• 1256. Takakura K, Xiaohong W, Takeuchi K, Yasuda Y, Fukuda SDeactivation of norepinephrine by peroxynitrite as a new pathogenesis in the hypotension of septic shock. Anesthesiology. 2003;98:928–934.[PubMed][Google Scholar]
• 1257. Takamatsu Y, Shimada K, Yamaguchi K, Kuroki S, Chijiiwa K, Tanaka MInhibition of inducible nitric oxide synthase prevents hepatic, but not pulmonary, injury following ischemia-reperfusion of rat liver. Dig Dis Sci. 2006;51:571–579.[PubMed][Google Scholar]
• 1258. Takizawa S, Aratani Y, Fukuyama N, Maeda N, Hirabayashi H, Koyama H, Shinohara Y, Nakazawa HDeficiency of myeloperoxidase increases infarct volume and nitrotyrosine formation in mouse brain. J Cereb Blood Flow Metab. 2002;22:50–54.[PubMed][Google Scholar]
• 1259. Takizawa S, Fukuyama N, Hirabayashi H, Nakazawa H, Shinohara YDynamics of nitrotyrosine formation and decay in rat brain during focal ischemia-reperfusion. J Cereb Blood Flow Metab. 1999;19:667–672.[PubMed][Google Scholar]
• 1260. Takizawa S, Hirabayashi H, Fukuyama N, Nakazawa H, Shinohara YPeroxynitrite production in cerebral ischemia. Rinsho Shinkeigaku. 1999;39:1295–1297.[PubMed][Google Scholar]
• 1261. Tan S, Yokoyama Y, Dickens E, Cash TG, Freeman BA, Parks DAXanthine oxidase activity in the circulation of rats following hemorrhagic shock. Free Radic Biol Med. 1993;15:407–414.[PubMed][Google Scholar]
• 1262. Tanabe T, Maeda S, Miyauchi T, Iemitsu M, Takanashi M, Irukayama-Tomobe Y, Yokota T, Ohmori H, Matsuda MExercise training improves ageing-induced decrease in eNOS expression of the aorta. Acta Physiol Scand. 2003;178:3–10.[PubMed][Google Scholar]
• 1263. Taner AS, Cinel I, Ozer L, Onde U, Taner D, Koksoy CPoly(ADP-ribose) synthetase inhibition reduces bacterial translocation in rats after endotoxin challenge. Shock. 2001;16:159–162.[PubMed][Google Scholar]
• 1264. Tannous M, Cheung R, Vignini A, Mutus BAtorvastatin increases ecNOS levels in human platelets of hyperlipidemic subjects. Thromb Haemost. 1999;82:1390–1394.[PubMed][Google Scholar]
• 1265. Tannous M, Rabini RA, Vignini A, Moretti N, Fumelli P, Zielinski B, Mazzanti L, Mutus BEvidence for iNOS-dependent peroxynitrite production in diabetic platelets. Diabetologia. 1999;42:539–544.[PubMed][Google Scholar]
• 1266. Tauskela JS, Brunette E, O’Reilly N, Mealing G, Comas T, Gendron TF, Monette R, Morley PAn alternative Ca^{-dependent mechanism of neuroprotection by the metalloporphyrin class of superoxide dismutase mimetics.} FASEB J. 2005;19:1734–1736.[PubMed][Google Scholar]
• 1267. Taylor EL, Rossi AG, Shaw CA, Dal Rio FP, Haslett C, Megson ILGEA 3162 decomposes to co-generate nitric oxide and superoxide and induces apoptosis in human neutrophils via a peroxynitrite-dependent mechanism. Br J Pharmacol. 2004;143:179–185.[Google Scholar]
• 1268. Tecder-Unal M, Kanzyk YPeroxynitrite in reperfusion arrhythmias and its whole blood chemiluminescence results. Pharmacol Res. 2004;49:7–16.[PubMed][Google Scholar]
• 1269. Tedeschi G, Cappelletti G, Negri A, Pagliato L, Maggioni MG, Maci R, Ronchi SCharacterization of nitroproteome in neuron-like PC12 cells differentiated with nerve growth factor: identification of two nitration sites in alpha-tubulin. Proteomics. 2005;5:2422–2432.[PubMed][Google Scholar]
• 1270. Tedgui A, Mallat ZAnti-inflammatory mechanisms in the vascular wall. Circ Res. 2001;88:877–887.[PubMed][Google Scholar]
• 1271. Teng RJ, Ye YZ, Parks DA, Beckman JSUrate produced during hypoxia protects heart proteins from peroxynitrite-mediated protein nitration. Free Radic Biol Med. 2002;33:1243–1249.[PubMed][Google Scholar]
• 1272. Thatcher GR, Nicolescu AC, Bennett BM, Toader VNitrates and NO release: contemporary aspects in biological and medicinal chemistry. Free Radic Biol Med. 2004;37:1122–1143.[PubMed][Google Scholar]
• 1273. Thiyagarajan M, Kaul CL, Sharma SSNeuroprotective efficacy and therapeutic time window of peroxynitrite decomposition catalysts in focal cerebral ischemia in rats. Br J Pharmacol. 2004;142:899–911.[Google Scholar]
• 1274. Thomas SM, Brugge JSCellular functions regulated by Src family kinases. Annu Rev Cell Dev Biol. 1997;13:513–609.[PubMed][Google Scholar]
• 1275. Thomson L, Trujillo M, Telleri R, Radi RKinetics of cytochrome c oxidation by peroxynitrite: implications for superoxide measurements in nitric oxide-producing biological systems. Arch Biochem Biophys. 1995;319:491–497.[PubMed][Google Scholar]
• 1276. Thorns V, Hansen L, Masliah EnNOS expressing neurons in the entorhinal cortex and hippocampus are affected in patients with Alzheimer’s disease. Exp Neurol. 1998;150:14–20.[PubMed][Google Scholar]
• 1277. Thuraisingham RC, Nott CA, Dodd SM, Yaqoob MMIncreased nitrotyrosine staining in kidneys from patients with diabetic nephropathy. Kidney Int. 2000;57:1968–1972.[PubMed][Google Scholar]
• 1278. Togo T, Katsuse O, Iseki ENitric oxide pathways in Alzheimer’s disease and other neurodegenerative dementias. Neurol Res. 2004;26:563–566.[PubMed][Google Scholar]
• 1279. Tohgi H, Abe T, Yamazaki K, Murata T, Ishizaki E, Isobe CAlterations of 3-nitrotyrosine concentration in the cerebrospinal fluid during aging and in patients with Alzheimer’s disease. Neurosci Lett. 1999;269:52–54.[PubMed][Google Scholar]
• 1280. Tohgi H, Abe T, Yamazaki K, Murata T, Ishizaki E, Isobe CRemarkable increase in cerebrospinal fluid 3-nitrotyrosine in patients with sporadic amyotrophic lateral sclerosis. Ann Neurol. 1999;46:129–131.[PubMed][Google Scholar]
• 1281. Tokime T, Nozaki K, Sugino T, Kikuchi H, Hashimoto N, Ueda KEnhanced poly(ADP-ribosyl)ation after focal ischemia in rat brain. J Cereb Blood Flow Metab. 1998;18:991–997.[PubMed][Google Scholar]
• 1282. Tominaga T, Sato S, Ohnishi T, Ohnishi STElectron paramagnetic resonance (EPR) detection of nitric oxide produced during forebrain ischemia of the rat. J Cereb Blood Flow Metab. 1994;14:715–722.[PubMed][Google Scholar]
• 1283. Tonks NKRedox redux: revisiting PTPs and the control of cell signaling. Cell. 2005;121:667–670.[PubMed][Google Scholar]
• 1284. Torreilles F, Salman-Tabcheh S, Guerin M, Torreilles JNeurodegenerative disorders: the role of peroxynitrite. Brain Res. 1999;30:153–163.[PubMed][Google Scholar]
• 1285. Tran MH, Yamada K, Nakajima A, Mizuno M, He J, Kamei H, Nabeshima TTyrosine nitration of a synaptic protein synaptophysin contributes to amyloid beta-peptide-induced cholinergic dysfunction. Mol Psychiatry. 2003;8:407–412.[PubMed][Google Scholar]
• 1286. Traylor TG, Sharma VSWhy NO? Biochemistry. 1992;31:2847–2849.[PubMed][Google Scholar]
• 1287. Trostchansky A, Ferrer-Sueta G, Batthyany C, Botti H, Batinic-Haberle I, Radi R, Rubbo HPeroxynitrite flux-mediated LDL oxidation is inhibited by manganese porphyrins in the presence of uric acid. Free Radic Biol Med. 2003;35:1293–1300.[PubMed][Google Scholar]
• 1288. Trostchansky A, Lind S, Hodara R, Oe T, Blair IA, Ischiropoulos H, Rubbo H, Souza JMInteraction with phospholipids modulates alpha-synuclein nitration and lipid-protein adduct formation. Biochem J. 2006;393:343–349.[Google Scholar]
• 1289. Trujillo M, Folkes L, Bartesaghi S, Kalyanaraman B, Wardman P, Radi RPeroxynitrite-derived carbonate and nitrogen dioxide radicals readily react with lipoic and dihydrolipoic acid. Free Radic Biol Med. 2005;39:279–288.[PubMed][Google Scholar]
• 1290. Tsai HH, Hamilton TP, Tsai JHM, Beckman JSAb initio studies of peroxynitrite anion-water complexes. Struct Chem. 1995;6:323–332.[PubMed][Google Scholar]
• 1291. Tsai JHM, Harrison JG, Martin JC, Hamilton TP, van der Woerd M, Jablonsky MJ, Beckman JSRole of conformation of peroxynitrite anion (ONOO^{) in its stability and toxicity.} J Am Chem Soc. 1994;116:4115–4116.[PubMed][Google Scholar]
• 1292. Tsao PS, Aoki N, Lefer DJ, Johnson G, 3rd, Lefer AMTime course of endothelial dysfunction and myocardial injury during myocardial ischemia and reperfusion in the cat. Circulation. 1990;82:1402–1412.[PubMed][Google Scholar]
• 1293. Tsoukias NM, Kavdia M, Popel AS. A theoretical model of nitric oxide transport in arterioles: frequency- vs. amplitude-dependent control of cGMP formation. Am J Physiol Heart Circ Physiol. 2004;286:H1043–H1056.[PubMed]
• 1294. Tsoukias NM, Popel ASErythrocyte consumption of nitric oxide in presence and absence of plasma-based hemoglobin. Am J Physiol Heart Circ Physiol. 2002;282:H2265–H2277.[PubMed][Google Scholar]
• 1295. Tsuchihashi S, Kaldas F, Chida N, Sudo Y, Tamura K, Zhai Y, Qiao B, Busuttil RW, Kupiec-Weglinski JWFK330, a novel inducible nitric oxide synthase inhibitor, prevents ischemia and reperfusion injury in rat liver transplantation. Am J Transplant. In press. [[PubMed]
• 1296. Tsukada K, Hasegawa T, Tsutsumi S, Katoh H, Kuwano H, Miyazaki T, Yamamoto YEffect of uric acid on liver injury during hemorrhagic shock. Surgery. 2000;127:439–446.[PubMed][Google Scholar]
• 1297. Turan N, Csonka C, Csont T, Giricz Z, Fodor G, Bencsik P, Gyongyosi M, Cakici I, Ferdinandy PThe role of peroxynitrite in chemical preconditioning with 3-nitropropionic acid in rat hearts. Cardiovasc Res. In press. [[PubMed]
• 1298. Turko IV, Li L, Aulak KS, Stuehr DJ, Chang JY, Murad F. Protein tyrosine nitration in the mitochondria from diabetic mouse heart. Implications to dysfunctional mitochondria in diabetes. J Biol Chem. 2003;278:33972–33977.[PubMed]
• 1299. Turko IV, Marcondes S, Murad FDiabetes-associated nitration of tyrosine and inactivation of succinyl-CoA:3-oxoacid CoA-transferase. Am J Physiol Heart Circ Physiol. 2001;281:H2289–H2294.[PubMed][Google Scholar]
• 1300. Turko IV, Murad FProtein nitration in cardiovascular diseases. Pharmacol Rev. 2002;54:619–634.[PubMed][Google Scholar]
• 1301. Uc A, Kooy NW, Conklin JL, Bishop WPPeroxynitrite inhibits epidermal growth factor receptor signaling in Caco-2 cells. Dig Dis Sci. 2003;48:2353–2359.[PubMed][Google Scholar]
• 1302. Uchigata Y, Yamamoto H, Kawamura A, Okamoto HProtection by superoxide dismutase, catalase, poly(ADP-ribose) synthetase inhibitors against alloxan- and streptozotocin-induced islet DNA strand breaks and against the inhibition of proinsulin synthesis. J Biol Chem. 1982;257:6084–6088.[PubMed][Google Scholar]
• 1303. Ungvari Z, Csiszar A, Bagi Z, Koller AImpaired nitric oxide-mediated flow-induced coronary dilation in hyperhomocysteinemia: morphological and functional evidence for increased peroxynitrite formation. Am J Pathol. 2002;161:145–153.[Google Scholar]
• 1304. Ungvari Z, Csiszar A, Huang A, Kaminski PM, Wolin MS, Koller AHigh pressure induces superoxide production in isolated arteries via protein kinase C-dependent activation of NAD(P)H oxidase. Circulation. 2003;108:1253–1258.[PubMed][Google Scholar]
• 1305. Ungvari Z, Csiszar A, Kaminski PM, Wolin MS, Koller AChronic high pressure-induced arterial oxidative stress: involvement of protein kinase C-dependent NAD(P)H oxidase and local renin-angiotensin system. Am J Pathol. 2004;165:219–226.[Google Scholar]
• 1306. Ungvari Z, Gupte SA, Recchia FA, Batkai S, Pacher PRole of oxidative-nitrosative stress and downstream pathways in various forms of cardiomyopathy and heart failure. Curr Vasc Pharmacol. 2005;3:221–229.[Google Scholar]
• 1307. Upmacis RK, Deeb RS, Resnick MJ, Lindenbaum R, Gamss C, Mittar D, Hajjar DPInvolvement of the mitogen-activated protein kinase cascade in peroxynitrite-mediated arachidonic acid release in vascular smooth muscle cells. Am J Physiol Cell Physiol. 2004;286:C1271–C1280.[PubMed][Google Scholar]
• 1308. Valdez LB, Zaobornyj T, Alvarez S, Bustamante J, Costa LE, Boveris A. Heart mitochondrial nitric oxide synthase. Effects of hypoxia and aging. Mol Aspects Med. 2004;25:49–59.[PubMed]
• 1309. Valentine JS, Doucette PA, Potter SZCopper-zinc superoxide dismutase and amyotrophic lateral sclerosis. Annu Rev Biochem. 2005;74:563–593.[PubMed][Google Scholar]
• 1310. Vallet P, Charnay Y, Steger K, Ogier-Denis E, Kovari E, Herrmann F, Michel JP, Szanto INeuronal expression of the NADPH oxidase NOX4, its regulation in mouse experimental brain ischemia. Neuroscience. 2005;132:233–238.[PubMed][Google Scholar]
• 1311. Van der Loo B, Labugger R, Skepper JN, Bachschmid M, Kilo J, Powell JM, Palacios-Callender M, Erusalimsky JD, Quaschning T, Malinski T, Gygi D, Ullrich V, Luscher TFEnhanced peroxynitrite formation is associated with vascular aging. J Exp Med. 2000;192:1731–1744.[Google Scholar]
• 1312. Van der Veen RC, Hinton DR, Incardonna F, Hofman FMExtensive peroxynitrite activity during progressive stages of central nervous system inflammation. J Neuroimmunol. 1997;77:1–7.[PubMed][Google Scholar]
• 1313. Van der Veen RC, Roberts LJContrasting roles for nitric oxide and peroxynitrite in the peroxidation of myelin lipids. J Neuro-immunol. 1999;95:1–7.[PubMed][Google Scholar]
• 1314. Van der Vliet A, Eiserich JP, Halliwell B, Cross CE. Formation of reactive nitrogen species during peroxidase-catalyzed oxidation of nitrite. A potential additional mechanism of nitric oxide-dependent toxicity. J Biol Chem. 1997;272:7617–7625.[PubMed]
• 1315. Van der Vliet A, Eiserich JP, Shigenaga MK, Cross CEReactive nitrogen species and tyrosine nitration in the respiratory tract: epiphenomena or a pathobiologic mechanism of disease? Am J Respir Crit Care Med. 1999;160:1–9.[PubMed][Google Scholar]
• 1316. Van der Vliet A, Hristova M, Cross CE, Eiserich JP, Goldkorn TPeroxynitrite induces covalent dimerization of epidermal growth factor receptors in A431 epidermoid carcinoma cells. J Biol Chem. 1998;273:31860–31866.[PubMed][Google Scholar]
• 1317. Vanderheyden M, Bartunek J, Knaapen M, Kockx M, De Bruyne B, Goethals MHemodynamic effects of inducible nitric oxide synthase and nitrotyrosine generation in heart failure. J Heart Lung Transplant. 2004;23:723–728.[PubMed][Google Scholar]
• 1318. Vanhoutte PMEndothelial dysfunction in hypertension. J Hypertens Suppl. 1996;14:S83–S93.[PubMed][Google Scholar]
• 1319. Varadarajan R, Golden-Mason L, Young L, McLoughlin P, Nolan N, McEntee G, Traynor O, Geoghegan J, Hegarty JE, O’Farrelly CNitric oxide in early ischaemia reperfusion injury during human orthotopic liver transplantation. Transplantation. 2004;78:250–256.[PubMed][Google Scholar]
• 1320. Varela M, Herrera M, Garvin JLInhibition of Na-K-ATPase in thick ascending limbs by NO depends on O₂ ^{and is diminished by a high-salt diet.} Am J Physiol Renal Physiol. 2004;287:F224–F230.[PubMed][Google Scholar]
• 1321. Vargas MR, Pehar M, Cassina P, Beckman JS, Barbeito LIncreased glutathione biosynthesis by Nrf2 activation in astrocytes prevents p75NTR-dependent motor neuron apoptosis. J Neurochem. 2006;97:687–696.[PubMed][Google Scholar]
• 1322. Vargas MR, Pehar M, Cassina P, Estevez AG, Beckman JS, Barbeito LStimulation of nerve growth factor expression in astrocytes by peroxynitrite. In Vivo. 2004;18:269–274.[PubMed][Google Scholar]
• 1323. Vaziri ND, Liang K, Ding YIncreased nitric oxide inactivation by reactive oxygen species in lead-induced hypertension. Kidney Int. 1999;56:1492–1498.[PubMed][Google Scholar]
• 1324. Vaziri ND, Ni ZExpression of NOX-I, gp91phox, p47phox and P67phox in the aorta segments above and below coarctation. Biochim Biophys Acta. 2005;1723:321–327.[PubMed][Google Scholar]
• 1325. Vaziri ND, Ni Z, Oveisi F, Liang K, Pandian REnhanced nitric oxide inactivation and protein nitration by reactive oxygen species in renal insufficiency. Hypertension. 2002;39:135–141.[PubMed][Google Scholar]
• 1326. Vieira HL, Belzacq AS, Haouzi D, Bernassola F, Cohen I, Jacotot E, Ferri KF, El Hamel C, Bartle LM, Melino G, Brenner C, Goldmacher V, Kroemer GThe adenine nucleotide translocator: a target of nitric oxide, peroxynitrite, 4-hydroxynonenal. Oncogene. 2001;20:4305–4316.[PubMed][Google Scholar]
• 1327. Viera L, Ye Y, Estévez A, Beckman J. Immunohistochemical methods to detect nitrotyrosine. In: Packer L, editor. Nitric Oxide: Biological and Antioxidant Activities. San Diego, CA: Academic; 1998. pp. 373–381. [PubMed]
• 1328. Villa LM, Salas E, Darley-Usmar VM, Radomski MW, Moncada SPeroxynitrite induces both vasodilatation and impaired vascular relaxation in the isolated perfused rat heart. Proc Natl Acad Sci USA. 1994;91:12383–12387.[Google Scholar]
• 1329. Viner RI, Huhmer AF, Bigelow DJ, Schoneich CThe oxidative inactivation of sarcoplasmic reticulum Ca(2+)-ATPase by peroxynitrite. Free Radic Res. 1996;24:243–259.[PubMed][Google Scholar]
• 1330. Viner RI, Williams TD, Schoneich CPeroxynitrite modification of protein thiols: oxidation, nitrosylation, S-glutathiolation of functionally important cysteine residue(s) in the sarcoplasmic reticulum Ca-ATPase. Biochemistry. 1999;38:12408–12415.[PubMed][Google Scholar]
• 1331. Virag LStructure and function of poly(ADP-ribose) polymerase-1: role in oxidative stress-related pathologies. Curr Vasc Pharmacol. 2005;3:209–214.[PubMed][Google Scholar]
• 1332. Virag L, Szabo CBCL-2 protects peroxynitrite-treated thymocytes from poly(ADP-ribose) synthase (PARS)-independent apoptotic but not from PARS-mediated necrotic cell death. Free Radic Biol Med. 2000;29:704–713.[PubMed][Google Scholar]
• 1333. Virag L, Szabo CThe therapeutic potential of poly(ADP-ribose) polymerase inhibitors. Pharmacol Rev. 2002;54:375–429.[PubMed][Google Scholar]
• 1334. Virag L, Szabo E, Gergely P, Szabo CPeroxynitrite-induced cytotoxicity: mechanism and opportunities for intervention. Toxicol Lett. 2003;140–141:113–124.[PubMed][Google Scholar]
• 1335. Virdis A, Neves MF, Amiri F, Viel E, Touyz RM, Schiffrin ELSpironolactone improves angiotensin-induced vascular changes and oxidative stress. Hypertension. 2002;40:504–510.[PubMed][Google Scholar]
• 1336. Von der Leyen HE, Gibbons GH, Morishita R, Lewis NP, Zhang L, Nakajima M, Kaneda Y, Cooke JP, Dzau VJGene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene. Proc Natl Acad Sci USA. 1995;92:1137–1141.[Google Scholar]
• 1337. Walder CE, Green SP, Darbonne WC, Mathias J, Rae J, Dinauer MC, Curnutte JT, Thomas GRIschemic stroke injury is reduced in mice lacking a functional NADPH oxidase. Stroke. 1997;28:2252–2258.[PubMed][Google Scholar]
• 1338. Waldow T, Alexiou K, Witt W, Wagner FM, Kappert U, Knaut M, Matschke KProtection of lung tissue against ischemia/reper-fusion injury by preconditioning with inhaled nitric oxide in an in situ pig model of normothermic pulmonary ischemia. Nitric Oxide. 2004;10:195–201.[PubMed][Google Scholar]
• 1339. Walford GA, Moussignac RL, Scribner AW, Loscalzo J, Leopold JAHypoxia potentiates nitric oxide-mediated apoptosis in endothelial cells via peroxynitrite-induced activation of mitochondria-dependent and -independent pathways. J Biol Chem. 2004;279:4425–4432.[PubMed][Google Scholar]
• 1340. Wallace MN, Geddes JG, Farquhar DA, Masson MRNitric oxide synthase in reactive astrocytes adjacent to beta-amyloid plaques. Exp Neurol. 1997;144:266–272.[PubMed][Google Scholar]
• 1341. Wang HC, Zhang HF, Guo WY, Su H, Zhang KR, Li QX, Yan W, Ma XL, Lopez BL, Christopher TA, Gao FHypoxic postconditioning enhances the survival and inhibits apoptosis of cardio-myocytes following reoxygenation: role of peroxynitrite formation. Apoptosis. 2006;11:1453–1460.[PubMed][Google Scholar]
• 1342. Wang HD, Xu S, Johns DG, Du Y, Quinn MT, Cayatte AJ, Cohen RARole of NADPH oxidase in the vascular hypertrophic and oxidative stress response to angiotensin II in mice. Circ Res. 2001;88:947–953.[PubMed][Google Scholar]
• 1343. Wang JS, Singh H, Zhang F, Ishizuka T, Deng H, Kemp R, Wolin MS, Hintze TH, Abraham NG, Nasjletti A, Laniado-Schwartzman MEndothelial dysfunction and hypertension in rats transduced with CYP4A2 adenovirus. Circ Res. 2006;98:962–969.[PubMed][Google Scholar]
• 1344. Wang P, Zweier JL. Measurement of nitric oxide and peroxynitrite generation in the postischemic heart. Evidence for peroxynitrite-mediated reperfusion injury. J Biol Chem. 1996;271:29223–29230.[PubMed]
• 1345. Wang W, Sawicki G, Schulz RPeroxynitrite-induced myocardial injury is mediated through matrix metalloproteinase-2. Cardiovasc Res. 2002;53:165–174.[PubMed][Google Scholar]
• 1346. Wang X, Feuerstein GZRole of immune and inflammatory mediators in CNS injury. Drug News Perspect. 2000;13:133–140.[PubMed][Google Scholar]
• 1347. Wang Y, Lawson JA, Jaeschke HDifferential effect of 2-aminoethyl-isothiourea, an inhibitor of the inducible nitric oxide synthase, on microvascular blood flow and organ injury in models of hepatic ischemia-reperfusion and endotoxemia. Shock. 1998;10:20–25.[PubMed][Google Scholar]
• 1348. Watanabe H, Muramatsu Y, Kurosaki R, Michimata M, Matsubara M, Imai Y, Araki TProtective effects of neuronal nitric oxide synthase inhibitor in mouse brain against MPTP neurotoxicity: an immunohistological study. Eur Neuropsychopharmacol. 2004;14:93–104.[PubMed][Google Scholar]
• 1349. Wattanapitayakul SK, Weinstein DM, Holycross BJ, Bauer JAEndothelial dysfunction and peroxynitrite formation are early events in angiotensin-induced cardiovascular disorders. FASEB J. 2000;14:271–278.[PubMed][Google Scholar]
• 1350. Watts JA, Grattan RM, Whitlow BS, Kline JAActivation of poly(ADP-ribose) polymerase in severe hemorrhagic shock and resuscitation. Am J Physiol Gastrointest Liver Physiol. 2001;281:G498–G506.[PubMed][Google Scholar]
• 1351. Weber M, Lauer N, Mulsch A, Kojda GThe effect of peroxynitrite on the catalytic activity of soluble guanylyl cyclase. Free Radic Biol Med. 2001;31:1360–1367.[PubMed][Google Scholar]
• 1352. Wei XQ, Charles IG, Smith A, Ure J, Feng GJ, Huang FP, Xu D, Muller W, Moncada S, Liew FYAltered immune responses in mice lacking inducible nitric oxide synthase. Nature. 1995;375:408–411.[PubMed][Google Scholar]
• 1353. Weinberg JBNitric oxide production and nitric oxide synthase type 2 expression by human mononuclear phagocytes: a review. Mol Med. 1998;4:557–591.[Google Scholar]
• 1354. Weinberg JB, Granger DL, Pisetsky DS, Seldin MF, Misukonis MA, Mason SN, Pippen AM, Ruiz P, Wood ER, Gilkeson GSThe role of nitric oxide in the pathogenesis of spontaneous murine autoimmune disease: increased nitric oxide production and nitric oxide synthase expression in MRL-lpr/lpr mice, reduction of spontaneous glomerulonephritis and arthritis by orally administered N^{-monomethyl-L-arginine.} J Exp Med. 1994;179:651–660.[Google Scholar]
• 1355. Weinstein DM, Mihm MJ, Bauer JACardiac peroxynitrite formation and left ventricular dysfunction following doxorubicin treatment in mice. J Pharmacol Exp Ther. 2000;294:396–401.[PubMed][Google Scholar]
• 1356. Weiss JN, Korge P, Honda HM, Ping PRole of the mitochondrial permeability transition in myocardial disease. Circ Res. 2003;93:292–301.[PubMed][Google Scholar]
• 1357. Weksler ME, Gouras G, Relkin NR, Szabo PThe immune system, amyloid-beta peptide, Alzheimer’s disease. Immunol Rev. 2005;205:244–256.[PubMed][Google Scholar]
• 1358. Wendt S, Schlattner U, Wallimann T. Differential effects of peroxynitrite on human mitochondrial creatine kinase isoenzymes. Inactivation, octamer destabilization, identification of involved residues. J Biol Chem. 2003;278:1125–1130.[PubMed]
• 1359. Weydt P, Moller TNeuroinflammation in the pathogenesis of amyotrophic lateral sclerosis. Neuroreport. 2005;16:527–531.[PubMed][Google Scholar]
• 1360. Whalen MJ, Clark RS, Dixon CE, Robichaud P, Marion DW, Vagni V, Graham SH, Virag L, Hasko G, Stachlewitz R, Szabo C, Kochanek PMReduction of cognitive and motor deficits after traumatic brain injury in mice deficient in poly(ADP-ribose) polymerase. J Cereb Blood Flow Metab. 1999;19:835–842.[PubMed][Google Scholar]
• 1361. Wheeler MD, Katuna M, Smutney OM, Froh M, Dikalova A, Mason RP, Samulski RJ, Thurman RGComparison of the effect of adenoviral delivery of three superoxide dismutase genes against hepatic ischemia-reperfusion injury. Hum Gene Ther. 2001;12:2167–2177.[PubMed][Google Scholar]
• 1362. Wheeler-Jones CPCell signalling in the cardiovascular system: an overview. Heart. 2005;91:1366–1374.[Google Scholar]
• 1363. White BC, Sullivan JM, DeGracia DJ, O’Neil BJ, Neumar RW, Grossman LI, Rafols JA, Krause GSBrain ischemia and reper-fusion: molecular mechanisms of neuronal injury. J Neurol Sci. 2000;179:1–33.[PubMed][Google Scholar]
• 1364. White CR, Brock TA, Chang LY, Crapo J, Briscoe P, Ku D, Bradley WA, Gianturco SH, Gore J, Freeman BA, Tarpey MMSuperoxide and peroxynitrite in atherosclerosis. Proc Natl Acad Sci USA. 1994;91:1044–1048.[Google Scholar]
• 1365. White CR, Moellering D, Patel RP, Kirk M, Barnes S, Darley-Usmar VMFormation of the NO donors glyceryl mononitrate and glyceryl mononitrite from the reaction of peroxynitrite with glycerol. Biochem J. 1997;328:517–524.[Google Scholar]
• 1366. Whiteman M, Armstrong JS, Cheung NS, Siau JL, Rose P, Schantz JT, Jones DP, Halliwell BPeroxynitrite mediates calcium-dependent mitochondrial dysfunction and cell death via activation of calpains. FASEB J. 2004;18:1395–1397.[PubMed][Google Scholar]
• 1367. Whiteman M, Halliwell B. Protection against peroxynitrite-dependent tyrosine nitration and alpha 1-antiproteinase inactivation by ascorbic acid. A comparison with other biological antioxidants. Free Radic Res. 1996;25:275–283.[PubMed]
• 1368. Whiteman M, Kaur H, Halliwell BProtection against peroxynitrite dependent tyrosine nitration and alpha 1-antiproteinase inactivation by some anti-inflammatory drugs and by the antibiotic tetracycline. Ann Rheum Dis. 1996;55:383–387.[Google Scholar]
• 1369. Whiteman M, Tritschler H, Halliwell BProtection against peroxynitrite-dependent tyrosine nitration and alpha 1-antiproteinase inactivation by oxidized and reduced lipoic acid. FEBS Lett. 1996;379:74–76.[PubMed][Google Scholar]
• 1370. Wild S, Roglic G, Green A, Sicree R, King HGlobal prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047–1053.[PubMed][Google Scholar]
• 1371. Wildhirt SM, Weis M, Schulze C, Conrad N, Pehlivanli S, Rieder G, Enders G, von Scheidt W, Reichart BExpression of endomyocardial nitric oxide synthase and coronary endothelial function in human cardiac allografts. Circulation. 2001;104(Suppl I):I-336–I-343.[PubMed][Google Scholar]
• 1372. Willerson JT, Kereiakes DJEndothelial dysfunction. Circulation. 2003;108:2060–2061.[PubMed][Google Scholar]
• 1373. Willmot M, Gibson C, Gray L, Murphy S, Bath PNitric oxide synthase inhibitors in experimental ischemic stroke and their effects on infarct size and cerebral blood flow: a systematic review. Free Radic Biol Med. 2005;39:412–425.[PubMed][Google Scholar]
• 1374. Willmot M, Gray L, Gibson C, Murphy S, Bath PMA systematic review of nitric oxide donors and L-arginine in experimental stroke; effects on infarct size and cerebral blood flow. Nitric Oxide. 2005;12:141–149.[PubMed][Google Scholar]
• 1375. Wink D, Kasprzak K, Maragos C, Elespuru R, Misra M, Dunams T, Cebula T, Koch W, Andrews A, Allen J, Keefer LDNA deaminating ability and genotoxicity of nitric oxide and its progenitors. Science. 1991;254:1001–1003.[PubMed][Google Scholar]
• 1376. Wink DA, Darbyshire JF, Nims RW, Saavedra JE, Ford PCReactions of the bioregulatory agent nitric oxide in oxygenated aqueous media: determination of the kinetics for oxidation and nitrosation by intermediates generated in the NO/O₂ reaction. Chem Res Toxicol. 1993;6:23–27.[PubMed][Google Scholar]
• 1377. Wise DL, Houghton GDiffusion coefficients of neon, krypton, xenon, carbon monoxide and nitric oxide in water at 10–60°C. Chem Eng Sci. 1968;23:1211–1216.[PubMed][Google Scholar]
• 1378. Wolin MSInteractions of oxidants with vascular signaling systems. Arterioscler Thromb Vasc Biol. 2000;20:1430–1442.[PubMed][Google Scholar]
• 1379. Wolin MSLoss of vascular regulation by soluble guanylate cyclase is emerging as a key target of the hypertensive disease process. Hypertension. 2005;45:1068–1069.[PubMed][Google Scholar]
• 1380. Wolin MSReactive oxygen species and vascular signal transduction mechanisms. Microcirculation. 1996;3:1–17.[PubMed][Google Scholar]
• 1381. Wolin MS, Ahmad M, Gupte SAOxidant and redox signaling in vascular oxygen sensing mechanisms: basic concepts, current controversies, potential importance of cytosolic NADPH. Am J Physiol Lung Cell Mol Physiol. 2005;289:L159–L173.[PubMed][Google Scholar]
• 1382. Wolin MS, Ahmad M, Gupte SAThe sources of oxidative stress in the vessel wall. Kidney Int. 2005;67:1659–1661.[PubMed][Google Scholar]
• 1383. Wolin MS, Xie YW, Hintze THNitric oxide as a regulator of tissue oxygen consumption. Curr Opin Nephrol Hypertens. 1999;8:97–103.[PubMed][Google Scholar]
• 1384. Wong NK, Strong MJNitric oxide synthase expression in cervical spinal cord in sporadic amyotrophic lateral sclerosis. Eur J Cell Biol. 1998;77:338–343.[PubMed][Google Scholar]
• 1385. Wood J, Garthwaite JModels of the diffusional spread of nitric oxide: implications for neural nitric oxide signalling and its pharmacological properties. Neuropharmacology. 1994;33:1235–1244.[PubMed][Google Scholar]
• 1386. Woodman CR, Price EM, Laughlin MHAging induces muscle-specific impairment of endothelium-dependent dilation in skeletal muscle feed arteries. J Appl Physiol. 2002;93:1685–1690.[PubMed][Google Scholar]
• 1387. Woolum JC, Tiezzi E, Commoner BElectron spin resonance of iron-nitric oxide complexes with amino acids, peptides and proteins. Biochim Biophys Acta. 1968;160:311–320.[PubMed][Google Scholar]
• 1388. Wu GNitric oxide synthesis and the effect of aminoguanidine and N^{-monomethyl-L-arginine on the onset of diabetes in the spontaneously diabetic BB rat.} Diabetes. 1995;44:360–364.[PubMed][Google Scholar]
• 1389. Wu M, Pritchard KA, Jr, Kaminski PM, Fayngersh RP, Hintze TH, Wolin MSInvolvement of nitric oxide and nitrosothiols in relaxation of pulmonary arteries to peroxynitrite. Am J Physiol Heart Circ Physiol. 1994;266:H2108–H2113.[PubMed][Google Scholar]
• 1390. Wu W, Chen Y, Hazen SL. Eosinophil peroxidase nitrates protein tyrosyl residues. Implications for oxidative damage by nitrating intermediates in eosinophilic inflammatory disorders. J Biol Chem. 1999;274:25933–25944.[PubMed]
• 1391. Wykes V, Bellamy TC, Garthwaite JKinetics of nitric oxide-cyclic GMP signalling in CNS cells and its possible regulation by cyclic GMP. J Neurochem. 2002;83:37–47.[PubMed][Google Scholar]
• 1392. Xia Y, Dawson VL, Dawson TM, Snyder SH, Zweier JLNitric oxide synthase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cellular injury. Proc Natl Acad Sci USA. 1996;93:6770–6774.[Google Scholar]
• 1393. Xia Y, Zweier JLSuperoxide and peroxynitrite generation from inducible nitric oxide synthase in macrophages. Proc Natl Acad Sci USA. 1997;94:6954–6958.[Google Scholar]
• 1394. Xie J, Roddy P, Rife TK, Murad F, Young APTwo closely linked but separable promoters for human neuronal nitric oxide synthase gene transcription. Proc Natl Acad Sci USA. 1995;92:1242–1246.[Google Scholar]
• 1395. Xie QW, Cho HJ, Calaycay J, Mumford RA, Swiderek KM, Lee TD, Ding A, Troso T, Nathan CCloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science. 1992;256:225–228.[PubMed][Google Scholar]
• 1396. Xie YW, Kaminski PM, Wolin MSInhibition of rat cardiac muscle contraction and mitochondrial respiration by endogenous peroxynitrite formation during posthypoxic reoxygenation. Circ Res. 1998;82:891–897.[PubMed][Google Scholar]
• 1397. Xu S, Ying J, Jiang B, Guo W, Adachi T, Sharov V, Lazar H, Menzoian J, Knyushko TV, Bigelow D, Schoneich C, Cohen RADetection of sequence-specific tyrosine nitration of manganese SOD and SERCA in cardiovascular disease and aging. Am J Physiol Heart Circ Physiol. 2006;290:H2220–H2227.[PubMed][Google Scholar]
• 1398. Xu Y, Armstrong SJ, Arenas IA, Pehowich DJ, Davidge STCardioprotection by chronic estrogen or superoxide dismutase mimetic treatment in the aged female rat. Am J Physiol Heart Circ Physiol. 2004;287:H165–H171.[PubMed][Google Scholar]
• 1399. Xu Y, Huang S, Liu ZG, Han JPoly(ADP-ribose) polymerase-1 signaling to mitochondria in necrotic cell death requires RIP1/TRAF2-mediated JNK1 activation. J Biol Chem. 2006;281:8788–8795.[PubMed][Google Scholar]
• 1400. Yabe Y, Kobayashi N, Nishihashi T, Takahashi R, Nishikawa M, Takakura Y, Hashida MPrevention of neutrophil-mediated hepatic ischemia/reperfusion injury by superoxide dismutase and catalase derivatives. J Pharmacol Exp Ther. 2001;298:894–899.[PubMed][Google Scholar]
• 1401. Yamaguchi T, Yoshida N, Ichiishi E, Sugimoto N, Naito Y, Yoshikawa TDiffering effects of two nitric oxide synthase inhibitors on experimental colitis. Hepatogastroenterology. 2001;48:118–122.[PubMed][Google Scholar]
• 1402. Yamaguchi Y, Yoshikawa N, Kagota S, Nakamura K, Haginaka J, Kunitomo MElevated circulating levels of markers of oxidative-nitrative stress and inflammation in a genetic rat model of metabolic syndrome. Nitric Oxide. In press. [[PubMed]
• 1403. Yamakura F, Ikeda KModification of tryptophan and tryptophan residues in proteins by reactive nitrogen species. Nitric Oxide. 2006;14:152–161.[PubMed][Google Scholar]
• 1404. Yamakura F, Matsumoto T, Ikeda K, Taka H, Fujimura T, Murayama K, Watanabe E, Tamaki M, Imai T, Takamori K0Nitrated and oxidized products of a single tryptophan residue in human Cu,Zn-superoxide dismutase treated with either peroxynitrite-carbon dioxide or myeloperoxidase-hydrogen peroxidenitrite. J Biochem. 2005;138:57–69.[PubMed][Google Scholar]
• 1405. Yamakura F, Taka H, Fujimura T, Murayama KInactivation of human manganese-superoxide dismutase by peroxynitrite is caused by exclusive nitration of tyrosine 34 to 3-nitrotyrosine. J Biol Chem. 1998;273:14085–14089.[PubMed][Google Scholar]
• 1406. Yamashita H, Akamine S, Sumida Y, Inoue M, Sawada T, Nagayasu T, Oka TInhaled nitric oxide attenuates apoptosis in ischemia-reperfusion injury of the rabbit lung. Ann Thorac Surg. 2004;78:292–297.[PubMed][Google Scholar]
• 1407. Yamashita T, Ando Y, Obayashi K, Uchino M, Ando MChanges in nitrite and nitrate (NO2−/NO3−) levels in cerebrospinal fluid of patients with multiple sclerosis. J Neurol Sci. 1997;153:32–34.[PubMed][Google Scholar]
• 1408. Yan C, Huang A, Wu Z, Kaminski PM, Wolin MS, Hintze TH, Kaley G, Sun DIncreased superoxide leads to decreased flow-induced dilation in resistance arteries of Mn-SOD-deficient mice. Am J Physiol Heart Circ Physiol. 2005;288:H2225–H2231.[Google Scholar]
• 1409. Yang B, Larson DF, Watson RRModulation of iNOS activity in age-related cardiac dysfunction. Life Sci. 2004;75:655–667.[PubMed][Google Scholar]
• 1410. Yang G, Chan PH, Chen J, Carlson E, Chen SF, Weinstein P, Epstein CJ, Kamii HHuman copper-zinc superoxide dismutase transgenic mice are highly resistant to reperfusion injury after focal cerebral ischemia. Stroke. 1994;25:165–170.[PubMed][Google Scholar]
• 1411. Yang H, Shi M, Story J, Richardson A, Guo ZFood restriction attenuates age-related increase in the sensitivity of endothelial cells to oxidized lipids. J Gerontol A Biol Sci Med Sci. 2004;59:316–323.[PubMed][Google Scholar]
• 1412. Yardim-Akaydin S, Kesimer M, Imren E, Sepici A, Simsek B, Torun MUrate oxidation during percutaneous transluminal coronary angioplasty and thrombolysis in patients with coronary artery disease. Clin Chim Acta. 2005;362:131–137.[PubMed][Google Scholar]
• 1413. Yasmin W, Strynadka KD, Schulz RGeneration of peroxynitrite contributes to ischemia-reperfusion injury in isolated rat hearts. Cardiovasc Res. 1997;33:422–432.[PubMed][Google Scholar]
• 1414. Ye YZ, Strong M, Huang ZQ, Beckman JSAntibodies that recognize nitrotyrosine. Methods Enzymol. 1996;269:201–209.[PubMed][Google Scholar]
• 1415. Yellon DM, Hausenloy DJRealizing the clinical potential of ischemic preconditioning and postconditioning. Nat Clin Pract Cardiovasc Med. 2005;2:568–575.[PubMed][Google Scholar]
• 1416. Yokozawa T, Chen CP, Rhyu DY, Tanaka T, Park JC, Kitani KPotential of sanguiin H-6 against oxidative damage in renal mitochondria and apoptosis mediated by peroxynitrite in vivo. Nephron. 2002;92:133–141.[PubMed][Google Scholar]
• 1417. Yokozawa T, Ishida A, Kashiwada Y, Cho EJ, Kim HY, Ikeshiro YCoptidis Rhizoma: protective effects against peroxynitrite-induced oxidative damage and elucidation of its active components. J Pharm Pharmacol. 2004;56:547–556.[PubMed][Google Scholar]
• 1418. Yokozawa T, Rhyu DY, Cho EJ(−)-Epicatechin 3-O-gallate ameliorates the damages related to peroxynitrite production by mechanisms distinct from those of other free radical inhibitors. J Pharm Pharmacol. 2004;56:231–239.[PubMed][Google Scholar]
• 1419. Yonekura Y, Koshiishi I, Yamada K, Mori A, Uchida S, Nakamura T, Utsumi HAssociation between the expression of inducible nitric oxide synthase by chondrocytes and its nitric oxide-generating activity in adjuvant arthritis in rats. Nitric Oxide. 2003;8:164–169.[PubMed][Google Scholar]
• 1420. Yoo K, Choi JW, Choi MS, Ryu MK, Park GH, Jeon MJ, Ko KHMitogen-activated protein kinases (MAPKs) mediate SIN-1/glucose deprivation-induced death in rat primary astrocytes. Arch Pharm Res. 2005;28:942–947.[PubMed][Google Scholar]
• 1421. Yoshida T, Limmroth V, Irikura K, Moskowitz MAThe NOS inhibitor, 7-nitroindazole, decreases focal infarct volume but not the response to topical acetylcholine in pial vessels. J Cereb Blood Flow Metab. 1994;14:924–929.[PubMed][Google Scholar]
• 1422. Yu H, Venkatarangan L, Wishnok JS, Tannenbaum SRQuantitation of four guanine oxidation products from reaction of DNA with varying doses of peroxynitrite. Chem Res Toxicol. 2005;18:1849–1857.[Google Scholar]
• 1423. Yu J, deMuinck ED, Zhuang Z, Drinane M, Kauser K, Rubanyi GM, Qian HS, Murata T, Escalante B, Sessa WCEndothelial nitric oxide synthase is critical for ischemic remodeling, mural cell recruitment, blood flow reserve. Proc Natl Acad Sci USA. 2005;102:10999–11004.[Google Scholar]
• 1424. Yu SW, Wang H, Poitras MF, Coombs C, Bowers WJ, Federoff HJ, Poirier GG, Dawson TM, Dawson VLMediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor. Science. 2002;297:259–263.[PubMed][Google Scholar]
• 1425. Yu ZF, Bruce-Keller AJ, Goodman Y, Mattson MPUric acid protects neurons against excitotoxic and metabolic insults in cell culture, against focal ischemic brain injury in vivo. J Neurosci Res. 1998;53:613–625.[PubMed][Google Scholar]
• 1426. Yue G, Lai PS, Yin K, Sun FF, Nagele RG, Liu X, Linask KK, Wang C, Lin KT, Wong PYColon epithelial cell death in 2,4,6-trinitrobenzenesulfonic acid-induced colitis is associated with increased inducible nitric-oxide synthase expression and peroxynitrite production. J Pharmacol Exp Ther. 2001;297:915–925.[PubMed][Google Scholar]
• 1427. Yuen EC, Gunther EC, Bothwell MNitric oxide activation of TrkB through peroxynitrite. Neuroreport. 2000;11:3593–3597.[PubMed][Google Scholar]
• 1428. Zafiriou O, McFarland MDetermination of trace levels of nitric oxide in aqueous solution. Anal Chem. 1980;52:1662–1667.[PubMed][Google Scholar]
• 1429. Zahmatkesh M, Kadkhodaee M, Arab HA, Shams SEffects of co-administration of an iNOS inhibitor with a broad-spectrum reactive species scavenger in rat renal ischemia/reperfusion injury. Nephron Exp Nephrol. 2006;103:119–125.[PubMed][Google Scholar]
• 1430. Zhang C, Walker LM, Mayeux PRRole of nitric oxide in lipopolysaccharide-induced oxidant stress in the rat kidney. Biochem Pharmacol. 2000;59:203–209.[PubMed][Google Scholar]
• 1431. Zhang F, Slungaard A, Vercellotti GM, Iadecola CSuperoxide-dependent cerebrovascular effects of homocysteine. Am J Physiol Regul Integr Comp Physiol. 1998;274:R1704–R1711.[PubMed][Google Scholar]
• 1432. Zhang F, White JG, Iadecola CNitric oxide donors increase blood flow and reduce brain damage in focal ischemia: evidence that nitric oxide is beneficial in the early stages of cerebral ischemia. J Cereb Blood Flow Metab. 1994;14:217–226.[PubMed][Google Scholar]
• 1433. Zhang L, Dawson VL, Dawson TMRole of nitric oxide in Parkinson’s disease. Pharmacol Ther. 2006;109:33–41.[PubMed][Google Scholar]
• 1434. Zhang P, Wang YZ, Kagan E, Bonner JCPeroxynitrite targets the epidermal growth factor receptor, Raf-1, MEK independently to activate MAPK. J Biol Chem. 2000;275:22479–22486.[PubMed][Google Scholar]
• 1435. Zhang R, Ma J, Xia M, Zhu H, Ling WMild hyperhomocysteinemia induced by feeding rats diets rich in methionine or deficient in folate promotes early atherosclerotic inflammatory processes. J Nutr. 2004;134:825–830.[PubMed][Google Scholar]
• 1436. Zhang X, Chen J, Graham SH, Du L, Kochanek PM, Draviam R, Guo F, Nathaniel PD, Szabo C, Watkins SC, Clark RSIntranuclear localization of apoptosis-inducing factor (AIF) and large scale DNA fragmentation after traumatic brain injury in rats and in neuronal cultures exposed to peroxynitrite. J Neurochem. 2002;82:181–191.[PubMed][Google Scholar]
• 1437. Zhang Y, Bissing JW, Xu L, Ryan AJ, Martin SM, Miller FJ, Jr, Kregel KC, Buettner GR, Kerber RENitric oxide synthase inhibitors decrease coronary sinus-free radical concentration and ameliorate myocardial stunning in an ischemia-reperfusion model. J Am Coll Cardiol. 2001;38:546–554.[PubMed][Google Scholar]
• 1438. Zhang Y, Davies LR, Martin SM, Coddington WJ, Miller FJ, Jr, Buettner GR, Kerber REThe nitric oxide donor S-nitroso-N-acetylpenicillamine (SNAP) increases free radical generation and degrades left ventricular function after myocardial ischemia-reperfusion. Resuscitation. 2003;59:345–352.[Google Scholar]
• 1439. Zhang Y, Wang H, Li J, Dong L, Xu P, Chen W, Neve RL, Volpe JJ, Rosenberg PAIntracellular zinc release and ERK phosphorylation are required upstream of 12-lipoxygenase activation in peroxynitrite toxicity to mature rat oligodendrocytes. J Biol Chem. 2006;281:9460–9470.[PubMed][Google Scholar]
• 1440. Zhang Y, Wang H, Li J, Jimenez DA, Levitan ES, Aizenman E, Rosenberg PAPeroxynitrite-induced neuronal apoptosis is mediated by intracellular zinc release and 12-lipoxygenase activation. J Neurosci. 2004;24:10616–10627.[Google Scholar]
• 1441. Zhang YH, Lin JX, Vilcek JInterleukin-6 induction by tumor necrosis factor and interleukin-1 in human fibroblasts involves activation of a nuclear factor binding to a kappa B-like sequence. Mol Cell Biol. 1990;10:3818–3823.[Google Scholar]
• 1442. Zhang YJ, Xu YF, Liu YH, Yin J, Li HL, Wang Q, Wang JZPeroxynitrite induces Alzheimer-like tau modifications and accumulation in rat brain and its underlying mechanisms. FASEB J. 2006;20:1431–1442.[PubMed][Google Scholar]
• 1443. Zhang ZG, Chopp M, Gautam S, Zaloga C, Zhang RL, Schmidt HH, Pollock JS, Forstermann UUpregulation of neuronal nitric oxide synthase and mRNA, selective sparing of nitric oxide synthase-containing neurons after focal cerebral ischemia in rat. Brain Res. 1994;654:85–95.[PubMed][Google Scholar]
• 1444. Zhang ZG, Chopp M, Zaloga C, Pollock JS, Forstermann UCerebral endothelial nitric oxide synthase expression after focal cerebral ischemia in rats. Stroke. 1993;24:2016–2021.[PubMed][Google Scholar]
• 1445. Zhang ZG, Reif D, Macdonald J, Tang WX, Kamp DK, Gentile RJ, Shakespeare WC, Murray RJ, Chopp MARL 17477, a potent and selective neuronal NOS inhibitor decreases infarct volume after transient middle cerebral artery occlusion in rats. J Cereb Blood Flow Metab. 1996;16:599–604.[PubMed][Google Scholar]
• 1446. Zhao H, Joseph J, Fales HM, Sokoloski EA, Levine RL, Vasquez-Vivar J, Kalyanaraman BDetection and characterization of the product of hydroethidine and intracellular superoxide by HPLC and limitations of fluorescence. Proc Natl Acad Sci USA. 2005;102:5727–5732.[Google Scholar]
• 1447. Zhao S, Zhang Y, Gu Y, Lewis DF, Wang YHeme oxygenase-1 mediates up-regulation of adhesion molecule expression induced by peroxynitrite in endothelial cells. J Soc Gynecol Invest. 2004;11:465–471.[PubMed][Google Scholar]
• 1448. Zhao Y, Patzer A, Herdegen T, Gohlke P, Culman JActivation of cerebral peroxisome proliferator-activated receptors gamma promotes neuroprotection by attenuation of neuronal cyclooxygenase-2 overexpression after focal cerebral ischemia in rats. FASEB J. 2006;20:1162–1175.[PubMed][Google Scholar]
• 1449. Zhao ZQ, Corvera JS, Halkos ME, Kerendi F, Wang NP, Guyton RA, Vinten-Johansen JInhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol. 2003;285:H579–H588.[PubMed][Google Scholar]
• 1450. Zhou JL, Zhu XG, Ling YL, Li QMelatonin reduces peroxynitrite-induced injury in aortic smooth muscle cells. Acta Pharmacol. 2004;25:186–190.[PubMed][Google Scholar]
• 1451. Zhu C, Wang X, Qiu L, Peeters-Scholte C, Hagberg H, Blomgren KNitrosylation precedes caspase-3 activation and translocation of apoptosis-inducing factor in neonatal rat cerebral hypoxia-ischaemia. J Neurochem. 2004;90:462–471.[PubMed][Google Scholar]
• 1452. Zhu C, Xu F, Wang X, Shibata M, Uchiyama Y, Blomgren K, Hagberg HDifferent apoptotic mechanisms are activated in male and female brains after neonatal hypoxia-ischaemia. J Neurochem. 2006;96:1016–1027.[PubMed][Google Scholar]
• 1453. Zhu S, Basiouny KF, Crow JP, Matalon SCarbon dioxide enhances nitration of surfactant protein A by activated alveolar macrophages. Am J Physiol Lung Cell Mol Physiol. 2000;278:L1025–L1031.[PubMed][Google Scholar]
• 1454. Zhu T, Ling Y, Zhao RRole of peroxynitrite on airway hyperresponsiveness in asthmatic guinea-pigs. Zhonghua Jie He He Hu Xi Za Zhi. 2000;23:538–541.[PubMed][Google Scholar]
• 1455. Zielonka J, Zhao H, Xu Y, Kalyanaraman BMechanistic similarities between oxidation of hydroethidine by Fremy’s salt and superoxide: stopped-flow optical and EPR studies. Free Radic Biol Med. 2005;39:853–863.[PubMed][Google Scholar]
• 1456. Zingarelli B, Cuzzocrea S, Szabo C, Salzman ALMercapto-ethylguanidine, a combined inhibitor of nitric oxide synthase and peroxynitrite scavenger, reduces trinitrobenzene sulfonic acid-induced colonic damage in rats. J Pharmacol Exp Ther. 1998;287:1048–1055.[PubMed][Google Scholar]
• 1457. Zingarelli B, Day BJ, Crapo JD, Salzman AL, Szabo CThe potential role of peroxynitrite in the vascular contractile and cellular energetic failure in endotoxic shock. Br J Pharmacol. 1997;120:259–267.[Google Scholar]
• 1458. Zingarelli B, Hake PW, Burroughs TJ, Piraino G, O’Connor M, Denenberg AActivator protein-1 signalling pathway and apoptosis are modulated by poly(ADP-ribose) polymerase-1 in experimental colitis. Immunology. 2004;113:509–517.[Google Scholar]
• 1459. Zingarelli B, Hake PW, O’Connor M, Denenberg A, Wong HR, Kong S, Aronow BJDifferential regulation of activator protein-1 and heat shock factor-1 in myocardial ischemia and reperfusion injury: role of poly(ADP-ribose) polymerase-1. Am J Physiol Heart Circ Physiol. 2004;286:H1408–H1415.[PubMed][Google Scholar]
• 1460. Zingarelli B, Ischiropoulos H, Salzman AL, Szabo CAmelioration by mercaptoethylguanidine of the vascular and energetic failure in haemorrhagic shock in the anesthetised rat. Eur J Pharmacol. 1997;338:55–65.[PubMed][Google Scholar]
• 1461. Zingarelli B, O’Connor M, Hake PWInhibitors of poly(ADP-ribose) polymerase modulate signal transduction pathways in colitis. Eur J Pharmacol. 2003;469:183–194.[PubMed][Google Scholar]
• 1462. Zingarelli B, O’Connor M, Wong H, Salzman AL, Szabo CPeroxynitrite-mediated DNA strand breakage activates poly-adenosine diphosphate ribosyl synthetase and causes cellular energy depletion in macrophages stimulated with bacterial lipopolysaccharide. J Immunol. 1996;156:350–358.[PubMed][Google Scholar]
• 1463. Zingarelli B, Salzman AL, Szabo CProtective effects of nicotinamide against nitric oxide-mediated delayed vascular failure in endotoxic shock: potential involvement of polyADP-ribosyl synthetase. Shock. 1996;5:258–264.[PubMed][Google Scholar]
• 1464. Zingarelli B, Szabo C, Salzman ALReduced oxidative and nitrosative damage in murine experimental colitis in the absence of inducible nitric oxide synthase. Gut. 1999;45:199–209.[Google Scholar]
• 1465. Ziolo MT, Katoh H, Bers DMExpression of inducible nitric oxide synthase depresses beta-adrenergic-stimulated calcium release from the sarcoplasmic reticulum in intact ventricular myocytes. Circulation. 2001;104:2961–2966.[PubMed][Google Scholar]
• 1466. Zou M, Jendral M, Ullrich VProstaglandin endoperoxide-dependent vasospasm in bovine coronary arteries after nitration of prostacyclin synthase. Br J Pharmacol. 1999;126:1283–1292.[Google Scholar]
• 1467. Zou M, Yesilkaya A, Ullrich VPeroxynitrite inactivates prostacyclin synthase by hemethiolate-catalyzed tyrosine nitration. Drug Metab Rev. 1999;31:343–349.[PubMed][Google Scholar]
• 1468. Zou MH, Bachschmid MHypoxia-reoxygenation triggers coronary vasospasm in isolated bovine coronary arteries via tyrosine nitration of prostacyclin synthase. J Exp Med. 1999;190:135–139.[Google Scholar]
• 1469. Zou MH, Cohen R, Ullrich VPeroxynitrite and vascular endothelial dysfunction in diabetes mellitus. Endothelium. 2004;11:89–97.[PubMed][Google Scholar]
• 1470. Zou MH, Hou XY, Shi CM, Kirkpatick S, Liu F, Goldman MH, Cohen RA. Activation of 5′-AMP-activated kinase is mediated through c-Src and phosphoinositide 3-kinase activity during hypoxia-reoxygenation of bovine aortic endothelial cells. Role of peroxynitrite. J Biol Chem. 2003;278:34003–34010.[PubMed]
• 1471. Zou MH, Hou XY, Shi CM, Nagata D, Walsh K, Cohen RAModulation by peroxynitrite of Akt- and AMP-activated kinase-dependent Ser1179 phosphorylation of endothelial nitric oxide synthase. J Biol Chem. 2002;277:32552–32557.[PubMed][Google Scholar]
• 1472. Zou MH, Leist M, Ullrich VSelective nitration of prostacyclin synthase and defective vasorelaxation in atherosclerotic bovine coronary arteries. Am J Pathol. 1999;154:1359–1365.[Google Scholar]
• 1473. Zou MH, Shi C, Cohen RAHigh glucose via peroxynitrite causes tyrosine nitration and inactivation of prostacyclin synthase that is associated with thromboxane/prostaglandin H(2) receptor-mediated apoptosis and adhesion molecule expression in cultured human aortic endothelial cells. Diabetes. 2002;51:198–203.[PubMed][Google Scholar]
• 1474. Zou MH, Shi C, Cohen RAOxidation of the zinc-thiolate complex and uncoupling of endothelial nitric oxide synthase by peroxynitrite. J Clin Invest. 2002;109:817–826.[Google Scholar]
• 1475. Zou MH, Ullrich VPeroxynitrite formed by simultaneous generation of nitric oxide and superoxide selectively inhibits bovine aortic prostacyclin synthase. FEBS Lett. 1996;382:101–104.[PubMed][Google Scholar]
• 1476. Zouki C, Jozsef L, Ouellet S, Paquette Y, Filep JGPeroxynitrite mediates cytokine-induced IL-8 gene expression and production by human leukocytes. J Leukoc Biol. 2001;69:815–824.[PubMed][Google Scholar]
• 1477. Zouki C, Zhang SL, Chan JS, Filep JGPeroxynitrite induces integrin-dependent adhesion of human neutrophils to endothelial cells via activation of the Raf-1/MEK/Erk pathway. FASEB J. 2001;15:25–27.[PubMed][Google Scholar]
• 1478. Zweier JL, Fertmann J, Wei GNitric oxide and peroxynitrite in postischemic myocardium. Antioxid Redox Signal. 2001;3:11–22.[PubMed][Google Scholar]